
<html lang="en"     class="pb-page"  data-request-id="c0cba5f0-7ef9-416a-bfa2-f57ac18f36b0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.5b01357;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-5;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="A Parallel Synthesis Approach to the Identification of Novel Diheteroarylamide-Based Compounds Blocking HIV Replication: Potential Inhibitors of HIV-1 Pre-mRNA Alternative Splicing" /></meta><meta name="dc.Creator" content="Peter K.  Cheung" /></meta><meta name="dc.Creator" content="David  Horhant" /></meta><meta name="dc.Creator" content="Laura E.  Bandy" /></meta><meta name="dc.Creator" content="Maryam  Zamiri" /></meta><meta name="dc.Creator" content="Safwat M.  Rabea" /></meta><meta name="dc.Creator" content="Stoyan K.  Karagiosov" /></meta><meta name="dc.Creator" content="Mitra  Matloobi" /></meta><meta name="dc.Creator" content="Steven  McArthur" /></meta><meta name="dc.Creator" content="P. Richard  Harrigan" /></meta><meta name="dc.Creator" content="Benoit  Chabot" /></meta><meta name="dc.Creator" content="David S.  Grierson" /></meta><meta name="dc.Description" content="A 256-compound library was evaluated in an anti-HIV screen to identify structural “mimics” of the fused tetracyclic indole compound 1 (IDC16) that conserve its anti-HIV activity without associated ..." /></meta><meta name="Description" content="A 256-compound library was evaluated in an anti-HIV screen to identify structural “mimics” of the fused tetracyclic indole compound 1 (IDC16) that conserve its anti-HIV activity without associated ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 29, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01357" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01357" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01357" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01357" /></link>
        
    
    

<title>A Parallel Synthesis Approach to the Identification of Novel Diheteroarylamide-Based Compounds Blocking HIV Replication: Potential Inhibitors of HIV-1 Pre-mRNA Alternative Splicing | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01357" /></meta><meta property="og:title" content="A Parallel Synthesis Approach to the Identification of Novel Diheteroarylamide-Based Compounds Blocking HIV Replication: Potential Inhibitors of HIV-1 Pre-mRNA Alternative Splicing" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0005.jpeg" /></meta><meta property="og:description" content="A 256-compound library was evaluated in an anti-HIV screen to identify structural “mimics” of the fused tetracyclic indole compound 1 (IDC16) that conserve its anti-HIV activity without associated cytotoxicity. Four diheteroarylamide-type compounds, containing a common 5-nitroisobenzothiazole motif, were identified as active. In subsequent screens, the most potent compound 9 (1C8) was active against wild-type HIV-1IIIB (subtype B, X4-tropic) and HIV-1 97USSN54 (subtype A, R5-tropic) with EC50’s of 0.6 and 0.9 μM, respectively. Compound 9 also inhibited HIV strains resistant to drugs targeting HIV reverse transcriptase, protease, integrase, and coreceptor CCR5 with EC50’s ranging from 0.9 to 1.5 μM. The CC50 value obtained in a cytotoxicity assay for compound 9 was &gt;100 μM, corresponding to a therapeutic index (CC50/EC50) of approximately 100. Further comparison studies revealed that, whereas the anti-HIV activity for compound 9 and the parent molecule 1 are similar, the cytotoxic effect for compound 9 was, as planned, markedly suppressed." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01357"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01357">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01357&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01357&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01357&amp;href=/doi/10.1021/acs.jmedchem.5b01357" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1869-1879</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01336" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01429" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Parallel Synthesis Approach to the Identification of Novel Diheteroarylamide-Based Compounds Blocking HIV Replication: Potential Inhibitors of HIV-1 Pre-mRNA Alternative Splicing</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+K.++Cheung">Peter K. Cheung</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Horhant">David Horhant</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura+E.++Bandy">Laura E. Bandy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maryam++Zamiri">Maryam Zamiri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Safwat+M.++Rabea">Safwat M. Rabea</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stoyan+K.++Karagiosov">Stoyan K. Karagiosov</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mitra++Matloobi">Mitra Matloobi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++McArthur">Steven McArthur</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=P.+Richard++Harrigan">P. Richard Harrigan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benoit++Chabot">Benoit Chabot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+S.++Grierson">David S. Grierson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Faculty of Pharmaceutical Sciences, <sup>§</sup>Department of Microbiology and Immunology, and <sup>∥</sup>Department of Medicine, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Département de microbiologie et d’infectiologie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, 3201, rue Jean-Mignault, Sherbrooke, Québec J1E 4K8 Canada</span></div><div class="corresp-info"><strong>*</strong>Phone +1 604 8273353. E-mail: <a href="/cdn-cgi/l/email-protection#7b1f1c09121e0908143b161a1217550e191855181a"><span class="__cf_email__" data-cfemail="137774617a7661607c537e727a7f3d6671703d7072">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01357&amp;href=/doi/10.1021%2Facs.jmedchem.5b01357" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1869–1879</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 15, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 September 2015</li><li><span class="item_label"><b>Published</b> online</span>29 February 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 March 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01357" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01357</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1869%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPeter%2BK.%2BCheung%252C%2BDavid%2BHorhant%252C%2BLaura%2BE.%2BBandy%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D5%26contentID%3Dacs.jmedchem.5b01357%26title%3DA%2BParallel%2BSynthesis%2BApproach%2Bto%2Bthe%2BIdentification%2Bof%2BNovel%2BDiheteroarylamide-Based%2BCompounds%2BBlocking%2BHIV%2BReplication%253A%2BPotential%2BInhibitors%2Bof%2BHIV-1%2BPre-mRNA%2BAlternative%2BSplicing%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1879%26publicationDate%3DMarch%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01357"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1734</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01357" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Parallel Synthesis Approach to the Identification of Novel Diheteroarylamide-Based Compounds Blocking HIV Replication: Potential Inhibitors of HIV-1 Pre-mRNA Alternative Splicing&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;K. Cheung&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Horhant&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;E. Bandy&quot;},{&quot;first_name&quot;:&quot;Maryam&quot;,&quot;last_name&quot;:&quot;Zamiri&quot;},{&quot;first_name&quot;:&quot;Safwat&quot;,&quot;last_name&quot;:&quot;M. Rabea&quot;},{&quot;first_name&quot;:&quot;Stoyan&quot;,&quot;last_name&quot;:&quot;K. Karagiosov&quot;},{&quot;first_name&quot;:&quot;Mitra&quot;,&quot;last_name&quot;:&quot;Matloobi&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;McArthur&quot;},{&quot;first_name&quot;:&quot;P.&quot;,&quot;last_name&quot;:&quot;Richard Harrigan&quot;},{&quot;first_name&quot;:&quot;Benoit&quot;,&quot;last_name&quot;:&quot;Chabot&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;S. Grierson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;1869-1879&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01357&quot;},&quot;abstract&quot;:&quot;A 256-compound library was evaluated in an anti-HIV screen to identify structural “mimics” of the fused tetracyclic indole compound 1 (IDC16) that conserve its anti-HIV activity without associated cytotoxicity. Four diheteroarylamide-type compounds, containing a common 5-nitroisobenzothiazole motif, were identified as active. In subsequent screens, the most potent compound 9 (1C8) was active against wild-type HIV-1IIIB (subtype B, X4-tropic) and HIV-1 97USSN54 (subtype A, R5-tropic) with EC50’s of 0.6 and 0.9 μM, respectively. Compound 9 also inhibited HIV strains resistant to drugs targeting HIV reverse transcriptase, protease, integrase, and coreceptor CCR5 with EC50’s ranging from 0.9 to 1.5 μM. The CC50 value obtained in a cytotoxicity assay for compound 9 was &gt;100 μM, corresponding to a therapeutic index (CC50/EC50) of approximately 100. Further comparison studies revealed that, whereas the anti-HIV activity for compound 9 and the parent molecule 1 are similar, the cytotoxic effect for compound 9 was, as&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01357&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01357" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01357&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01357" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01357&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01357" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01357&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01357&amp;href=/doi/10.1021/acs.jmedchem.5b01357" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01357" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01357" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01357%26sid%3Dliteratum%253Aachs%26pmid%3D26878150%26genre%3Darticle%26aulast%3DCheung%26date%3D2016%26atitle%3DA%2BParallel%2BSynthesis%2BApproach%2Bto%2Bthe%2BIdentification%2Bof%2BNovel%2BDiheteroarylamide-Based%2BCompounds%2BBlocking%2BHIV%2BReplication%253A%2BPotential%2BInhibitors%2Bof%2BHIV-1%2BPre-mRNA%2BAlternative%2BSplicing%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D5%26spage%3D1869%26epage%3D1879%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=292035" title="Viruses">Viruses</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/jmcmar.2016.59.issue-5/20160310-01/jmcmar.2016.59.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A 256-compound library was evaluated in an anti-HIV screen to identify structural “mimics” of the fused tetracyclic indole compound <b>1</b> (IDC16) that conserve its anti-HIV activity without associated cytotoxicity. Four diheteroarylamide-type compounds, containing a common 5-nitroisobenzothiazole motif, were identified as active. In subsequent screens, the most potent compound <b>9</b> (1C8) was active against wild-type HIV-1<sub>IIIB</sub> (subtype B, X4-tropic) and HIV-1 97USSN54 (subtype A, R5-tropic) with EC<sub>50</sub>’s of 0.6 and 0.9 μM, respectively. Compound <b>9</b> also inhibited HIV strains resistant to drugs targeting HIV reverse transcriptase, protease, integrase, and coreceptor CCR5 with EC<sub>50</sub>’s ranging from 0.9 to 1.5 μM. The CC<sub>50</sub> value obtained in a cytotoxicity assay for compound <b>9</b> was >100 μM, corresponding to a therapeutic index (CC<sub>50</sub>/EC<sub>50</sub>) of approximately 100. Further comparison studies revealed that, whereas the anti-HIV activity for compound <b>9</b> and the parent molecule <b>1</b> are similar, the cytotoxic effect for compound <b>9</b> was, as planned, markedly suppressed.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Anti-retroviral therapy (ART) has changed the prognosis of HIV infection to the point where, in developed countries, it is considered a chronic infection. In light of this success in reducing morbidity,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> significant steps are now being taken to bring ART to the developing world where the majority of HIV infected people reside. The necessity of these initiatives is underscored by the fact that, in spite of progress, an estimated 2 million new infections occur and approximately 1.2 million people die from AIDS per year.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> In practice, the advantage of ART therapy is that the use of a combination of drugs reduces the chance of viral escape, which results from acquired drug resistance to each individual drug. However, there are inherent long-term limitations to ART, which include the necessity for strict adherence to treatment schedules,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> drug toxicity,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and the emergence of drug-resistant HIV strains,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> which are no longer sensitive to the drug cocktails employed. These issues take on added significance as the scale and diversity of the populations receiving treatment increases.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> There is need for the continued development of new drugs, and in particular those that act through unexplored mechanisms of action, which bypass resistance, display minimal toxicity, and address the problem of activating the latent viral pool.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> We are exploring the potential of new anti-HIV agents that block HIV replication through perturbation of HIV pre-mRNA alternative splicing.</div><div class="NLM_p">Through random screening of compound libraries several molecules<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16">(10-16)</a> have been identified that either directly or indirectly interfere with the events whereby HIV pre-mRNA is alternatively spliced.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17-20)</a> Pertinent to the present work, screening of the Institut Curie compound collection<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> identified the fused tetracyclic indole compound <b>1</b> (IDC16) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) as a molecule that blocks replication of HIV through inhibition of the exonic splicing enhancer activity of SRSF1.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> This SR protein plays a crucial role in human RNA splicing, and it has been implicated in alternative splicing, mRNA stability, and translation.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In HIV-1 infected cells it specifically regulates alternative splicing events that are vital to the production of critical HIV proteins including Tat, Rev, and Nef. The RNA-binding proteins Tat and Rev are key regulators for the expression of HIV-1 viral genes, for the synthesis of full-length genomic RNA and, ultimately, for the production of progeny virions.<a onclick="showRef(event, 'ref17 ref23'); return false;" href="javascript:void(0);" class="ref ref17 ref23">(17, 23)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Strategy for the parallel synthesis of compound <b>1</b> mimics, showing the different linker motifs <b>2</b>–<b>7</b> that were investigated, the general formula <b>8</b> for the series of 119 diheteroarylamides synthesized, and the structures of the compounds <b>9</b>–<b>12</b> identified as active in the preliminary anti-HIV screen.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>1</b> and other pyridocarbazole alkaloid analogues have been developed primarily as cytotoxic agents, acting, among other mechanisms, as DNA intercalators and/or topoisomerase II inhibitors.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28">(24-28)</a> Consequently, although <b>1</b> blocks HIV replication at concentrations lower than the threshold of its cytotoxic effect (see ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a> and results in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), it is not a suitable molecule to carry down the drug development process as an anti-HIV drug destined for long-term use. Be this as it may, the significant anti-HIV activity displayed by this molecule strongly suggests that it interacts with its target SR protein in a way that it disrupts its contact with other spliceosome components. It is possible, therefore, that the information contained in the structure of <b>1</b> (geometry, polarity, presence of aromatic rings), which is at the root of its anti-HIV activity, could be translated into a different and more flexible type of molecule that maintains this mechanism of action, without displaying affinity for DNA. Further, it is anticipated that such molecules would bind more strongly in the putative site than the rigid and flat compound <b>1</b>.</div><div class="NLM_p">Our approach to identify molecules with these features has been to use parallel synthesis to construct a library of ring-opened, and more conformationally mobile “mimics” of <b>1</b> and to evaluate the library components for anti-HIV activity. In the absence of high-resolution structural data for the SR proteins and only a limited vision of their interactions at the molecular level, the library design strategy adopted was to construct molecules that retain a structural resemblance to the outline of <b>1</b>, when projected onto a flat (two-dimensional) surface. Of importance was to also include molecules in the library that incorporate functionality and/or structural motifs that project beyond the outline of <b>1</b>. It was expected that, in this way, supplementary binding interactions not exploited by <b>1</b> could be located, which improve potency and/or target selectivity.</div><div class="NLM_p last">As described in the present report, the screening of a small molecule library of structural mimics of <b>1</b> led to the identification of four active diheteroarylamide (DHA)-type compounds (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). The most potent hit in this new class of anti-HIV agents was carried forward to determine its anti-HIV profile against HIV mutant strains resistant to the current drugs used in ART.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02483" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02483" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry and Preliminary Screen</h3><div class="NLM_p">The tetracyclic indole compound <b>1</b> contains three nitrogen atoms in an otherwise highly lipophilic polyaromatic structure. Taking as a supposition that these polar heteroatoms play an important role in interactions with the SR protein, the principle objective in the synthesis of mimics of this molecule was to generate structures that position nitrogen and/or oxygen functionality into the same space occupied by its indole and A/D-ring nitrogen atoms. Further, as the B- and C-rings in <b>1</b> may be contributing little to binding, the idea was to replace one or both of these rings by an appropriate spacer element that connects the different motifs used as alternatives to the A- and D-rings (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Spacer elements explored, which replace rings B and C, included a 1,2,4-oxadiazole motif <b>2</b>, an extended 1,2,4-oxadiazole-3-carboxamide system <b>3</b>, and a simple amide function <b>4</b>. Fused bicyclic A/B-type ring systems, where the B-ring is part of the spacer element and the C-ring is eliminated included imidazopyridine <b>5</b>, pyrazolopyridine <b>6</b>, and pyridoimidazolone <b>7</b> systems. Using a parallel synthesis approach, a diverse library of 256 compound <b>1</b> mimics was prepared by combining A-and A/B-ring components with different D-ring motifs (see Table 1 in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01357/suppl_file/jm5b01357_si_001.pdf" class="ext-link">Supporting Information</a> for a complete listing of all compounds in the library).</div><div class="NLM_p">Focusing in on the subset of IDC16 mimics containing an amide linker, a total of 119 compounds, represented by general formula <b>8</b>, were prepared by reaction of the acid chloride derivative of the selected A-ring carboxylic acid components with a diverse set of functionalized aromatic and heteroaromatic amines (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Looking at the set of D-ring components explored, one see that, in some cases, substituents were situated at different positions of the aromatic and heteroaromatic ring that are similar in size to the chlorine atom in <b>1</b>. In other cases, more extended heteroatom-containing side chains were explored, and in still other cases the D-ring alternatives corresponded to fused and nonfused bicylic motifs.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of the different A- and D-ring subunits employed in the synthesis of the 119 dihereroarylamides <b>8</b> present in the compound library.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Preliminary evaluation of these and the other library molecules was carried out in a cell-based anti-HIV screen, in which reporter CEM-GXR cells were infected by coculture with 1% HIV-1<sub>NL4-3</sub> infected (GFP positive) cells at the start of the assay (day 0). CEM-GXR cells are an immortalized CD4+ T-lymphocyte line that expresses GFP due to the activation of the Tat-dependent promoter upon HIV-1 infection.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> A different library molecule in DMSO was added to the culture in each microplate well immediately after the inoculation by infected cells. The final library compound concentration was fixed at 2 μM, and the final DMSO concentration was <0.1%. The percent of infected cells in the culture was determined by flow cytometry on day 3. Four DHA-type compounds, <b>9</b> (1C8), <b>10</b> (3C2), <b>11</b> (2D3) and <b>12</b> (1E5) (microplate number and compound location) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), were identified as active, inhibiting HIV-1 replication in the low micromolar range (see Figure 1a–d in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01357/suppl_file/jm5b01357_si_001.pdf" class="ext-link">Supporting Information</a> for the screening results). The immediately apparent feature of these molecules was that, whereas the A-ring motif could be varied among different pyridine/pyridinone structures, they all had in common the presence of a 5-nitro substituted benzo[<i>d</i>]isothiazole motif as the D-ring subunit.</div><div class="NLM_p">The four step preparation of compound <b>9</b> involved (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>a): (i) the conversion of 4-chloropyridine <b>13</b> to 4-chloronicotinic acid <b>14</b> through reaction with LDA followed by CO<sub>2</sub> gas;<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (ii) refluxing this intermediate in H<sub>2</sub>O at reflux;<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (iii) reaction of the derived 4-pyridinone <b>15</b><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> with excess methyl iodide to give <b>16</b><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (using KHCO<sub>3</sub> rather than NaOH as the base; 90% yield); and (iv) the reaction of the acid chloride derivative of <i>N</i>-methyl-4-pyridinone-3-carboxylic acid <b>16</b> with 5-nitrobenzo[<i>d</i>]isothiazol-3-amine.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (ref <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">30</a>) LDA, THF, −78 °C, then CO<sub>2</sub>; (ii) (ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a>) H<sub>2</sub>O reflux 2 h; (iii) KHCO<sub>3</sub>, DMF-H<sub>2</sub>O, then MeI, 100 °C, 1 h; (iv) SOCl<sub>2</sub>, RT or 90 °C, then 5-nitrobenzo[<i>d</i>]isothiazol-3-amine, DMF or THF, Et<sub>3</sub>N or K<sub>2</sub>CO<sub>3</sub>, rt, 10–24 h; (v) 2-methoxyethan-1-ol, Na, 90 °C, then 4-chloronicotinic acid, 90 °C, 4 h; (vi) 2-bromoethyl methyl ether, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 4 h; (vii) LiOH, THF-H<sub>2</sub>O, rt, 4 h.</p></p></figure><div class="NLM_p">Compound <b>10</b> was prepared (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>a) by reaction of 4-chloronicotinic acid <b>14</b> with the anion of 2-methoxyethanol to give <b>17</b>, followed by subsequent conversion of <b>17</b> to the acid chloride and its reaction with 5-nitrobenzo[<i>d</i>]isothiazol-3-amine. In a similar way (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>b), the commercially available 2-methoxypyridine-4-carboxylic acid <b>18</b> was treated with SOCl<sub>2</sub>, and the derived acid chloride intermediate was reacted with 5-nitrobenzo[<i>d</i>]isothiazol-3-amine to give <b>11</b>.</div><div class="NLM_p last">To obtain compound <b>12</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>c), the 4-hydroxyl group in pyridinone <b>19</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> was O-alkylated to give <b>20</b> through reaction with 2-methoxy-1-bromoethane, and the ester function in <b>20</b> was subsequently hydrolyzed to give the acid intermediate <b>21</b> in high overall yield. Conversion of <b>21</b> to <b>12</b> was again achieved through the acid chloride route. With the exception of compound <b>12</b>, the isolated yields for the diheteroarylamide products in the library were generally low (2–30%), due to the formation of multiple side products and consequent difficulties encountered during column chromatography. However, all diheteroarylamide compounds were obtained in >95% purity, as determined by <sup>1</sup>H NMR. In the <sup>1</sup>H NMR spectra of the four active compounds, the three peaks for the benzisothiazole motif (singlet between δ 8.85 and 9.40 for H-4′, and doublets for the adjacent H-6′/7′ protons between δ 8.13 and 8.17 and δ 7.75 and 7.77) were readily distinguished from the absorptions for the pyridine/pyridinone protons of the A-ring components.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Anti-HIV Activity of <b>9</b> against Wild-Type and Drug-Resistant HIV Strains</h3><div class="NLM_p">Assessment of the four initial hits by dose–response relations indicated that compounds <b>10</b> and <b>12</b> did not respond to the increasing doses. This correlates with their poor DMSO-H<sub>2</sub>O solubility. In contrast, compounds <b>9</b> and <b>11</b> displayed good response. As the antiviral potency of <b>9</b> was approximately 3-fold higher than that for <b>11</b>, compound <b>9</b> was selected for further antiviral activity testing and therapeutic index evaluation.</div><div class="NLM_p">Given that the antiviral activity of anti-HIV drugs can vary significantly due to the genetic variation of HIV-1 subtypes and its coreceptor usage, <b>9</b> was evaluated in the above-described anti-HIV screen assay of viral spread using different HIV-1 subtypes and tropisms. In the experiment, the culture contained serial dilutions of molecule <b>9</b> in final concentrations between 100 nM and 10 μM, and the half maximal effective concentration (EC<sub>50</sub>) values were calculated by nonlinear regression with GraphPad Prism software. Compound <b>9</b> exhibited activity against wild-type HIV-1<sub>IIIB</sub> (subtype B, X4-tropic), and HIV-1 97USSN54 (subtype A, R5-tropic) with EC<sub>50</sub> values of 0.6 and 0.9 μM, respectively (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A,B). To validate these EC<sub>50</sub> values, the anti-HIV drug, emtricitabine (FTC) was included in the anti-HIV assay as a positive control (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Serial dilutions of FTC in final concentrations between 1 nM and 10 μM were tested, and an EC<sub>50</sub> value of 0.039 μM was determined.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Anti-HIV-1 activity of <b>9</b> against wild-type subtypes A and B and drug-resistant viruses. (A) HIV-1<sub>IIIB</sub> (subtype B), (B) 97USSN54 (subtype A), (C) (N)NRTI-resistant isolate, (D) PI-resistant isolate, (E) INI-resistant isolate, (F) Maraviroc-resistant R5 strain. The anti-HIV activity for emtricitabine (FTC) as a positive control is also shown in (A). In the presence of increasing <b>9</b> concentrations, HIV-1 infectivity on CEM-GXR cells was assessed by measuring GFP positive cells 3 days after infection. The inhibition curves were then fitted by nonlinear regression with GraphPad Prism software, allowing EC<sub>50</sub> calculation. Results represent the average of three independent determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To assess its potential against drug-resistant strains, the antiretroviral activity of the <b>9</b> was tested against key HIV-1 strains resistant to at least one of the current four major drug target categories: (non)-nucleoside reverse transcriptase inhibitor (N)NRTI, protease inhibitor (PI), integrase inhibitor (INI), and coreceptor inhibitor (CRI). A summary of mutations in HIV-1 proteins associated with resistance to antiviral drugs can be found in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Mutations in Drug-Resistant HIV-1 Strains Associated with Resistance to ARV Drugs<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">drug-resistant HIV-1 strain</th><th class="colsep0 rowsep0" align="center">viral protein</th><th class="colsep0 rowsep0" align="center">primary mutations</th><th class="colsep0 rowsep0" align="center">resistance to ARV drugs</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">E00443</td><td class="colsep0 rowsep0" align="left">reverse transcriptase</td><td class="colsep0 rowsep0" align="left">K103N, D67N, K70R, Y115F, Q151M, M184V, K219Q</td><td class="colsep0 rowsep0" align="left">EFV, NVP, 3TC, ABC, AZT, FTC</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2948</td><td class="colsep0 rowsep0" align="left">protease</td><td class="colsep0 rowsep0" align="left">G48V, L90M</td><td class="colsep0 rowsep0" align="left">ATV, LPV</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11845</td><td class="colsep0 rowsep0" align="left">integrase</td><td class="colsep0 rowsep0" align="left">G140S, Q148H</td><td class="colsep0 rowsep0" align="left">RAL, EVG, DTG</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MVC-res</td><td class="colsep0 rowsep0" align="left">envelop-V3</td><td class="colsep0 rowsep0" align="left">A19T, L20F, T22A, E25D, I26V</td><td class="colsep0 rowsep0" align="left">MVC</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Abbreviations: efavirenz (EFV), nevirapine (NVP), lamivudine (3TC), abacavir (ABC), zidovudine (AZT), emtricitabine (FTC), atazanavir (ATV), lopinavir (LPV), raltegravir (RAL), elvitegravir (EVG), dolutegravir (DTG), and maraviroc (MVC).</p></div></div></div><div class="NLM_p">Compound <b>9</b> was evaluated against the isolate (E00443), which greatly reduces susceptibility to both NNRTI’s and NRTI’s. Indeed, this isolate harbors a variety of mutations, including the widely recognized NNRTI-resistance mutation K103N that confer high level resistance to efavirenz (EFV) and nevirapine (NVP). This virus also carries the NRTI-resistance mutations D67N, K70R, Y115F, Q151M, M184V, and K219Q, which confer high-level resistance to lamivudine (3TC), abacavir (ABC), zidovudine (AZT), and emtricitabine (FTC).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In the assay compound <b>9</b> remained active, with an EC<sub>50</sub> of 1.3 μM (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C).</div><div class="NLM_p">Compound <b>9</b> similarly retained its potency (EC<sub>50</sub> of 1.40 μM; <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D) against the PI-resistant isolate (2948), which contains substitutions G48V and L90M. This combination reduces the susceptibility to atazanavir (ATV) and lopinavir (LPV), currently the two of the three most frequently prescribed HIV protease inhibitors.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">To determine whether <b>9</b> targets HIV-1 integrase, it was tested against a clinical isolate (11845), which harbors G140S and Q148H substitutions that reduce susceptibility to raltegravir (RAL) and elvitegravir (EVG) more than 100-fold<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and reduce sensitivity toward dolutegravir (DTG) up to 10-fold.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Compound <b>9</b> showed activity against this isolate with an EC<sub>50</sub> of 1.36 μM (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>E).</div><div class="NLM_p last">Lastly, <b>9</b> retained activity (EC<sub>50</sub> of 0.9 μM; <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>F) against an HIV-1 strain that is resistant to the entry inhibitor-based drug maraviroc (MVC). This maraviroc-resistant variant derived from a R5 strain of HIV-1<sub>BaL</sub> contains five mutations within the envelope V3 loop: A19T, L20F, T22A, E25D, and I26V.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> The Cytotoxicity and Therapeutic Index of <b>9</b></h3><div class="NLM_p">To establish that the observed antiviral activities of <b>9</b> were not the result of cytotoxicity after exposure, therapeutic indexes were determined. The therapeutic index (TI = CC<sub>50</sub>/EC<sub>50</sub>) provided the relative effectiveness of compound <b>9</b> in antiviral activities compared to inducing cell death. In other words, a high therapeutic index signifies desirable antiviral activity with minimal cell toxicity. The potential adverse effect of <b>9</b> on CEM-GXR cells viability was determined by the Guava ViaCount assay. This assay differentially stains viable and nonviable cells based on their permeability to the DNA-binding dyes and uses the forward scatter (FSC) properties to distinguish free nuclei and cellular debris from intact cells to quantify cell count. CEM-GXR cells were incubated with <b>9</b> at concentrations ranging between 0.5 and 100 μM for 24 h. At the highest concentration tested (100 μM of <b>9</b>), a decrease in cell viability from 98.0 to 68.8% (±6.8) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) was observed. The cytotoxic concentration resulting in the 50% death of the host cells (CC<sub>50</sub>) was, thus, >100 μM. As the EC<sub>50</sub>s in all the tested viruses ranged between 0.6 and 1.5 μM, the calculated therapeutic indexes are >66–100 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Evaluation of <b>9</b> on CEM-GXR cell viability in the Guava ViaCount assay. Cells were analyzed after 24 h incubation with compound <b>9</b> in concentrations ranging between 0.5 and 100 μM. Results are expressed as the percentage (%) of viable cells ± SEM of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antiviral Potencies of Compound <b>9</b> in Cells Infected with Wild-Type or Drug-Resistant Virus Strains<a class="ref internalNav" href="#t2fn4" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">WT and drug resistant virus</th><th class="colsep0 rowsep0" align="center">resistance to drug category</th><th class="colsep0 rowsep0" align="center" char=".">CC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">therapeutic index<a class="ref internalNav" href="#t2fn3" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HIV-1<sub>IIIB</sub></td><td class="colsep0 rowsep0" align="left">none</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">>166</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">97USSN54</td><td class="colsep0 rowsep0" align="left">none</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">>111</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">E00443</td><td class="colsep0 rowsep0" align="left">RTI</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">>77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2948</td><td class="colsep0 rowsep0" align="left">PI</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">>71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11845</td><td class="colsep0 rowsep0" align="left">INI</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">>66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MVC-res</td><td class="colsep0 rowsep0" align="left">CRI</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">>111</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn4"><div class="footnote" id="t2fn4"><sup>a</sup><p class="last">Abbreviations: reverse transcriptase inhibitor (RTI), protease inhibitor (PI), integrase inhibitor (INI), and coreceptor inhibitor (CRI).</p></div><div class="footnote" id="t2fn1"><sup>b</sup><p class="last">Cytotoxic concentration resulting in the death of 50% of the host cells (CC<sub>50</sub>) measured by ViaCount assay (Millipore).</p></div><div class="footnote" id="t2fn2"><sup>c</sup><p class="last">Effective concentration resulting in 50% reduction of viral infected cells measured by GFP expression signal.</p></div><div class="footnote" id="t2fn3"><sup>d</sup><p class="last">Therapeutic index calculated as the ratio of CC<sub>50</sub> to EC<sub>50</sub>.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Comparative Study of <b>1</b> and <b>9</b> on Cell Viability and Anti-HIV Activity</h3><div class="NLM_p">To study further cell viability versus anti-HIV activity, a comparison study was made between <b>1</b> and the mimic <b>9</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A,B). Serial dilutions of both molecules in final concentrations between 62.5 nM and 16 μM were added in the culture containing either CEM-GXR cells alone for the viability study or in one percent of HIV-1<sub>IIIB</sub> infected CEM-GXR cells for antiviral activity assessment. At 1 μM concentration, both molecules showed comparable antiviral activities with 18.4% infected cells detected in <b>9</b> and 17.7% detected in <b>1</b>. The half-maximal effective concentration (EC<sub>50</sub>) values for both molecules were calculated using the Igor Pro software. Compounds <b>1</b> and <b>9</b> exhibited equivalent activity against HIV-1<sub>IIIB</sub> with EC<sub>50</sub> values of 0.959 ± 0.026 and 0.902 ± 0.113 μM, respectively. Similar effects on cell viability were observed for both molecules at 1 μM, as 89.6% viable cells were detected in <b>9</b> and 85.5% were found in <b>1</b>. At higher concentrations, however, the cell viability dropped considerably for <b>1</b> (33.2% at 4 μM, 19.9% at 8 μM, and 11.9% at 16 μM) reflecting its cytotoxicity, while only minimal effect on viability was observed for <b>9</b> (81.5% at 4 μM, 80.9% at 8 μM, and 78.7% at 16 μM).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Evaluation of anti-HIV-1 activity (column) and GXR-CEM cell viability (line) for <b>1</b> (A) and <b>9</b> (B) at concentrations between 62.5 nM and 16 μM (0 provides the value when no compound was added). HIV-1 infection in CEM-GXR cells was assessed by measuring GFP positive cells 3 days after infection. CEM-GXR cell viability was measured after 24 h incubation within the same range of concentrations. Results were expressed from three independent experiments for both the anti-HIV-1 activity and cell viability assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Taken together, the anti-HIV assay results strongly suggest that compound <b>9</b> does not inhibit HIV replication through a mechanism involving inhibition of the four current HIV protein drug targets. Looking at the structure of this molecule, the importance of the 5-nitro isobenzoisothiazole system to activity was evident from its appearance as the D-ring component in all four initial hit molecules. Although, at this stage, the screening results provide only a primitive guide to future SAR studies on this subunit, it is interesting to note the absence of activity for the 4-pyridinone-based compounds <b>22</b> (1B8) and <b>23</b> (1D8) and the 2-pyridinone molecules <b>24</b> (4B2) and <b>25</b> (4F3), which contain a single five-membered heterocycle as the D-ring subunit (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). It is further noteworthy that the isomeric benzothiazole compounds <b>26</b> (4C2) and <b>27</b> (4A4), where the benzo-ring has an “extended” spatial orientation versus the “bent orientation found in <b>9</b> and <b>12</b>, were also inactive. However, replacement of the benzisothiazole subunit by a related isoquinoline motif, as in the <b>12</b>-type compound <b>28</b> (4C3), also resulted in a loss of activity.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Library components providing cursory SAR on compound <b>9</b> and the structure of <b>30 (</b>ABX-464).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Important to future SAR studies on the active mimics of <b>1</b> was the observation that considerable latitude exists to replace the A-ring of <b>1</b> by alternate substructures. Indeed, the position of the pyridine nitrogen atom relative to the carboxamide function can be changed, a 2-pyridinone system is tolerated, and the indole nitrogen in <b>1</b> can be replaced by the 4-pyridinone carbonyl oxygen atom, as in <b>9</b>, or a 2-methoxyethanol side chain, as in <b>10</b> and <b>12</b>. Interestingly, compound <b>29</b> (2C3), lacking this oxygen substituted side chain, is inactive.</div><div class="NLM_p">Importantly, the activity versus viability data in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a> revealed a distinct advantage of <b>9</b> over <b>1</b> as an anti-HIV agent. Both compounds exhibited comparable EC<sub>50</sub> values and had little effect on cell viability at 1 μM concentration. However, at higher concentrations, toxicity toward <b>1</b> was strongly manifested, whereas, the mimic <b>9</b> remained minimally toxic to the CEM-GXR cells. This result was highly encouraging, as it confirmed that, unlike <b>1</b>, compound <b>9</b> displays no significant affinity for DNA. However, when taking into consideration long-term anti-HIV therapy, an important issue in moving forward with development of this molecule is the presence of the 5-nitro substituent on the isobenzoisothiazole motif. A priority will thus be given to establishing whether the nitro is crucial to activity, and if so, whether it can be replaced by a suitable bioisostere motif, which is less prone to bioactivation.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p last">Finally, having discovered a new prototype anti-HIV agent, which was inspired by the structure of <b>1</b>, it remains to determine whether, like the parent compound, <b>9</b> blocks HIV replication through perturbation of HIV-1 pre-mRNA alternative splicing. In this context, it is noteworthy that the anti-HIV agent <b>30</b> (ABX-464), whose development was also inspired by the structure of <b>1</b>, interfered with HIV alternative splicing in a manner that does not implicate SRSF1.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Considering that <b>1</b> and <b>9</b> are, in several ways, structurally dissimilar, one cannot, therefore, assume that they share the same mechanism of action. This line of reasoning was reinforced by the fact that compound <b>31</b> (1H7) (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>), which mostly closely follow the outline of <b>1</b>, was inactive. This suggested that the amide linker in the DHA compounds may not correctly emulate the B- and C-rings of <b>1</b> (i.e., capture the same interactions these rings are implicated in upon binding to the SR protein) and/or that the extra phenyl ring in the bennzoisothiazole system captured additional interactions, which compensate for this possible deficiency. To establish the mode of action of <b>9</b>, very detailed experiments have been carried out, which both eliminated SRSF1 as the target of <b>9</b> and confirmed that it deregulates HIV-1 pre-mRNA alternative splicing in a complex process involving other SR proteins. The results of these ongoing studies<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> serve to validate the approach taken to design <b>9</b> as HIV alternative splicing inhibitor. They further provide the tools necessary for continued research to identify the optimal <b>9</b> analog that blocks HIV replication without detrimental effect on normal cellular splicing/alternative splicing processes.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32203" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32203" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Experimental General</h3><div class="NLM_p">All chemicals were purchased from Sigma-Aldrich or Oakwood Chemicals, and they were used without purification unless mentioned. All solvents were dried and kept under N<sub>2</sub>. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at 400 and 100 MHz, respectively, on a Bruker AC 400 Ultrashield 10 spectrophotometer. Chemical shifts are expressed in ppm, (δ scale). When peak multiplicities are reported, the following abbreviations are used: s (singlet), d (doublet), m (multiplet), dd (doublet of doublet). Coupling constants are reported in Hz. Low- and high-resolution mass spectra were recorded on a AB Sciex UHPLC/MS/MS System and a Thermo Scientific Q Exactive Orbitrap High-Resolution Mass Spectrometer, respectively. Flash column chromatography was performed using silica gel (Silicycle, Siliaflash F60, 40–63 μm, 230–400 mesh) or on a Biotage Isolera purification system, (PartnerTech Atvidaberg AB) using prepacked silica gel columns (Biotage, part no. FSKO-1107-0010, FSKO-1107-0025, or FSKO-1107-0050). Intermediates <b>15</b>–<b>21</b> and the final compounds <b>9</b>, <b>10</b>, and <b>12</b> were confirmed to be >95% pure by <sup>1</sup>H NMR spectroscopy. Final compound <b>11</b> contained trace amounts (approximately 5%) of an unidentified impurity (see <sup>1</sup>H NMR spectrum in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01357/suppl_file/jm5b01357_si_001.pdf" class="ext-link">Supporting Information</a>). For the biological assays: nelfinavir, efavirenz and 3′-azido-3′-deoxythymidine (AZT) were obtained from Sigma-Aldrich (St. Louis, MO). Maraviroc, raltegravir, elvitegravir, dolutegraver, and emtricitabine were obtained from Cedarlane Laboratories (Ontario, Canada). Indicator cell line CEM-GXR was obtained from Dr. Mark Brockman (Simon Fraser University). The (N)NRTI-resistant virus (E00443) was obtained from Dr. Zabrina Brumme (Simon Fraser University). The HIV-1 CXCR4-tropic laboratory-adapted strain NL4-3, and IIIB, HIV-1 CCR5-tropic BaL, integrase inhibitor-resistant virus (11845), protease inhibitor-resistant virus (2948), and HIV-1 subtype A (4114) were obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH).</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> 1-Methyl-<i>N</i>-(5-nitrobenzo[<i>d</i>]isothiazol-3-yl)-4-oxo-1,4-dihydropyridine-3-carboxamide (<b>9</b>)</h4><div class="NLM_p last">Thionyl chloride (0.23 mL, 3.13 mmol, 1.2 equiv) was added dropwise to an ice-bath cooled suspension of 1-methyl-4-oxo-1,4-dihydropyridine-3-carboxylic acid <b>16</b> (400 mg, 2.6 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (6 mL) under a flow of nitrogen. After the addition, the reaction mixture was warmed to room temperature and then stirred at room temperature for 2 h. The resulting solution was then concentrated under reduced pressure, and the crude acyl chloride was dried in vacuo for 1 h. The solid product was dissolved in DMF (3 mL) containing Et<sub>3</sub>N (4.5 mL) and cooled to 0 °C. Then a solution of 5-nitrobenzo[<i>d</i>]isothiazol-3-amine (612.5 mg, 3.13 mmol) in DMF (8 mL) was added dropwise, and the reaction mixture was warmed to room temperature and stirred for 24 h. The DMF was removed under reduced pressure, and the solid mixture was washed with acetone (30 mL), filtered and concentrated. The solid obtained was purified twice by flash column chromatography (DCM/MeOH 95:5) to afford <b>9</b> as a red-brown solid (80 mg, 9%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 15.58 (s, 1H), 8.85 (s, 1H), 8.75 (d, <i>J</i> = 2.0 Hz, 1H), 8.16 (dd, <i>J</i> = 9.6, 2.3 Hz, 1H), 8.04 (d, <i>J</i> = 7.10 Hz, 1H), 7.77 (d, <i>J</i> = 9.6 Hz, 1H), 6.75 (d, <i>J</i> = 7.10 Hz), 1H), 3.92 (s, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 176.41, 157.91, 147.09, 143.80, 141.60, 122.45, 122.15, 120.08, 119.69, 118.22 (3 peaks for quaternary carbons are missing); HRMS (HESI) <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>9</sub>N<sub>4</sub>O<sub>4</sub>S [M + H]<sup>−</sup> 329.03500, found 329.03531</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> 4-(2-Methoxyethoxy)-<i>N</i>-(5-nitrobenzo[<i>d</i>]isothiazol-3-yl)nicotinamide (<b>10</b>)</h4><div class="NLM_p last">Thionyl chloride (1.8 mL) was added to acid <b>17</b> (50 mg, 0.25 mmol), and the mixture was heated at 90 °C for 1 h. The excess of thionyl chloride was removed under reduced pressure, and the crude acyl chloride was suspended in THF (3 mL). Potassium carbonate (70 mg, 0.51 mmol) and 5-nitrobenzo[<i>d</i>]isothiazol-3-amine (50 mg, 0.26 mmol) were then added, and the resulting mixture was stirred at room temperature for 10 h. The solvent was removed in vacuo, and the solid obtained was silica-gel flash column chromatographed (EtOAc to EtOAc/MeOH 9:1). Compound <b>10</b> was isolated pure as a yellow solid (5 mg, 5%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.05 (br s, 1H), 9.45 (d, <i>J</i> = 2.3 Hz, 1H), 8.79 (br s, 1H), 8.66 (d, <i>J</i> = 5.9 Hz, 1H), 8.16 (dd, <i>J</i> = 9.7, 2.3 Hz, 1H), 7.77 (d, <i>J</i> = 9.7 Hz, 1H), 7.37 (d, <i>J</i> = 5.9 Hz 1H,), 4.37 (m, 2H), 3.71 (m, 2H), 3.20 (s, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.56, 162.82, 162.41, 157.79, 154,30, 150.66, 141,77, 122.27, 122.03, 120.02, 119.64, 118.36, 108.69, 69.79, 68.24, 58.17; HRMS (HESI) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>13</sub>N<sub>4</sub>O<sub>5</sub>S [M – H]<sup>−</sup> 373.06121, found 373.06107.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 2-Methoxy-<i>N</i>-(5-nitrobenzo[<i>d</i>]isothiazol-3-yl)isonicotinamide (<b>11</b>)</h4><div class="NLM_p last">Thionyl chloride (10 mL) was added to acid <b>18</b> (500 mg, 3.27 mmol) (commercially available), and the mixture was heated at 90 °C for 1h. The excess of thionyl chloride was removed under reduced pressure, and the crude acyl chloride was suspended in THF (30 mL). Potassium carbonate (902 mg, 6.54 mmol, 2 equiv) and 5-nitrobenzo[<i>d</i>]isothiazol-3-amine (637 mg, 3.27 mmol) were then added, and the resulting mixture was stirred at room temperature for 10 h. The mixture was then filtered, and the solid material was washed with THF. The filtrate was concentrated in vacuo and flash column chromatographed (silica-gel: 0–2% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), providing <b>11</b> as a yellow solid (20 mg, 2%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.18 (br s, 1H), 9.70 (s, 1H), 8.47 (d, <i>J</i> = 5.2 Hz, 1H), 8.16 (dd, <i>J</i> = 1.2, 9.6 Hz, 1H), 7.77 (d, <i>J</i> = 9.6 Hz, 1H), 7.63 (d, <i>J</i> = 5.2 Hz, 1H), 7.55 (s, 1H), 3.97 (s, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.04, 148.12, 141.74, 120.70, 120.03, 115.48, 109.86, 53.81 (6 peaks for quaternary carbons are missing); HRMS (HESI) <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>9</sub>N<sub>4</sub>O<sub>4</sub>S [M – H]<sup>−</sup> 329.03500, found 329.03531.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 4-(2-Methoxyethoxy)-1-methyl-<i>N</i>-(5-nitrobenzoisothiazol-3-yl)-6-oxo-1,6-dihydropyridine-3-carboxamide (<b>12</b>)</h4><div class="NLM_p last">4-(2-methoxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid <b>21</b> (100 mg, 0.40 mmol) was dissolved in an excess of thionyl chloride (1 mL), and the reaction mixture was heated at 85 °C for 1 h. The residual thionyl chloride was then removed in vacuo. 5-nitrobenzo[<i>d</i>]isothiazol-3-amine (66 mg, 0.34 mmol) in THF (3 mL) containing triethylamine (0.077 mL, 0.548 mmol) was then added, and the reaction mixture was stirred under nitrogen at room temperature overnight. The precipitate formed was removed by vacuum filtration, and the concentrated filtrate was washed with acetone. The acetone washed concentrate was silica-gel flash column chromatographed (EtOAc/MeOH; 9:1), providing compound <b>12</b> as a yellow solid (80 mg, 58%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.34 (s, 1H), 9.36 (s, 1H), 8.54 (s, 1H), 8.16 (d, 1H, <i>J</i> = 10 Hz), 7.75 (d, 1H, <i>J</i> = 10 Hz), 6.05 (s, 1H), 4.28 (s, 2H), 3.81 (s, 2H), 3.50 (s, 3H), 3.22 (s, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.43, 162.93, 162.71, 161.83, 157.79, 145.62, 141.62, 122.27, 122.03, 119.95, 119.38, 104.40, 96.15, 69.58, 68.18, 58.06, 36.50; HRMS (HESI) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>15</sub>N<sub>4</sub>O<sub>6</sub>S [M – H]<sup>−</sup> 403.07178; found 403.06946.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 4-Oxo-1,4-dihydropyridine-3-carboxylic acid (<b>15</b>)</h4><div class="NLM_p last">Adapting the procedure by Ross,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> 4-chloronicotinic acid <b>14</b> (1.29 g, 0.77 mmol) was dissolved in 20 mL of water and refluxed for 2 h. After the solution was cooled in an ice bath, a sufficient quantity of conc. HCl was added (if necessary) to ensure that the pH ≤ 4. The precipitate that formed was collected by suction filtration and washed with water. The aqueous filtrate was then concentrated and suspended in approximately 10 mL of water. After cooling at 0 °C, the precipitated material was again collected by suction filtration, washed with Et<sub>2</sub>O, and dried in vacuo to afford <b>15</b> as a colorless solid (800 mg, 75%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.94 (bs, 1H), 8.60 (s 1H), 8.07 (m, 1H), 6.73 (d, <i>J</i> = 7.1 Hz, 1H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 179.43, 166.73, 143.38, 141.34, 118.13, 115.77; HRMS (HESI) <i>m</i>/<i>z</i>: calcd for C<sub>6</sub>H<sub>4</sub>NO<sub>3</sub> [M – H]<sup>−</sup> 138.01967, found 138.01811.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 1-Methyl-4-oxo-1,4-dihydropyridine-3-carboxylic acid (<b>16</b>)</h4><div class="NLM_p last">Adapting the procedure in ref <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">32</a>, 4-oxo-1,4-dihydropyridine-3-carboxylic acid <b>15</b> (792 mg, 5.7 mmol) was dissolved in DMF/water (5/1) (12 mL), and KHCO<sub>3</sub> (590 mg, 5.9 mmol) was added. The mixture was heated at 40 °C for 1 h. After cooling to room temperature, a white solid was collected by suction filtration and washed with DMF (2 mL). To the filtrate was added MeI (1.42 mL, 0.023 mol, 4 equiv), and the mixture was heated at 100 °C for 1 h. It was then concentrated in vacuo, and the residue was washed with acetone, filtered, and rinsed with a 1/1 mixture of acetone/MeOH. The solid material was triturated with hot MeOH, and the MeOH washes were concentrated and dried in vacuo to afford <b>16</b> as a colorless solid (0.745 g, 85%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.70 (d, <i>J</i> = 2.3 Hz, 1H), 8.10 (dd, <i>J</i> = 7.8, 2.3 Hz, 1H), 6.76 (d, <i>J</i> = 7.8 Hz, 1H), 3.89 (s, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 178.29, 165.54, 147. 31, 145.43, 118.56, 115.60, 34.88; HRMS (HESI) <i>m</i>/<i>z</i>: calcd for C<sub>7</sub>H<sub>8</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 154.04987, found 154.04977.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 4-(2-Methoxyethoxy)nicotinic acid (<b>17</b>)</h4><div class="NLM_p last">A suspension of sodium (1.15 g, 50 mmol) in 2-methoxyethan-1-ol (14 mL) was heated at 90°–100 °C under nitrogen until the sodium was consumed.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> 4-Chloronicotinic acid <b>14</b> (1.07 g, 6.79 mmol) was then added in one portion, and the reaction mixture was heated at 90 °C for 4 h. After cooling to room temperature, the reaction mixture was poured into ice water (75 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 30 mL). The aqueous phase was concentrated under reduced pressure to about 1/5 of the initial volume and acidified with 6 N HCl at 0 °C until pH 3.5–4.0 was attained. The precipitate formed was filtered, washed with ice water and ether, and dried in vacuo. Subsequent crystallization from ethanol/ether gave <b>17</b> (545 mg, 41%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.96 (br s, 1H), 8.67 (s, 1H), 8.53 (d, <i>J</i> = 5.7 Hz, 1H), 7.18 (d, <i>J</i> = 5.9 Hz, 1H), 4.26 (m, 2H), 3.68 (m, 2H), 3.31 (s, 3H); <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ 171.96, 163.91, 146.39, 145.92, 121.17, 113.20, 72.58, 71,21, 59.53; HRMS (HESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>12</sub>NO<sub>4</sub> [M + H]<sup>+</sup> 198.07608, found 198.07617.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Ethyl 4-(2-Methoxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate (<b>20</b>)</h4><div class="NLM_p last">To a solution of <b>19</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (4 g, 20.30 mmol) in DMF (120 mL) were added Cs<sub>2</sub>CO<sub>3</sub> (8.4 g, 25.78 mmol) and 2-bromoethyl methyl ether (2.4 mL, 25.54 mmol). The yellow colored mixture was stirred for 4 h at 100 °C and then concentrated under reduced pressure. The resulting orange solid was taken-up in water and CH<sub>2</sub>Cl<sub>2</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 50 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude product mixture was silica-gel flash chromatographed (0–2% of MeOH in EtOAc), providing compound <b>20</b> as a colorless solid (4.45 g, 86%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.07 (s, 1H), 5.83 (s, 1H), 4.22 (dd, 2H, <i>J</i> = 14.3 Hz, <i>J</i> = 7.1 Hz), 4.04 (t, 2H, <i>J</i> = 4.5 Hz), 3.75 (t, 2H, <i>J</i> = 4.2 Hz), 3.49 (s, 3H), 3.41 (s, 3H), 1.30 (t, 3H, <i>J</i> = 7.1 Hz); <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 165.74, 163.92, 163.36, 145.14, 104.62, 97.09, 70.23, 68.35, 60.88, 59.37, 37.29, 14.24; HRMS (HESI) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup>: calcd for C<sub>12</sub>H<sub>18</sub>NO<sub>5</sub> 256.11795; found 256.11765.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 4-(2-Methoxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid (<b>21</b>)</h4><div class="NLM_p last">A mixture of <b>20</b> (7.8 g, 30.6 mmol) and LiOH (2.2 g, 52.8 mmol) in THF/H<sub>2</sub>O (2–1) (470 mL) was stirred for 4 h at room temperature. The mixture was then acidified to pH 1 using concentrated HCl. The product was extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the aqueous layer was washed with CH<sub>2</sub>Cl<sub>2</sub> (4 × 25 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtrated, and concentrated to afford <b>21</b> as a colorless solid (6.18 g, 89%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.34 (s, 1H), 5.99 (s, 1H), 4.26 (t, 2H, <i>J</i> = 9 Hz), 3.80 (t, 2H, <i>J</i> = 9 Hz), 3.57 (s, 3H), 3.45 (s, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.18, 163.85, 163.85, 147.03, 102.77, 97.58, 69.54, 68.96, 59.38, 37.73; HRMS (HESI) <i>m</i>/<i>z</i>: [M – H]<sup>+</sup>: calcd for C<sub>10</sub>H<sub>14</sub>NO<sub>5</sub> 228.08665 ; found 228.08621.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Preliminary Library Screen for Anti-HIV-1 Activity</h3><div class="NLM_p last">The anti-HIV-1 activity of the library molecules was measured using a human T-cell reporter assay based on CEM-GXR cells.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> These cells naturally express the HIV-1 receptor CD4 and coreceptor CXCR4 and have been engineered to expresses the other HIV-1 coreceptor, CCR5. Upon HIV-1 infection, CEM-GXR cells express GFP due to the activation of an exogenous Tat-driven LTR-GFP expression cassette, and the level of infection was monitored using flow cytometric analysis (guavaSoft 2.2 software, Guava HT8, Millipore). Cells were grown in RPMI-1640 media (Invitrogen) supplemented with 10% fetal calf serum (Invitrogen) and 100 U per ml penicillin-streptomycin. During propagation, CEM-GXR cells were selected with 0.2 mg/mL G418 (Invitrogen) and 0.1 mg/mL hygromycin B (Calbiochem). Antiviral activity was evaluated in the assay that measures inhibition of HIV-1 spread in a coculture of CEM-GXR cells containing 1% of HIV-1<sub>NL4–3</sub> infected (GFP positive) cells. Infection was performed in T25 flasks or in 96-well plates containing 1 × 10<sup>6</sup> or 8 × 10<sup>4</sup> CEM-GXR cells, respectively. The library molecules at 2 μM concentration and commercially available anti-HIV-1 reagents zidovudine 2 μM and nelfinavir 100 nM were added to the culture immediately after the inoculation by infected cells. All compounds were prepared in DMSO at the final concentration in culture that were <0.1% DMSO. The percent of infected cells in the culture was determined by flow cytometry on day 3.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> HIV-1 Inhibition Assay for <b>9</b></h3><div class="NLM_p last">Compound <b>9</b> was further evaluated in the human T-cell reporter assay based on CEM-GXR cells with the following modifications. The inhibition assay was performed in a 96-well plate and was inoculated by cells that were infected with different viral strains of interest (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). These strains of viruses were chosen based on their subtypes (A and B), coreceptor usage (CCR5, and CXCR4), and resistance to four major drug targets (reverse transcriptase, protease, integrase, and coreceptor). The culture contains serial dilutions of molecule <b>9</b> in the final concentrations between 100 nM and 10 μM. The inhibition curves were then fitted by nonlinear regression with GraphPad Prism software, allowing EC<sub>50</sub> calculation. All data are reported as the mean ± s.e.m. from three independent determinations.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> ViaCount Viability Assay</h3><div class="NLM_p">The ViaCount assay was performed with the guava easyCyte 8HT flow cytometer according to the manufacturer’s manual (Guava Technologies, Inc., Hayward, CA, USA). In brief, CEM-GXR cells were seeded in 96-well plates 8 × 10<sup>4</sup> cells/well in the absence or presence of compound <b>9</b> in concentrations ranging between 0.5 and 100 μM. Twenty-four h later, 25 μL of cell suspension was mixed with 225 μL of Guava ViaCount reagent, and the mixture was incubated for 5 min at room temperature. Sample acquisition and data analysis were performed with the selection of EasyFit analysis feature using the ViaCount software module. All data are reported as the mean ± s.e.m. from three independent determinations.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Antiviral Activity and Cell Viability for <b>1</b> and <b>9</b></h4><div class="NLM_p last">The same experimental protocols were followed as stated in the HIV-1 Inhibition Assay for <b>9</b> and in the ViaCount Viability Assay with the following exception: The concentration range for both <b>1</b> and <b>9</b> was chosen between 62.5 nM and 16 μM. The half-maximal effective concentration (EC<sub>50</sub>) values were calculated in Igor Pro software in which <b>1</b> antiviral data were fit to a sigmoidal curve <i>f</i>(<i>x</i>) = <i>a</i> + [<i>b</i>/(1 + <i>ê</i>[(<i>c</i> – <i>x</i>)/<i>d</i>])], while <b>9</b> antiviral data were fit to a hyperbolic curve <i>f</i>(<i>x</i>) = <i>a</i> + [<i>bx</i>/(1 + <i>cx</i>)].</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01357">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11277" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11277" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01357" class="ext-link">10.1021/acs.jmedchem.5b01357</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Composition of the 256-membered library of compound <b>1</b> “mimics” (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), plus bar graph presentation of the preliminary anti-HIV screening results (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a–d), and NMR (<sup>1</sup>H and <sup>13</sup>C) and high-resolution mass spectral data for the active compounds <b>9</b>–<b>12</b> and synthetic intermediates <b>15</b>–<b>21</b> described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01357/suppl_file/jm5b01357_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES string for all compounds prepared (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01357/suppl_file/jm5b01357_si_002.xls" class="ext-link">XLS</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01357/suppl_file/jm5b01357_si_001.pdf">jm5b01357_si_001.pdf (5.33 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01357/suppl_file/jm5b01357_si_002.xls">jm5b01357_si_002.xls (26.5 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01357" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40066" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40066" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David S. Grierson</span> - <span class="hlFld-Affiliation affiliation">†Faculty of Pharmaceutical Sciences, §Department of Microbiology
and Immunology, and ∥Department of
Medicine, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">British
Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Département
de microbiologie et d’infectiologie, Faculté de médecine
et des sciences de la santé, Université
de Sherbrooke, 3201,
rue Jean-Mignault, Sherbrooke, Québec J1E 4K8 Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#197d7e6b707c6b6a765974787075376c7b7a377a78"><span class="__cf_email__" data-cfemail="fb9f9c89929e898894bb969a9297d58e9998d5989a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter K. Cheung</span> - <span class="hlFld-Affiliation affiliation">British
Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Horhant</span> - <span class="hlFld-Affiliation affiliation">†Faculty of Pharmaceutical Sciences, §Department of Microbiology
and Immunology, and ∥Department of
Medicine, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">British
Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Département
de microbiologie et d’infectiologie, Faculté de médecine
et des sciences de la santé, Université
de Sherbrooke, 3201,
rue Jean-Mignault, Sherbrooke, Québec J1E 4K8 Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura E. Bandy</span> - <span class="hlFld-Affiliation affiliation">†Faculty of Pharmaceutical Sciences, §Department of Microbiology
and Immunology, and ∥Department of
Medicine, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">British
Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Département
de microbiologie et d’infectiologie, Faculté de médecine
et des sciences de la santé, Université
de Sherbrooke, 3201,
rue Jean-Mignault, Sherbrooke, Québec J1E 4K8 Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maryam Zamiri</span> - <span class="hlFld-Affiliation affiliation">†Faculty of Pharmaceutical Sciences, §Department of Microbiology
and Immunology, and ∥Department of
Medicine, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">British
Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Département
de microbiologie et d’infectiologie, Faculté de médecine
et des sciences de la santé, Université
de Sherbrooke, 3201,
rue Jean-Mignault, Sherbrooke, Québec J1E 4K8 Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Safwat M. Rabea</span> - <span class="hlFld-Affiliation affiliation">†Faculty of Pharmaceutical Sciences, §Department of Microbiology
and Immunology, and ∥Department of
Medicine, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">British
Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Département
de microbiologie et d’infectiologie, Faculté de médecine
et des sciences de la santé, Université
de Sherbrooke, 3201,
rue Jean-Mignault, Sherbrooke, Québec J1E 4K8 Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stoyan K. Karagiosov</span> - <span class="hlFld-Affiliation affiliation">†Faculty of Pharmaceutical Sciences, §Department of Microbiology
and Immunology, and ∥Department of
Medicine, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">British
Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Département
de microbiologie et d’infectiologie, Faculté de médecine
et des sciences de la santé, Université
de Sherbrooke, 3201,
rue Jean-Mignault, Sherbrooke, Québec J1E 4K8 Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mitra Matloobi</span> - <span class="hlFld-Affiliation affiliation">†Faculty of Pharmaceutical Sciences, §Department of Microbiology
and Immunology, and ∥Department of
Medicine, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">British
Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Département
de microbiologie et d’infectiologie, Faculté de médecine
et des sciences de la santé, Université
de Sherbrooke, 3201,
rue Jean-Mignault, Sherbrooke, Québec J1E 4K8 Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven McArthur</span> - <span class="hlFld-Affiliation affiliation">†Faculty of Pharmaceutical Sciences, §Department of Microbiology
and Immunology, and ∥Department of
Medicine, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">British
Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Département
de microbiologie et d’infectiologie, Faculté de médecine
et des sciences de la santé, Université
de Sherbrooke, 3201,
rue Jean-Mignault, Sherbrooke, Québec J1E 4K8 Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">P. Richard Harrigan</span> - <span class="hlFld-Affiliation affiliation">British
Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benoit Chabot</span> - <span class="hlFld-Affiliation affiliation">Département
de microbiologie et d’infectiologie, Faculté de médecine
et des sciences de la santé, Université
de Sherbrooke, 3201,
rue Jean-Mignault, Sherbrooke, Québec J1E 4K8 Canada</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d269e2344-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was generously supported by grants from the Canadian Institutes of Health Research (CIHR) (and HOP90183 and HOP120238). Special thanks goes to Dr. Florence Mahuteau-Betzer (Institut Curie, Fr) for providing a sample of compound <b>1</b> (IDC16).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> Abbreviations Used</h2><tr><td class="NLM_term">CCR5</td><td class="NLM_def"><p class="first last">C–C chemokine receptor type 5</p></td></tr><tr><td class="NLM_term">CXCR4</td><td class="NLM_def"><p class="first last">C–X–C chemokine receptor type 4</p></td></tr><tr><td class="NLM_term">SRSF1</td><td class="NLM_def"><p class="first last">serine-/arginine-rich splicing factor 1</p></td></tr><tr><td class="NLM_term">Tat</td><td class="NLM_def"><p class="first last">trans-activator of transcription</p></td></tr><tr><td class="NLM_term">Rev</td><td class="NLM_def"><p class="first last">regulator of viral protein expression</p></td></tr><tr><td class="NLM_term">nef</td><td class="NLM_def"><p class="first last">negative regulatory factor</p></td></tr><tr><td class="NLM_term">GFP</td><td class="NLM_def"><p class="first last">green fluorescent protein</p></td></tr><tr><td class="NLM_term">LTR-GFP</td><td class="NLM_def"><p class="first last">long terminal repeat-green fluorescent protein</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25755" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25755" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Logan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterne, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez-Diaz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Sighem, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wolf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costagliota, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanoy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucher, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Wyl, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casbona, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Amo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justice, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philips, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Hoyos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia de Olalla, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, M. A.</span><span> </span><span class="NLM_article-title">The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span><span class="refDoi"> DOI: 10.1097/QAD.0b013e3283324283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1097%2FQAD.0b013e3283324283" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=123-137&author=R.+M.+Loganauthor=J.+A.+Sterneauthor=S.+Hernandez-Diazauthor=J.+M.+Robinsauthor=C.+Sabinauthor=L.+Bansiauthor=A.+van+Sighemauthor=F.+de+Wolfauthor=D.+Costagliotaauthor=E.+Lanoyauthor=H.+C.+Bucherauthor=V.+von+Wylauthor=J.+Casbonaauthor=J.+del+Amoauthor=S.+Morenoauthor=A.+Justiceauthor=J.+Gouletauthor=S.+Lodiauthor=A.+Philipsauthor=R.+Sengauthor=L.+Meyerauthor=S.+Perez-Hoyosauthor=P.+Garcia+de+Olallaauthor=M.+A.+Herman&title=The+effect+of+combined+antiretroviral+therapy+on+the+overall+mortality+of+HIV-infected+individuals&doi=10.1097%2FQAD.0b013e3283324283"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1097%2FQAD.0b013e3283324283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAD.0b013e3283324283%26sid%3Dliteratum%253Aachs%26aulast%3DLogan%26aufirst%3DR.%2BM.%26aulast%3DSterne%26aufirst%3DJ.%2BA.%26aulast%3DHernandez-Diaz%26aufirst%3DS.%26aulast%3DRobins%26aufirst%3DJ.%2BM.%26aulast%3DSabin%26aufirst%3DC.%26aulast%3DBansi%26aufirst%3DL.%26aulast%3Dvan%2BSighem%26aufirst%3DA.%26aulast%3Dde%2BWolf%26aufirst%3DF.%26aulast%3DCostagliota%26aufirst%3DD.%26aulast%3DLanoy%26aufirst%3DE.%26aulast%3DBucher%26aufirst%3DH.%2BC.%26aulast%3Dvon%2BWyl%26aufirst%3DV.%26aulast%3DCasbona%26aufirst%3DJ.%26aulast%3Ddel%2BAmo%26aufirst%3DJ.%26aulast%3DMoreno%26aufirst%3DS.%26aulast%3DJustice%26aufirst%3DA.%26aulast%3DGoulet%26aufirst%3DJ.%26aulast%3DLodi%26aufirst%3DS.%26aulast%3DPhilips%26aufirst%3DA.%26aulast%3DSeng%26aufirst%3DR.%26aulast%3DMeyer%26aufirst%3DL.%26aulast%3DPerez-Hoyos%26aufirst%3DS.%26aulast%3DGarcia%2Bde%2BOlalla%26aufirst%3DP.%26aulast%3DHerman%26aufirst%3DM.%2BA.%26atitle%3DThe%2520effect%2520of%2520combined%2520antiretroviral%2520therapy%2520on%2520the%2520overall%2520mortality%2520of%2520HIV-infected%2520individuals%26jtitle%3DAIDS%26date%3D2010%26volume%3D24%26spage%3D123%26epage%3D137%26doi%3D10.1097%2FQAD.0b013e3283324283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span> </span><span class="NLM_article-title">Statistics: Worldwide</span>. <span class="NLM_publisher-name">amfAR, The Foundation for AIDS Research</span>; <a href="http://www.amfar.org/About-HIV-and-AIDS/Facts-and-Stats/Statistics--Worldwide/" class="extLink">http://www.amfar.org/About-HIV-and-AIDS/Facts-and-Stats/Statistics--Worldwide/</a> (Accessed <span class="NLM_access-date">September 2, 2014</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Statistics%3A+Worldwide.+amfAR%2C+The+Foundation+for+AIDS+Research%3B+http%3A%2F%2Fwww.amfar.org%2FAbout-HIV-and-AIDS%2FFacts-and-Stats%2FStatistics%2D%2DWorldwide%2F+%28Accessed+September+2%2C+2014%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DStatistics%253A%2520Worldwide%26pub%3DamfAR%252C%2520The%2520Foundation%2520for%2520AIDS%2520Research" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hankins, C.</span><span> </span><span class="NLM_article-title">Overview of the current state of the epidemic</span> <span class="citation_source-journal">Current HIV/AIDS Reports</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1007/s11904-013-0156-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1007%2Fs11904-013-0156-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=23579359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A280%3ADC%252BC3srksFahsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=113-123&author=C.+Hankins&title=Overview+of+the+current+state+of+the+epidemic&doi=10.1007%2Fs11904-013-0156-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the current state of the epidemic</span></div><div class="casAuthors">Hankins Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Current HIV/AIDS reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">At the end of 2011, about half of the 34.0 million [31.4-35.9 million] people living with HIV infection knew their HIV status.  With large regional variations, an estimated 0.8% of all adults aged 15 to 49 years have HIV infection and HIV subtype diversity is increasing.  Although HIV incidence has declined in 39 countries, it is stable or increasing in others.  HIV prevalence continues to rise as antiretroviral treatment scale-up results in fewer HIV-related deaths while new infections continue to occur.  Increased treatment uptake is likely reducing HIV transmission in countries with large mortality declines.  Key populations, including sex workers, men who have sex with men, transgender people, people who inject drugs and young women in high prevalence settings require effective prevention programs urgently.  Correcting mismatches in resource allocation and reducing community viral load will accelerate incidence declines and affect future epidemic trends, if concerted action is taken now.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQd2Qiai-OqeTUE-swuRqsHfW6udTcc2eYHvjPbZlOScbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srksFahsg%253D%253D&md5=c620e0a9d72feac6fe848db663d29bcd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs11904-013-0156-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11904-013-0156-x%26sid%3Dliteratum%253Aachs%26aulast%3DHankins%26aufirst%3DC.%26atitle%3DOverview%2520of%2520the%2520current%2520state%2520of%2520the%2520epidemic%26jtitle%3DCurrent%2520HIV%252FAIDS%2520Reports%26date%3D2013%26volume%3D10%26spage%3D113%26epage%3D123%26doi%3D10.1007%2Fs11904-013-0156-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Chesney, M.</span><span> </span><span class="NLM_article-title">Adherence to HAART regimens</span> <span class="citation_source-journal">AIDS Patient Care STDs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1089/108729103321619773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1089%2F108729103321619773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=12737640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A280%3ADC%252BD3s3hs12hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=169-177&author=M.+Chesney&title=Adherence+to+HAART+regimens&doi=10.1089%2F108729103321619773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Adherence to HAART regimens</span></div><div class="casAuthors">Chesney Margaret</div><div class="citationInfo"><span class="NLM_cas:title">AIDS patient care and STDs</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">169-77</span>
        ISSN:<span class="NLM_cas:issn">1087-2914</span>.
    </div><div class="casAbstract">The problem of inadequate adherence to prescribed highly active antiretroviral therapy (HAART) drug regimens to treat HIV infection and AIDS is ubiquitous.  Adherence can be inadequate despite both provider and patient understanding of the consequences of nonadherence.  Successful long-term treatment of HIV/AIDS requires at least 95% adherence to HAART in order to prevent emergence of drug-resistant HIV variants that lead to regimen failure and limit options for future therapy.  Despite the prevalence of inadequate adherence, many patients succeed, and HAART has transformed HIV infection into a chronic illness increasingly managed in primary care.  The barriers to adherence observed in HIV treatment resemble barriers to the successful treatment of other chronic diseases: regimen complexity, side effects resulting in poor tolerability, patient lifestyle factors, and patient-provider relationships.  Treatment of HIV infection has shown that patient-provider collaboration can result in the selection of a lifestyle-tailored regimen characterized by convenient dosing, low pill burden, and tolerable side effects that enhances adherence, effectiveness, and the patient's willingness to remain on anti-HIV therapy long term.  This review focuses on the current understanding of adherence reporting, improvement of adherence, and, hence, improvement of treatment outcomes in HIV infection and AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtEdEdYQFKP1QKX3ooHxWjfW6udTcc2eYHvjPbZlOScbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3hs12hsw%253D%253D&md5=32a8a9e816911ae9018a1539ecec3212</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1089%2F108729103321619773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F108729103321619773%26sid%3Dliteratum%253Aachs%26aulast%3DChesney%26aufirst%3DM.%26atitle%3DAdherence%2520to%2520HAART%2520regimens%26jtitle%3DAIDS%2520Patient%2520Care%2520STDs%26date%3D2003%26volume%3D17%26spage%3D169%26epage%3D177%26doi%3D10.1089%2F108729103321619773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Deeks, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havlir, D. V.</span><span> </span><span class="NLM_article-title">The end of AIDS: HIV infection as a chronic disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">382</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">–</span> <span class="NLM_lpage">1533</span><span class="refDoi"> DOI: 10.1016/S0140-6736(13)61809-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2FS0140-6736%2813%2961809-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2013&pages=1525-1533&author=S.+G.+Deeksauthor=S.+R.+Lewinauthor=D.+V.+Havlir&title=The+end+of+AIDS%3A+HIV+infection+as+a+chronic+disease&doi=10.1016%2FS0140-6736%2813%2961809-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2813%2961809-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252813%252961809-7%26sid%3Dliteratum%253Aachs%26aulast%3DDeeks%26aufirst%3DS.%2BG.%26aulast%3DLewin%26aufirst%3DS.%2BR.%26aulast%3DHavlir%26aufirst%3DD.%2BV.%26atitle%3DThe%2520end%2520of%2520AIDS%253A%2520HIV%2520infection%2520as%2520a%2520chronic%2520disease%26jtitle%3DLancet%26date%3D2013%26volume%3D382%26spage%3D1525%26epage%3D1533%26doi%3D10.1016%2FS0140-6736%2813%2961809-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Paredes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet, B.</span><span> </span><span class="NLM_article-title">Clinical management of HIV-1 resistance</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2009.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2Fj.antiviral.2009.09.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=245-265&author=R.+Paredesauthor=B.+Clotet&title=Clinical+management+of+HIV-1+resistance&doi=10.1016%2Fj.antiviral.2009.09.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2009.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2009.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DParedes%26aufirst%3DR.%26aulast%3DClotet%26aufirst%3DB.%26atitle%3DClinical%2520management%2520of%2520HIV-1%2520resistance%26jtitle%3DAntiviral%2520Res.%26date%3D2010%26volume%3D85%26spage%3D245%26epage%3D265%26doi%3D10.1016%2Fj.antiviral.2009.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gupta, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sultan, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamers, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ndembi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertagnolio, S.</span><span> </span><span class="NLM_article-title">Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">380</span><span class="NLM_x">, </span> <span class="NLM_fpage">1250</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span><span class="refDoi"> DOI: 10.1016/S0140-6736(12)61038-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2FS0140-6736%2812%2961038-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2012&pages=1250-1258&author=R.+K.+Guptaauthor=M.+R.+Jordanauthor=B.+J.+Sultanauthor=A.+Hillauthor=D.+H.+J.+Davisauthor=J.+Gregsonauthor=A.+W.+Sawyerauthor=R.+L.+Hamersauthor=N.+Ndembiauthor=D.+Pillayauthor=S.+Bertagnolio&title=Global+trends+in+antiretroviral+resistance+in+treatment-naive+individuals+with+HIV+after+rollout+of+antiretroviral+treatment+in+resource-limited+settings%3A+a+global+collaborative+study+and+meta-regression+analysis&doi=10.1016%2FS0140-6736%2812%2961038-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2812%2961038-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252812%252961038-1%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DR.%2BK.%26aulast%3DJordan%26aufirst%3DM.%2BR.%26aulast%3DSultan%26aufirst%3DB.%2BJ.%26aulast%3DHill%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DD.%2BH.%2BJ.%26aulast%3DGregson%26aufirst%3DJ.%26aulast%3DSawyer%26aufirst%3DA.%2BW.%26aulast%3DHamers%26aufirst%3DR.%2BL.%26aulast%3DNdembi%26aufirst%3DN.%26aulast%3DPillay%26aufirst%3DD.%26aulast%3DBertagnolio%26aufirst%3DS.%26atitle%3DGlobal%2520trends%2520in%2520antiretroviral%2520resistance%2520in%2520treatment-naive%2520individuals%2520with%2520HIV%2520after%2520rollout%2520of%2520antiretroviral%2520treatment%2520in%2520resource-limited%2520settings%253A%2520a%2520global%2520collaborative%2520study%2520and%2520meta-regression%2520analysis%26jtitle%3DLancet%26date%3D2012%26volume%3D380%26spage%3D1250%26epage%3D1258%26doi%3D10.1016%2FS0140-6736%2812%2961038-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hamers, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kityo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wit, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugyenyi, P.</span><span> </span><span class="NLM_article-title">Global threat from drug resistant HIV in sub-Saharan Africa</span> <span class="citation_source-journal">Br. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">e4159</span><span class="refDoi"> DOI: 10.1136/bmj.e4159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1136%2Fbmj.e4159" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2012&pages=e4159&author=R.+L.+Hamersauthor=C.+Kityoauthor=J.+M.+Langeauthor=T.+F.+de+Witauthor=P.+Mugyenyi&title=Global+threat+from+drug+resistant+HIV+in+sub-Saharan+Africa&doi=10.1136%2Fbmj.e4159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1136%2Fbmj.e4159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.e4159%26sid%3Dliteratum%253Aachs%26aulast%3DHamers%26aufirst%3DR.%2BL.%26aulast%3DKityo%26aufirst%3DC.%26aulast%3DLange%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BWit%26aufirst%3DT.%2BF.%26aulast%3DMugyenyi%26aufirst%3DP.%26atitle%3DGlobal%2520threat%2520from%2520drug%2520resistant%2520HIV%2520in%2520sub-Saharan%2520Africa%26jtitle%3DBr.%2520Med.%2520J.%26date%3D2012%26volume%3D344%26spage%3De4159%26doi%3D10.1136%2Fbmj.e4159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chun, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauci, A. S.</span><span> </span><span class="NLM_article-title">HIV reservoirs: pathogenesis and obstacles to viral eradication and cure</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span><span class="refDoi"> DOI: 10.1097/QAD.0b013e328353f3f1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1097%2FQAD.0b013e328353f3f1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=22472858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A280%3ADC%252BC38rhvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1261-1268&author=T.+W.+Chunauthor=A.+S.+Fauci&title=HIV+reservoirs%3A+pathogenesis+and+obstacles+to+viral+eradication+and+cure&doi=10.1097%2FQAD.0b013e328353f3f1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">HIV reservoirs:  pathogenesis and obstacles to viral eradication and cure</span></div><div class="casAuthors">Chun Tae-Wook; Fauci Anthony S</div><div class="citationInfo"><span class="NLM_cas:title">AIDS (London, England)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1261-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasma HIV viremia can be suppressed and maintained below the limits of detection for prolonged periods of time in the vast majority of HIV-infected individuals who receive antiretroviral therapy (ART).  Thus, the clinical outcome for HIV-infected individuals who have access to these drugs is dramatically improved.  However, ART alone cannot eradicate HIV in infected individuals and this impediment is likely in part due to the persistence of viral reservoirs in the peripheral blood and lymphoid tissues of infected individuals despite the suppression of plasma viremia.  In recent years, major research efforts have been dedicated to a better understanding of the pathogenesis of persistent HIV infection and to the development of therapeutic strategies aimed at eradicating virus in infected individuals receiving ART.  In this review, we discuss the pathophysiology of CD4 T-cell HIV reservoirs, including recent advances in our understanding of the mechanisms of persistent viral infection and perspectives for eradication of HIV in infected individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2vqyzYLGTzJotVjB3IRIyfW6udTcc2eaLtIkjRP7zbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rhvF2qtw%253D%253D&md5=8923fc05a3d2a14be88259b1023ed6cb</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1097%2FQAD.0b013e328353f3f1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAD.0b013e328353f3f1%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DT.%2BW.%26aulast%3DFauci%26aufirst%3DA.%2BS.%26atitle%3DHIV%2520reservoirs%253A%2520pathogenesis%2520and%2520obstacles%2520to%2520viral%2520eradication%2520and%2520cure%26jtitle%3DAIDS%26date%3D2012%26volume%3D26%26spage%3D1261%26epage%3D1268%26doi%3D10.1097%2FQAD.0b013e328353f3f1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Taube, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterlin, B. M.</span><span> </span><span class="NLM_article-title">Lost in transcription: molecular mechanisms that control HIV latency</span> <span class="citation_source-journal">Viruses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">–</span> <span class="NLM_lpage">927</span><span class="refDoi"> DOI: 10.3390/v5030902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.3390%2Fv5030902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=23518577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsVSrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=902-927&author=R.+Taubeauthor=B.+M.+Peterlin&title=Lost+in+transcription%3A+molecular+mechanisms+that+control+HIV+latency&doi=10.3390%2Fv5030902"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Lost in transcription: molecular mechanisms that control HIV latency</span></div><div class="casAuthors">Taube, Ran; Peterlin, Boris Matija</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">902-928</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Highly active antiretroviral therapy (HAART) has limited the replication and spread of the human immunodeficiency virus (HIV).  However, despite treatment, HIV infection persists in latently infected reservoirs, and once therapy is interrupted, viral replication rebounds quickly.  Extensive efforts are being directed at eliminating these cell reservoirs.  This feat can be achieved by reactivating latent HIV while administering drugs that prevent new rounds of infection and allow the immune system to clear the virus.  However, current approaches to HIV eradication have not been effective.  Moreover, as HIV latency is multifactorial, the significance of each of its mol. mechanisms is still under debate.  Among these, transcriptional repression as a result of reduced levels and activity of the pos. transcription elongation factor b (P-TEFb: CDK9/cyclin T) plays a significant role.  Therefore, increasing levels of P-TEFb expression and activity is an excellent strategy to stimulate viral gene expression.  This review summarizes the multiple steps that cause HIV to enter into latency.  It positions the interplay between transcriptionally active and inactive host transcriptional activators and their viral partner Tat as valid targets for the development of new strategies to reactivate latent viral gene expression and eradicate HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP3nHdi5AyOLVg90H21EOLACvtfcHk0liPdl5RbKowTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsVSrtLk%253D&md5=a2ba0ed16a2b7cceef4a15e355fb63d2</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.3390%2Fv5030902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv5030902%26sid%3Dliteratum%253Aachs%26aulast%3DTaube%26aufirst%3DR.%26aulast%3DPeterlin%26aufirst%3DB.%2BM.%26atitle%3DLost%2520in%2520transcription%253A%2520molecular%2520mechanisms%2520that%2520control%2520HIV%2520latency%26jtitle%3DViruses%26date%3D2013%26volume%3D5%26spage%3D902%26epage%3D927%26doi%3D10.3390%2Fv5030902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Bakkour, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayadi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuteau-Betzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mettling, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabot, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanteur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tazi, J.</span><span> </span><span class="NLM_article-title">Small-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistance</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e159</span><span class="refDoi"> DOI: 10.1371/journal.ppat.0030159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1371%2Fjournal.ppat.0030159" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=e159&author=N.+Bakkourauthor=Y.-L.+Linauthor=S.+Marieauthor=L.+Ayadiauthor=F.+Mahuteau-Betzerauthor=C.+H.+Nguyenauthor=C.+Mettlingauthor=P.+Portalesauthor=D.+Griersonauthor=B.+Chabotauthor=P.+Jeanteurauthor=P.+Corbeauauthor=J.+Tazi&title=Small-molecule+inhibition+of+HIV+pre-mRNA+splicing+as+a+novel+antiretroviral+therapy+to+overcome+drug+resistance&doi=10.1371%2Fjournal.ppat.0030159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.0030159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.0030159%26sid%3Dliteratum%253Aachs%26aulast%3DBakkour%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DY.-L.%26aulast%3DMarie%26aufirst%3DS.%26aulast%3DAyadi%26aufirst%3DL.%26aulast%3DMahuteau-Betzer%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DC.%2BH.%26aulast%3DMettling%26aufirst%3DC.%26aulast%3DPortales%26aufirst%3DP.%26aulast%3DGrierson%26aufirst%3DD.%26aulast%3DChabot%26aufirst%3DB.%26aulast%3DJeanteur%26aufirst%3DP.%26aulast%3DCorbeau%26aufirst%3DP.%26aulast%3DTazi%26aufirst%3DJ.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520HIV%2520pre-mRNA%2520splicing%2520as%2520a%2520novel%2520antiretroviral%2520therapy%2520to%2520overcome%2520drug%2520resistance%26jtitle%3DPLoS%2520Pathog.%26date%3D2007%26volume%3D3%26spage%3De159%26doi%3D10.1371%2Fjournal.ppat.0030159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Soret, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakkour, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fic, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivalle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauzonne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanteur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tazi, J.</span><span> </span><span class="NLM_article-title">Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">8764</span><span class="NLM_x">–</span> <span class="NLM_lpage">8769</span><span class="refDoi"> DOI: 10.1073/pnas.0409829102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1073%2Fpnas.0409829102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=8764-8769&author=J.+Soretauthor=N.+Bakkourauthor=S.+Marieauthor=S.+Durandauthor=L.+Zekriauthor=M.+Gabutauthor=W.+Ficauthor=G.+Divaauthor=C.+Rivalleauthor=D.+Dauzonneauthor=C.-H.+Nguyenauthor=P.+Jeanteurauthor=J.+Tazi&title=Selective+modification+of+alternative+splicing+by+indole+derivatives+that+target+serine-arginine-rich+protein+splicing+factors&doi=10.1073%2Fpnas.0409829102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0409829102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0409829102%26sid%3Dliteratum%253Aachs%26aulast%3DSoret%26aufirst%3DJ.%26aulast%3DBakkour%26aufirst%3DN.%26aulast%3DMarie%26aufirst%3DS.%26aulast%3DDurand%26aufirst%3DS.%26aulast%3DZekri%26aufirst%3DL.%26aulast%3DGabut%26aufirst%3DM.%26aulast%3DFic%26aufirst%3DW.%26aulast%3DDiva%26aufirst%3DG.%26aulast%3DRivalle%26aufirst%3DC.%26aulast%3DDauzonne%26aufirst%3DD.%26aulast%3DNguyen%26aufirst%3DC.-H.%26aulast%3DJeanteur%26aufirst%3DP.%26aulast%3DTazi%26aufirst%3DJ.%26atitle%3DSelective%2520modification%2520of%2520alternative%2520splicing%2520by%2520indole%2520derivatives%2520that%2520target%2520serine-arginine-rich%2520protein%2520splicing%2520factors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D8764%26epage%3D8769%26doi%3D10.1073%2Fpnas.0409829102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Wong, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balachandran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrowski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochrane, A.</span><span> </span><span class="NLM_article-title">Digoxin suppresses HIV-1 replication by altering viral RNA processing</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1003241</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1003241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1371%2Fjournal.ppat.1003241" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=e1003241&author=R.+W.+Wongauthor=A.+Balachandranauthor=M.+A.+Ostrowskiauthor=A.+Cochrane&title=Digoxin+suppresses+HIV-1+replication+by+altering+viral+RNA+processing&doi=10.1371%2Fjournal.ppat.1003241"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1003241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1003241%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%2BW.%26aulast%3DBalachandran%26aufirst%3DA.%26aulast%3DOstrowski%26aufirst%3DM.%2BA.%26aulast%3DCochrane%26aufirst%3DA.%26atitle%3DDigoxin%2520suppresses%2520HIV-1%2520replication%2520by%2520altering%2520viral%2520RNA%2520processing%26jtitle%3DPLoS%2520Pathog.%26date%3D2013%26volume%3D9%26spage%3De1003241%26doi%3D10.1371%2Fjournal.ppat.1003241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wong, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balachandran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoilov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochrane, A.</span><span> </span><span class="NLM_article-title">Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">9471</span><span class="NLM_x">–</span> <span class="NLM_lpage">9483</span><span class="refDoi"> DOI: 10.1093/nar/gkt727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1093%2Fnar%2Fgkt727" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=9471-9483&author=R.+W.+Wongauthor=A.+Balachandranauthor=M.+Haalandauthor=P.+Stoilovauthor=A.+Cochrane&title=Characterization+of+novel+inhibitors+of+HIV-1+replication+that+function+via+alteration+of+viral+RNA+processing+and+rev+function&doi=10.1093%2Fnar%2Fgkt727"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt727%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%2BW.%26aulast%3DBalachandran%26aufirst%3DA.%26aulast%3DHaaland%26aufirst%3DM.%26aulast%3DStoilov%26aufirst%3DP.%26aulast%3DCochrane%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520novel%2520inhibitors%2520of%2520HIV-1%2520replication%2520that%2520function%2520via%2520alteration%2520of%2520viral%2520RNA%2520processing%2520and%2520rev%2520function%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2013%26volume%3D41%26spage%3D9471%26epage%3D9483%26doi%3D10.1093%2Fnar%2Fgkt727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balachandran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson-Belaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grey-Owen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochrane, A.</span><span> </span><span class="NLM_article-title">Differential effect of Clk SR kinases on HIV-1 expression: novel targets for therapy</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="refDoi"> DOI: 10.1186/1742-4690-8-47</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1186%2F1742-4690-8-47" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=47&author=R.+Wongauthor=A.+Balachandranauthor=A.+Maoauthor=W.+Dobson-Belaireauthor=S.+Grey-Owenauthor=A.+Cochrane&title=Differential+effect+of+Clk+SR+kinases+on+HIV-1+expression%3A+novel+targets+for+therapy&doi=10.1186%2F1742-4690-8-47"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-8-47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-8-47%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%26aulast%3DBalachandran%26aufirst%3DA.%26aulast%3DMao%26aufirst%3DA.%26aulast%3DDobson-Belaire%26aufirst%3DW.%26aulast%3DGrey-Owen%26aufirst%3DS.%26aulast%3DCochrane%26aufirst%3DA.%26atitle%3DDifferential%2520effect%2520of%2520Clk%2520SR%2520kinases%2520on%2520HIV-1%2520expression%253A%2520novel%2520targets%2520for%2520therapy%26jtitle%3DRetrovirology%26date%3D2011%26volume%3D8%26spage%3D47%26doi%3D10.1186%2F1742-4690-8-47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Fukuhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshiro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzenberg, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzenberg, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Utilization of host SR protein kinases and RNA-splicing machinery during viral replication</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">11329</span><span class="NLM_x">–</span> <span class="NLM_lpage">11333</span><span class="refDoi"> DOI: 10.1073/pnas.0604616103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1073%2Fpnas.0604616103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=11329-11333&author=T.+Fukuharaauthor=T.+Hosoyaauthor=S.+Shimizuauthor=K.+Sumiauthor=T.+Oshiroauthor=Y.+Yoshinakaauthor=M.+Suzukiauthor=N.+Yamamotoauthor=L.+A.+Herzenbergauthor=L.+A.+Herzenbergauthor=M.+Hagiwara&title=Utilization+of+host+SR+protein+kinases+and+RNA-splicing+machinery+during+viral+replication&doi=10.1073%2Fpnas.0604616103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0604616103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0604616103%26sid%3Dliteratum%253Aachs%26aulast%3DFukuhara%26aufirst%3DT.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DSumi%26aufirst%3DK.%26aulast%3DOshiro%26aufirst%3DT.%26aulast%3DYoshinaka%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DHerzenberg%26aufirst%3DL.%2BA.%26aulast%3DHerzenberg%26aufirst%3DL.%2BA.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DUtilization%2520of%2520host%2520SR%2520protein%2520kinases%2520and%2520RNA-splicing%2520machinery%2520during%2520viral%2520replication%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D11329%26epage%3D11333%26doi%3D10.1073%2Fpnas.0604616103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Campos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myburgh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vautrin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapasset, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadel, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuteau-Betzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornarelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basyuk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seveno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venables, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speck, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tazi, J.</span><span> </span><span class="NLM_article-title">Long lasting control of viral rebound with a new drug ABX464 targeting rev-mediated viral RNA biogenesis</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="refDoi"> DOI: 10.1186/s12977-015-0159-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1186%2Fs12977-015-0159-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=30&author=N.+Camposauthor=R.+Myburghauthor=A.+Garcelauthor=A.+Vautrinauthor=L.+Lapassetauthor=E.+S.+Nadelauthor=F.+Mahuteau-Betzerauthor=R.+Najmanauthor=P.+Fornarelliauthor=K.+Tantaleauthor=E.+Basyukauthor=M.+Sevenoauthor=J.+P.+Venablesauthor=B.+Pauauthor=E.+Bertrandauthor=M.+A.+Wainbergauthor=R.+F.+Speckauthor=D.+Scherrrauthor=J.+Tazi&title=Long+lasting+control+of+viral+rebound+with+a+new+drug+ABX464+targeting+rev-mediated+viral+RNA+biogenesis&doi=10.1186%2Fs12977-015-0159-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1186%2Fs12977-015-0159-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12977-015-0159-3%26sid%3Dliteratum%253Aachs%26aulast%3DCampos%26aufirst%3DN.%26aulast%3DMyburgh%26aufirst%3DR.%26aulast%3DGarcel%26aufirst%3DA.%26aulast%3DVautrin%26aufirst%3DA.%26aulast%3DLapasset%26aufirst%3DL.%26aulast%3DNadel%26aufirst%3DE.%2BS.%26aulast%3DMahuteau-Betzer%26aufirst%3DF.%26aulast%3DNajman%26aufirst%3DR.%26aulast%3DFornarelli%26aufirst%3DP.%26aulast%3DTantale%26aufirst%3DK.%26aulast%3DBasyuk%26aufirst%3DE.%26aulast%3DSeveno%26aufirst%3DM.%26aulast%3DVenables%26aufirst%3DJ.%2BP.%26aulast%3DPau%26aufirst%3DB.%26aulast%3DBertrand%26aufirst%3DE.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26aulast%3DSpeck%26aufirst%3DR.%2BF.%26aulast%3DScherrr%26aufirst%3DD.%26aulast%3DTazi%26aufirst%3DJ.%26atitle%3DLong%2520lasting%2520control%2520of%2520viral%2520rebound%2520with%2520a%2520new%2520drug%2520ABX464%2520targeting%2520rev-mediated%2520viral%2520RNA%2520biogenesis%26jtitle%3DRetrovirology%26date%3D2015%26volume%3D12%26spage%3D30%26doi%3D10.1186%2Fs12977-015-0159-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Stoltzfus, C. M.</span><span> </span><span class="NLM_article-title">Regulation of HIV-1 Alternative RNA splicing and its role in virus replication</span> <span class="citation_source-journal">Adv. Virus Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/S0065-3527(09)74001-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2FS0065-3527%2809%2974001-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=1-40&author=C.+M.+Stoltzfus&title=Regulation+of+HIV-1+Alternative+RNA+splicing+and+its+role+in+virus+replication&doi=10.1016%2FS0065-3527%2809%2974001-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0065-3527%2809%2974001-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-3527%252809%252974001-1%26sid%3Dliteratum%253Aachs%26aulast%3DStoltzfus%26aufirst%3DC.%2BM.%26atitle%3DRegulation%2520of%2520HIV-1%2520Alternative%2520RNA%2520splicing%2520and%2520its%2520role%2520in%2520virus%2520replication%26jtitle%3DAdv.%2520Virus%2520Res.%26date%3D2009%26volume%3D74%26spage%3D1%26epage%3D40%26doi%3D10.1016%2FS0065-3527%2809%2974001-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Karn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoltzfus, C. M.</span><span> </span><span class="NLM_article-title">Transcriptional and posttranscriptional regulation of HIV gene expression</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006916</span><span class="refDoi"> DOI: 10.1101/cshperspect.a006916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1101%2Fcshperspect.a006916" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=a006916&author=J.+Karnauthor=C.+M.+Stoltzfus&title=Transcriptional+and+posttranscriptional+regulation+of+HIV+gene+expression&doi=10.1101%2Fcshperspect.a006916"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006916%26sid%3Dliteratum%253Aachs%26aulast%3DKarn%26aufirst%3DJ.%26aulast%3DStoltzfus%26aufirst%3DC.%2BM.%26atitle%3DTranscriptional%2520and%2520posttranscriptional%2520regulation%2520of%2520HIV%2520gene%2520expression%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D4%26spage%3Da006916%26doi%3D10.1101%2Fcshperspect.a006916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Tazi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakkour, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayadi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboufirassi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branlant, C.</span><span> </span><span class="NLM_article-title">Alternative splicing: regulation of HIV-1 multiplication as a target for therapeutic action</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07522.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1111%2Fj.1742-4658.2009.07522.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2010&pages=867-876&author=J.+Taziauthor=N.+Bakkourauthor=V.+Marchandauthor=L.+Ayadiauthor=A.+Aboufirassiauthor=C.+Branlant&title=Alternative+splicing%3A+regulation+of+HIV-1+multiplication+as+a+target+for+therapeutic+action&doi=10.1111%2Fj.1742-4658.2009.07522.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07522.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07522.x%26sid%3Dliteratum%253Aachs%26aulast%3DTazi%26aufirst%3DJ.%26aulast%3DBakkour%26aufirst%3DN.%26aulast%3DMarchand%26aufirst%3DV.%26aulast%3DAyadi%26aufirst%3DL.%26aulast%3DAboufirassi%26aufirst%3DA.%26aulast%3DBranlant%26aufirst%3DC.%26atitle%3DAlternative%2520splicing%253A%2520regulation%2520of%2520HIV-1%2520multiplication%2520as%2520a%2520target%2520for%2520therapeutic%2520action%26jtitle%3DFEBS%2520J.%26date%3D2010%26volume%3D277%26spage%3D867%26epage%3D876%26doi%3D10.1111%2Fj.1742-4658.2009.07522.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hryckiewicz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowala-Piaskowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolewska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mozer-Lisewska, I.</span><span> </span><span class="NLM_article-title">HIV RNA splicing</span> <span class="citation_source-journal">HIV & AIDS Review</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/j.hivar.2011.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2Fj.hivar.2011.05.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=61-64&author=K.+Hryckiewiczauthor=M.+Buraauthor=A.+Kowala-Piaskowskaauthor=B.+Bolewskaauthor=I.+Mozer-Lisewska&title=HIV+RNA+splicing&doi=10.1016%2Fj.hivar.2011.05.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.hivar.2011.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.hivar.2011.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DHryckiewicz%26aufirst%3DK.%26aulast%3DBura%26aufirst%3DM.%26aulast%3DKowala-Piaskowska%26aufirst%3DA.%26aulast%3DBolewska%26aufirst%3DB.%26aulast%3DMozer-Lisewska%26aufirst%3DI.%26atitle%3DHIV%2520RNA%2520splicing%26jtitle%3DHIV%2520%2526%2520AIDS%2520Review%26date%3D2011%26volume%3D10%26spage%3D61%26epage%3D64%26doi%3D10.1016%2Fj.hivar.2011.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Florent, J.-C.</span><span> </span><span class="NLM_article-title">Chimiotheque de petites molecules, outil de recherche pour la biologie chimique</span> <span class="citation_source-journal">Biol. Aujourd'hui</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1051/jbio/2013006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1051%2Fjbio%2F2013006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=23694724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVemsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2013&pages=39-54&author=J.-C.+Florent&title=Chimiotheque+de+petites+molecules%2C+outil+de+recherche+pour+la+biologie+chimique&doi=10.1051%2Fjbio%2F2013006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Small compounds libraries: a research tool for chemical biology</span></div><div class="casAuthors">Florent, Jean-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Biologie Aujourd'hui</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-54</span>CODEN:
                <span class="NLM_cas:coden">BAIUBC</span>;
        ISSN:<span class="NLM_cas:issn">2105-0678</span>.
    
            (<span class="NLM_cas:orgname">EDP Sciences</span>)
        </div><div class="casAbstract">A review.  Obtaining and screening collections of small mols. remain a challenge for biologists.  Recent advances in anal. techniques and instrumentation now make screening possible in academia.  The history of the creation of such public or com. collections and their accessibility is related.  It shows that there is interest for an academic lab. involved in medicinal chem., chemogenomics or "chem. biol." to organize its own collection and make it available through existing networks such as the French National chimiotheque or the European partner network "European Infrastructure of open screening platforms for Chem. Biol." EU-OpenScreen under construction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2UOE0RcRGvbVg90H21EOLACvtfcHk0li8t8RX4VPHCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVemsrfF&md5=0bdfc727015126b93d534c6e7904cc95</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1051%2Fjbio%2F2013006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fjbio%252F2013006%26sid%3Dliteratum%253Aachs%26aulast%3DFlorent%26aufirst%3DJ.-C.%26atitle%3DChimiotheque%2520de%2520petites%2520molecules%252C%2520outil%2520de%2520recherche%2520pour%2520la%2520biologie%2520chimique%26jtitle%3DBiol.%2520Aujourd%2527hui%26date%3D2013%26volume%3D207%26spage%3D39%26epage%3D54%26doi%3D10.1051%2Fjbio%2F2013006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Zhong, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeld, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X. D.</span><span> </span><span class="NLM_article-title">SR proteins in vertical integration of gene expression from transcription to RNA processing to translation</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1016/j.molcel.2009.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2Fj.molcel.2009.06.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=1-10&author=X.+Y.+Zhongauthor=P.+Wangauthor=M.+G.+Rosenfeldauthor=X.+D.+Fu&title=SR+proteins+in+vertical+integration+of+gene+expression+from+transcription+to+RNA+processing+to+translation&doi=10.1016%2Fj.molcel.2009.06.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DX.%2BY.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DRosenfeld%26aufirst%3DM.%2BG.%26aulast%3DFu%26aufirst%3DX.%2BD.%26atitle%3DSR%2520proteins%2520in%2520vertical%2520integration%2520of%2520gene%2520expression%2520from%2520transcription%2520to%2520RNA%2520processing%2520to%2520translation%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D35%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.molcel.2009.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Stoltzfus, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, J. M.</span><span> </span><span class="NLM_article-title">Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative splicing</span> <span class="citation_source-journal">Curr. HIV Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.2174/157016206775197655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.2174%2F157016206775197655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=16454710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVyrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=43-45&author=C.+M.+Stoltzfusauthor=J.+M.+Madsen&title=Role+of+viral+splicing+elements+and+cellular+RNA+binding+proteins+in+regulation+of+HIV-1+alternative+splicing&doi=10.2174%2F157016206775197655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing</span></div><div class="casAuthors">Stoltzfus, C. Martin; Madsen, Joshua M.</div><div class="citationInfo"><span class="NLM_cas:title">Current HIV Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-55</span>CODEN:
                <span class="NLM_cas:coden">CHRUBF</span>;
        ISSN:<span class="NLM_cas:issn">1570-162X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In HIV-1 infected cells, over 40 different mRNA species are produced by alternative splicing of the single HIV-1 primary RNA transcript.  In addn., approx. half of the HIV-1 primary RNA transcripts are not spliced and are exported to the cytoplasm where they serve as mRNA and as genomic RNA.  In this article, we will review current knowledge of the mechanisms by which the HIV-1 alternative splicing is regulated.  Several neg. and pos.-acting cis-acting elements have been detected within the viral genome that repress or facilitate viral RNA splicing by binding to cellular proteins.  These include exonic splicing silencers (ESS) and an intronic splicing silencer (ISS) that are selectively bound either by members of the hnRNP A/B family (hnRNPs A1, A1B, A2, and B1) or by hnRNP H.  Exonic splicing enhancers (ESE) are also present within the HIV-1 genome and are selectively bound by members of the SR protein family.  ESS and ISS repression mediated by hnRNP A/B proteins occurs at early steps of splicing, prior to formation of pre-spliceosome complexes.  Current models propose that ESS elements promote cooperative binding of hnRNP A/B proteins to the exon and prevent efficient binding of essential cellular splicing factors to the 3' splice site.  SR proteins bound to ESE elements that are juxtaposed or overlapping ESS elements may counteract this inhibition.  We will review data indicating the importance of the HIV-1 splicing elements and their cognate binding proteins for efficient virus replication.  Differences in cis-acting splicing elements between the group M (major) and group O (outlier) HIV-1 strains will also be discussed.  Finally we will review evidence suggesting the possibility that there may be changes in regulation of HIV-1 alternative splicing in infected human T cells, human macrophages and rodent cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprD_VYzL2NCLVg90H21EOLACvtfcHk0li8t8RX4VPHCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVyrug%253D%253D&md5=a1933c3d54ae0d5211cf8063d953b1f5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F157016206775197655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157016206775197655%26sid%3Dliteratum%253Aachs%26aulast%3DStoltzfus%26aufirst%3DC.%2BM.%26aulast%3DMadsen%26aufirst%3DJ.%2BM.%26atitle%3DRole%2520of%2520viral%2520splicing%2520elements%2520and%2520cellular%2520RNA%2520binding%2520proteins%2520in%2520regulation%2520of%2520HIV-1%2520alternative%2520splicing%26jtitle%3DCurr.%2520HIV%2520Res.%26date%3D2006%26volume%3D4%26spage%3D43%26epage%3D45%26doi%3D10.2174%2F157016206775197655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Rivalle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tambourin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hloste, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisagni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherman, J. C.</span><span> </span><span class="NLM_article-title">Antitumor amino-substituted pyrido[3′,4′:4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new sidechain and heterocycle modifications</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1021/jm00356a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00356a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1983&pages=181-185&author=C.+Rivalleauthor=F.+Wendlingauthor=P.+Tambourinauthor=J.+M.+Hlosteauthor=E.+Bisagniauthor=J.+C.+Cherman&title=Antitumor+amino-substituted+pyrido%5B3%E2%80%B2%2C4%E2%80%B2%3A4%2C5%5Dpyrrolo%5B2%2C3-g%5Disoquinolines+and+pyrido%5B4%2C3-b%5Dcarbazole+derivatives%3A+synthesis+and+evaluation+of+compounds+resulting+from+new+sidechain+and+heterocycle+modifications&doi=10.1021%2Fjm00356a012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm00356a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00356a012%26sid%3Dliteratum%253Aachs%26aulast%3DRivalle%26aufirst%3DC.%26aulast%3DWendling%26aufirst%3DF.%26aulast%3DTambourin%26aufirst%3DP.%26aulast%3DHloste%26aufirst%3DJ.%2BM.%26aulast%3DBisagni%26aufirst%3DE.%26aulast%3DCherman%26aufirst%3DJ.%2BC.%26atitle%3DAntitumor%2520amino-substituted%2520pyrido%255B3%25E2%2580%25B2%252C4%25E2%2580%25B2%253A4%252C5%255Dpyrrolo%255B2%252C3-g%255Disoquinolines%2520and%2520pyrido%255B4%252C3-b%255Dcarbazole%2520derivatives%253A%2520synthesis%2520and%2520evaluation%2520of%2520compounds%2520resulting%2520from%2520new%2520sidechain%2520and%2520heterocycle%2520modifications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1983%26volume%3D26%26spage%3D181%26epage%3D185%26doi%3D10.1021%2Fjm00356a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Miller, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, F. O.</span><span> </span><span class="NLM_article-title">Isolation, biological activity and synthesis of the natural product ellipticine and related pyridocarbazoles</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">8883</span><span class="NLM_x">–</span> <span class="NLM_lpage">8918</span><span class="refDoi"> DOI: 10.1039/c2ra20584j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1039%2Fc2ra20584j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlKjtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=8883-8918&author=C.+M.+Millerauthor=F.+O.+McCarthy&title=Isolation%2C+biological+activity+and+synthesis+of+the+natural+product+ellipticine+and+related+pyridocarbazoles&doi=10.1039%2Fc2ra20584j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation, biological activity and synthesis of the natural product ellipticine and related pyridocarbazoles</span></div><div class="casAuthors">Miller, Charlotte M.; McCarthy, Florence O.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8883-8918</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The tetracyclic natural product ellipticine (5,11-dimethyl-6H-pyrido[4,3-b]carbazole) was first isolated from the plant material of Ochrosia elliptica Labill in 1959.  Woodward et al. reported the first synthesis of ellipticine later the same year, and this was followed by many different synthetic strategies in subsequent decades.  Investigation of the biol. activity of ellipticines uncovered potent anti-cancer properties and several ellipticine derivs. have been the subject of clin. trials.  The ellipticine family of compds. exert their biol. activity via several modes of action, the most well established of which are intercalation with DNA and topoisomerase II inhibition.  In recent times other modes of action have been revealed, including kinase inhibition, interaction with p53 transcription factor, bio-oxidn. and adduct formation.  The scope of this review covers key features of the biol. activity of ellipticine, with emphasis on new modes of action, followed by synthetic routes to ellipticine, including key early syntheses of pyrido[4,3-b]carbazoles and comprehensive coverage of the literature since the late 1980s, along with more recent syntheses of ellipticine analogs and substituted ellipticines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdUDXUL_E_S7Vg90H21EOLACvtfcHk0libaW6lTexMDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlKjtbbL&md5=cc0acb5dbdee793c83a39a145ae25e4f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2Fc2ra20584j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ra20584j%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DC.%2BM.%26aulast%3DMcCarthy%26aufirst%3DF.%2BO.%26atitle%3DIsolation%252C%2520biological%2520activity%2520and%2520synthesis%2520of%2520the%2520natural%2520product%2520ellipticine%2520and%2520related%2520pyridocarbazoles%26jtitle%3DRSC%2520Adv.%26date%3D2012%26volume%3D2%26spage%3D8883%26epage%3D8918%26doi%3D10.1039%2Fc2ra20584j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Poljakova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckschlager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrabeta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrebakova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smutny, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinek, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kizek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiborova, M.</span><span> </span><span class="NLM_article-title">The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1466</span><span class="NLM_x">–</span> <span class="NLM_lpage">1479</span><span class="refDoi"> DOI: 10.1016/j.bcp.2009.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2Fj.bcp.2009.01.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=1466-1479&author=J.+Poljakovaauthor=T.+Eckschlagerauthor=J.+Hrabetaauthor=J.+Hrebakovaauthor=S.+Smutnyauthor=E.+Freiauthor=V.+Martinekauthor=R.+Kizekauthor=M.+Stiborova&title=The+mechanism+of+cytotoxicity+and+DNA+adduct+formation+by+the+anticancer+drug+ellipticine+in+human+neuroblastoma+cells&doi=10.1016%2Fj.bcp.2009.01.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DPoljakova%26aufirst%3DJ.%26aulast%3DEckschlager%26aufirst%3DT.%26aulast%3DHrabeta%26aufirst%3DJ.%26aulast%3DHrebakova%26aufirst%3DJ.%26aulast%3DSmutny%26aufirst%3DS.%26aulast%3DFrei%26aufirst%3DE.%26aulast%3DMartinek%26aufirst%3DV.%26aulast%3DKizek%26aufirst%3DR.%26aulast%3DStiborova%26aufirst%3DM.%26atitle%3DThe%2520mechanism%2520of%2520cytotoxicity%2520and%2520DNA%2520adduct%2520formation%2520by%2520the%2520anticancer%2520drug%2520ellipticine%2520in%2520human%2520neuroblastoma%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D77%26spage%3D1466%26epage%3D1479%26doi%3D10.1016%2Fj.bcp.2009.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Stiborova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poljakova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinkova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borek-Dohalska, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckschlager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kizek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, E.</span><span> </span><span class="NLM_article-title">Ellipticine cytotoxicity to cancer cell lines- a comparative study</span> <span class="citation_source-journal">Interdiscip. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.2478/v10102-011-0017-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.2478%2Fv10102-011-0017-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=21753906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFamsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=98-105&author=M.+Stiborovaauthor=J.+Poljakovaauthor=E.+Martinkovaauthor=L.+Borek-Dohalskaauthor=T.+Eckschlagerauthor=R.+Kizekauthor=E.+Frei&title=Ellipticine+cytotoxicity+to+cancer+cell+lines-+a+comparative+study&doi=10.2478%2Fv10102-011-0017-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Ellipticine cytotoxicity to cancer cell lines a comparative study</span></div><div class="casAuthors">Stiborova, Marie; Poljakova, Jitka; Martinkova, Eva; Booek-Dohalska, Lucie; Eckschlager, Tomas; Kizek, Rene; Frei, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Interdisciplinary Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">98-105</span>CODEN:
                <span class="NLM_cas:coden">ITNOCQ</span>;
        ISSN:<span class="NLM_cas:issn">1337-6853</span>.
    
            (<span class="NLM_cas:orgname">Versita</span>)
        </div><div class="casAbstract">Ellipticine is a potent antineoplastic agent exhibiting multiple mechanisms of action.  This anticancer agent should be considered a pro-drug, whose pharmacol. efficiency and/or genotoxic side effects are dependent on its cytochrome P 450 (CYP)- and/or peroxidase-mediated activation to species forming covalent DNA adducts.  Ellipticine can also act as an inhibitor or inducer of biotransformation enzymes, thereby modulating its own metab. leading to its genotoxic and pharmacol. effects.  Here, a comparison of the toxicity of ellipticine to human breast adenocarcinoma MCF-7 cells, leukemia HL-60 and CCRF-CEM cells, neuroblastoma IMR-32, UKF-NB-3 and UKF-NB-4 cells and U87MG glioblastoma cells and mechanisms of its action to these cells were evaluated.  Treatment of all cells tested with ellipticine resulted in inhibition of cell growth and proliferation.  This effect was assocd. with formation of two covalent ellipticine-derived DNA adducts, identical to those formed by 13-hydroxy- and 12-hydroxyellipticine, the ellipticine metabolites generated by CYP and peroxidase enzymes, in MCF-7, HL-60, CCRF-CEM, UKF-NB-3, UKF-NB-4 and U87MG cells, but not in neuroblastoma UKF-NB-3 cells.  Therefore, DNA adduct formation in most cancer cell lines tested in this comparative study might be the predominant cause of their sensitivity to ellipticine treatment, whereas other mechanisms of ellipticine action also contribute to its cytotoxicity to neuroblastoma UKF-NB-3 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5I6frItT2ELVg90H21EOLACvtfcHk0ljmu-j-cNlikQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFamsLY%253D&md5=02b26a20fff3fa50213ade19d36e62e5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2478%2Fv10102-011-0017-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2478%252Fv10102-011-0017-7%26sid%3Dliteratum%253Aachs%26aulast%3DStiborova%26aufirst%3DM.%26aulast%3DPoljakova%26aufirst%3DJ.%26aulast%3DMartinkova%26aufirst%3DE.%26aulast%3DBorek-Dohalska%26aufirst%3DL.%26aulast%3DEckschlager%26aufirst%3DT.%26aulast%3DKizek%26aufirst%3DR.%26aulast%3DFrei%26aufirst%3DE.%26atitle%3DEllipticine%2520cytotoxicity%2520to%2520cancer%2520cell%2520lines-%2520a%2520comparative%2520study%26jtitle%3DInterdiscip.%2520Toxicol.%26date%3D2011%26volume%3D4%26spage%3D98%26epage%3D105%26doi%3D10.2478%2Fv10102-011-0017-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chacon-Garcia, L.</span><span> </span><span class="NLM_article-title">The search of DNA-intercalators as antitumoral drugs: what worked and what did not work</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.2174/0929867053363414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.2174%2F0929867053363414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=15638732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=127-151&author=R.+Martinezauthor=L.+Chacon-Garcia&title=The+search+of+DNA-intercalators+as+antitumoral+drugs%3A+what+worked+and+what+did+not+work&doi=10.2174%2F0929867053363414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The search of DNA-intercalators as antitumoral drugs: What it worked and what did not work</span></div><div class="casAuthors">Martinez, R.; Chacon-Garcia, L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-151</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The discovery of new compds. with antitumoral activity has become one of the most important goals in medicinal chem.  One interesting group of chemotherapeutic agents used in cancer therapy comprises mols. that interact with DNA.  Research in this area has revealed a range of DNA recognizing mols. that act as antitumoral agents, including groove binders, alkylating and intercalator compds.  DNA intercalators (mols. that intercalate between DNA base pairs) have attracted particular attention due to their antitumoral activity.  For example, a no. of acridine and anthracycline derivs. are excellent DNA intercalators that are now on the market as chemotherapeutic agents.  Com. available acridine and anthracycline derivs. were widely studied from a variety of viewpoints, such as physicochem. properties, structural requirements, synthesis and biol. activity.  However, the clin. application of these and other compds. of the same class has encountered problems such as multidrug resistance (MRD), and secondary and/or collateral effects.  These shortcomings have motivated the search for new compds. to be used either in place of, or in conjunction with, the existing compds.  Unfortunately, the results of this search have not met expectations.  The vast majority of candidate intercalator compds. tested for use as anticancer agents have shown little or no biol. activity.  Research in this area was not without benefits, however, for it has produced much information on the synthesis and antitumoral properties of hundreds of compds., which were tested on diverse tumoral cell lines.  This review considers the structural and biol. considerations relevant to the use of DNA intercalators and bis-intercalators as antitumoral agents, with an emphasis on the relationship between structure and activity, produced in last decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAY5OdG9bCCbVg90H21EOLACvtfcHk0ljYYgloIOh7DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOqsQ%253D%253D&md5=41d600f1698c211cf7a7de160d04dd5e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F0929867053363414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867053363414%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DChacon-Garcia%26aufirst%3DL.%26atitle%3DThe%2520search%2520of%2520DNA-intercalators%2520as%2520antitumoral%2520drugs%253A%2520what%2520worked%2520and%2520what%2520did%2520not%2520work%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D127%26epage%3D151%26doi%3D10.2174%2F0929867053363414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Brockman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, G. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, T. M.</span><span> </span><span class="NLM_article-title">Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry</span> <span class="citation_source-journal">J. Virol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span><span class="refDoi"> DOI: 10.1016/j.jviromet.2005.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2Fj.jviromet.2005.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=16182382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVShtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2006&pages=134-142&author=M.+A.+Brockmanauthor=G.+O.+Tanziauthor=B.+D.+Walkerauthor=T.+M.+Allen&title=Use+of+a+novel+GFP+reporter+cell+line+to+examine+replication+capacity+of+CXCR4-+and+CCR5-tropic+HIV-1+by+flow+cytometry&doi=10.1016%2Fj.jviromet.2005.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry</span></div><div class="casAuthors">Brockman, Mark A.; Tanzi, Giancarlo O.; Walker, Bruce D.; Allen, Todd M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">134-142</span>CODEN:
                <span class="NLM_cas:coden">JVMEDH</span>;
        ISSN:<span class="NLM_cas:issn">0166-0934</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The rate of HIV-1 disease progression correlates strongly with plasma viral load and is likely to be influenced by both host and viral determinants.  Though interest in the impact of viral replication capacity during HIV-1 infection has been increasing, esp. with respect to drug resistance mutations, its influence on disease course remains poorly understood.  This is due in part to significant drawbacks in conventional means of measuring HIV-1 growth in vitro (i.e. expense, inconvenience, and exptl. variability).  A FACS-based method is described here to measure HIV-1 replication sensitively and a modification of this method can be used to det. viral titer accurately.  Importantly, the target cells used are permissive to CXCR4- and CCR5-tropic HIV-1 strains.  In pilot expts., the growth kinetics of lab.-adapted strains NL4-3 and IIIB were examd. carefully.  Using this method, differences were obsd. in growth kinetics between three lab. strains and seven primary isolates, indicating the potential for a broad range of in vitro replication capacities among individual isolates.  In conclusion, this FACS-based method provides a sensitive approach to measure the replication capacity of HIV-1 and may prove useful in studies examg. the impact of viral fitness on disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxN2IocQ7gR7Vg90H21EOLACvtfcHk0ljYYgloIOh7DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVShtA%253D%253D&md5=8f3863a9ffb1f75d6f080e68350f66b6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.jviromet.2005.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jviromet.2005.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DBrockman%26aufirst%3DM.%2BA.%26aulast%3DTanzi%26aufirst%3DG.%2BO.%26aulast%3DWalker%26aufirst%3DB.%2BD.%26aulast%3DAllen%26aufirst%3DT.%2BM.%26atitle%3DUse%2520of%2520a%2520novel%2520GFP%2520reporter%2520cell%2520line%2520to%2520examine%2520replication%2520capacity%2520of%2520CXCR4-%2520and%2520CCR5-tropic%2520HIV-1%2520by%2520flow%2520cytometry%26jtitle%3DJ.%2520Virol.%2520Methods%26date%3D2006%26volume%3D131%26spage%3D134%26epage%3D142%26doi%3D10.1016%2Fj.jviromet.2005.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Guillier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nivoliers, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queguiner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneikus, V.</span><span> </span><span class="NLM_article-title">Combined metalation-palladium-catalyzed cross coupling strategies. A formal synthesis of the marine alkaloid amphimedine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1021/jo00107a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00107a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=292-296&author=F.+Guillierauthor=F.+Nivoliersauthor=A.+Godardauthor=F.+Marsaisauthor=G.+Queguinerauthor=M.+A.+Siddiquiauthor=V.+Sneikus&title=Combined+metalation-palladium-catalyzed+cross+coupling+strategies.+A+formal+synthesis+of+the+marine+alkaloid+amphimedine&doi=10.1021%2Fjo00107a004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Fjo00107a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00107a004%26sid%3Dliteratum%253Aachs%26aulast%3DGuillier%26aufirst%3DF.%26aulast%3DNivoliers%26aufirst%3DF.%26aulast%3DGodard%26aufirst%3DA.%26aulast%3DMarsais%26aufirst%3DF.%26aulast%3DQueguiner%26aufirst%3DG.%26aulast%3DSiddiqui%26aufirst%3DM.%2BA.%26aulast%3DSneikus%26aufirst%3DV.%26atitle%3DCombined%2520metalation-palladium-catalyzed%2520cross%2520coupling%2520strategies.%2520A%2520formal%2520synthesis%2520of%2520the%2520marine%2520alkaloid%2520amphimedine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D292%26epage%3D296%26doi%3D10.1021%2Fjo00107a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Marsais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trecourt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queguiner, G.</span><span> </span><span class="NLM_article-title">Directed lithiation of 4-halopyridines: chemoselectivity, regioselectivity, and application to synthesis</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1002/jhet.5570250112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1002%2Fjhet.5570250112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1988&pages=81-87&author=F.+Marsaisauthor=F.+Trecourtauthor=P.+Breantauthor=G.+Queguiner&title=Directed+lithiation+of+4-halopyridines%3A+chemoselectivity%2C+regioselectivity%2C+and+application+to+synthesis&doi=10.1002%2Fjhet.5570250112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570250112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570250112%26sid%3Dliteratum%253Aachs%26aulast%3DMarsais%26aufirst%3DF.%26aulast%3DTrecourt%26aufirst%3DF.%26aulast%3DBreant%26aufirst%3DP.%26aulast%3DQueguiner%26aufirst%3DG.%26atitle%3DDirected%2520lithiation%2520of%25204-halopyridines%253A%2520chemoselectivity%252C%2520regioselectivity%252C%2520and%2520application%2520to%2520synthesis%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1988%26volume%3D25%26spage%3D81%26epage%3D87%26doi%3D10.1002%2Fjhet.5570250112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Ross, W. C. J.</span><span> </span><span class="NLM_article-title">The preparation of some 4-substituted nicotinic acids and nicotinamide<i>s</i></span> <span class="citation_source-journal">J. Chem. Soc. C</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_fpage">1816</span><span class="NLM_x">–</span> <span class="NLM_lpage">1821</span><span class="refDoi"> DOI: 10.1039/j39660001816</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1039%2Fj39660001816" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADyaF28XkvF2htr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1966&pages=1816-1821&author=W.+C.+J.+Ross&title=The+preparation+of+some+4-substituted+nicotinic+acids+and+nicotinamides&doi=10.1039%2Fj39660001816"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of some 4-substituted nicotinic acids and nicotinamides</span></div><div class="casAuthors">Ross, W. C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society [Section] C:  Organic</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1816-21</span>CODEN:
                <span class="NLM_cas:coden">JSOOAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-4952</span>.
    </div><div class="casAbstract">Nicotinamide adenine dinucleotide (NAD) analogs in which the 4-position of the pyridine ring carries a substituent are potential inhibitors of the glycolytic process by which many cancer cells derive an appreciable proportion of their energy requirements.  Such analogs should be produced in vivo by the administration of 4-substituted nicotinic acid derivs.  The prepn. of the following derivs. is described: 4-hydroxy-, 4-methoxy-, 4-butoxy-, 4-(2-hydroxyethylthio)-, 4-S-cysteinyl-, 4-amino-, 4-anilino-, and 4-benzylamino-nicotinic acids and -nicotinamides.  4-Ethoxy- and 4-(2-bromoethylthio)nicotinic acids and 4-benzylthionicotinamide were also obtained.  A preliminary report on the biol. activity of some of the derivs, is given.  17 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZvCDb5NWqbbVg90H21EOLACvtfcHk0ljds1bh21mxFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28XkvF2htr0%253D&md5=232589877c794de9c7b09a8f225a9082</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fj39660001816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fj39660001816%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DW.%2BC.%2BJ.%26atitle%3DThe%2520preparation%2520of%2520some%25204-substituted%2520nicotinic%2520acids%2520and%2520nicotinamides%26jtitle%3DJ.%2520Chem.%2520Soc.%2520C%26date%3D1966%26spage%3D1816%26epage%3D1821%26doi%3D10.1039%2Fj39660001816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Beak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeigler, J. M.</span><span> </span><span class="NLM_article-title">Self-association and the protomeric equilibria of 4-hydroxypyridine - 4-pyridone and related compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1021/jo00395a047</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00395a047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=177-178&author=P.+Beakauthor=J.+B.+Covingtonauthor=J.+M.+Zeigler&title=Self-association+and+the+protomeric+equilibria+of+4-hydroxypyridine+-+4-pyridone+and+related+compounds&doi=10.1021%2Fjo00395a047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo00395a047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00395a047%26sid%3Dliteratum%253Aachs%26aulast%3DBeak%26aufirst%3DP.%26aulast%3DCovington%26aufirst%3DJ.%2BB.%26aulast%3DZeigler%26aufirst%3DJ.%2BM.%26atitle%3DSelf-association%2520and%2520the%2520protomeric%2520equilibria%2520of%25204-hydroxypyridine%2520-%25204-pyridone%2520and%2520related%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1978%26volume%3D43%26spage%3D177%26epage%3D178%26doi%3D10.1021%2Fjo00395a047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bernofsky, C.</span><span> </span><span class="NLM_article-title">New synthesis of the 4- and 6-pyridones of 1-methylnicotinamide and 1-methylnicotinic acid (trigonelline)</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span><span class="refDoi"> DOI: 10.1016/0003-2697(79)90572-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2F0003-2697%2879%2990572-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1979&pages=189-200&author=C.+Bernofsky&title=New+synthesis+of+the+4-+and+6-pyridones+of+1-methylnicotinamide+and+1-methylnicotinic+acid+%28trigonelline%29&doi=10.1016%2F0003-2697%2879%2990572-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2879%2990572-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252879%252990572-4%26sid%3Dliteratum%253Aachs%26aulast%3DBernofsky%26aufirst%3DC.%26atitle%3DNew%2520synthesis%2520of%2520the%25204-%2520and%25206-pyridones%2520of%25201-methylnicotinamide%2520and%25201-methylnicotinic%2520acid%2520%2528trigonelline%2529%26jtitle%3DAnal.%2520Biochem.%26date%3D1979%26volume%3D96%26spage%3D189%26epage%3D200%26doi%3D10.1016%2F0003-2697%2879%2990572-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Di Marco, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferlan, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bombi, G. G.</span><span> </span><span class="NLM_article-title">Methyl-hydroxypyridinecarboxylic acids as possible bidentate chelating agents for aluminium(III): synthesis and metal-ligand solution chemistry</span> <span class="citation_source-journal">Eur. J. Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">1284</span><span class="NLM_x">–</span> <span class="NLM_lpage">1293</span><span class="refDoi"> DOI: 10.1002/ejic.200500986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1002%2Fejic.200500986" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=1284-1293&author=V.+B.+Di+Marcoauthor=A.+Deanauthor=M.+G.+Ferlanauthor=R.+A.+Yokelauthor=H.+Liauthor=A.+Venzoauthor=G.+G.+Bombi&title=Methyl-hydroxypyridinecarboxylic+acids+as+possible+bidentate+chelating+agents+for+aluminium%28III%29%3A+synthesis+and+metal-ligand+solution+chemistry&doi=10.1002%2Fejic.200500986"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1002%2Fejic.200500986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.200500986%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarco%26aufirst%3DV.%2BB.%26aulast%3DDean%26aufirst%3DA.%26aulast%3DFerlan%26aufirst%3DM.%2BG.%26aulast%3DYokel%26aufirst%3DR.%2BA.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DVenzo%26aufirst%3DA.%26aulast%3DBombi%26aufirst%3DG.%2BG.%26atitle%3DMethyl-hydroxypyridinecarboxylic%2520acids%2520as%2520possible%2520bidentate%2520chelating%2520agents%2520for%2520aluminium%2528III%2529%253A%2520synthesis%2520and%2520metal-ligand%2520solution%2520chemistry%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2006%26volume%3D2006%26spage%3D1284%26epage%3D1293%26doi%3D10.1002%2Fejic.200500986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Wallace, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarski, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otten, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorami, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woessner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, K.</span><span> </span><span class="NLM_article-title">Potent and selective mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors. 1. 4-(bromo-2-fluorophenylamino)-1-methylpyridin-2(1<i>H</i>)-ones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1021/jm050834y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050834y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=441-444&author=E.+M.+Wallaceauthor=J.+Lyssikatosauthor=J.+F.+Blakeauthor=J.+Seoauthor=H.+W.+Yangauthor=T.+C.+Yehauthor=M.+Perrierauthor=H.+Jarskiauthor=V.+Marshauthor=G.+Pochauthor=M.+G.+Livingstonauthor=J.+Ottenauthor=G.+Hingoramiauthor=R.+Woessnerauthor=P.+Leeauthor=J.+Winklerauthor=K.+Koch&title=Potent+and+selective+mitogen-activated+protein+kinase+kinase+%28MEK%29+1%2C2+inhibitors.+1.+4-%28bromo-2-fluorophenylamino%29-1-methylpyridin-2%281H%29-ones&doi=10.1021%2Fjm050834y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm050834y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050834y%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DE.%2BM.%26aulast%3DLyssikatos%26aufirst%3DJ.%26aulast%3DBlake%26aufirst%3DJ.%2BF.%26aulast%3DSeo%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DH.%2BW.%26aulast%3DYeh%26aufirst%3DT.%2BC.%26aulast%3DPerrier%26aufirst%3DM.%26aulast%3DJarski%26aufirst%3DH.%26aulast%3DMarsh%26aufirst%3DV.%26aulast%3DPoch%26aufirst%3DG.%26aulast%3DLivingston%26aufirst%3DM.%2BG.%26aulast%3DOtten%26aufirst%3DJ.%26aulast%3DHingorami%26aufirst%3DG.%26aulast%3DWoessner%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DWinkler%26aufirst%3DJ.%26aulast%3DKoch%26aufirst%3DK.%26atitle%3DPotent%2520and%2520selective%2520mitogen-activated%2520protein%2520kinase%2520kinase%2520%2528MEK%2529%25201%252C2%2520inhibitors.%25201.%25204-%2528bromo-2-fluorophenylamino%2529-1-methylpyridin-2%25281H%2529-ones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D441%26epage%3D444%26doi%3D10.1021%2Fjm050834y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Saag, M. S.</span><span> </span><span class="NLM_article-title">Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">126</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><span class="refDoi"> DOI: 10.1086/498348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1086%2F498348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=16323102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsValsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=126-131&author=M.+S.+Saag&title=Emtricitabine%2C+a+new+antiretroviral+agent+with+activity+against+HIV+and+hepatitis+B+virus&doi=10.1086%2F498348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus</span></div><div class="casAuthors">Saag, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-131</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  Emtricitabine (FTC) is a new nucleoside agent that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus.  It is very similar to lamivudine (3TC) with respect to its activity, convenience, and safety and resistance profile.  Indeed, with the exception of the longer intracellular half-life of triphosphate FTC, there is little to distinguish between the 2 drugs.  Clin. trials comparing FTC with 3TC as part of a triple-drug regimen have demonstrated their equivalence, whereas a study comparing activity of FTC with that of stavudine demonstrated FTC's superiority.  In clin. practice, the choice of 3TC vs. FTC will most likely be made in the context of drugs coformulated with them.  Although FTC is not formally approved for use in patients coinfected with HIV and hepatitis B virus, it is often a preferred choice for such patients when combined with tenofovir, which also has anti-hepatitis B virus activity.  Recent treatment guidelines for the treatment of HIV infection by both the International AIDS Society-USA and US Department of Health and Human Services have placed FTC in combination with tenofovir, didanosine, or zidovudine in the preferred category of nucleoside backbone regimens for patients receiving antiretroviral therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvgFcWq9cy_rVg90H21EOLACvtfcHk0liJ-VmbyfH2Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsValsw%253D%253D&md5=8c629c051a97702611a846e044b6b6fc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1086%2F498348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F498348%26sid%3Dliteratum%253Aachs%26aulast%3DSaag%26aufirst%3DM.%2BS.%26atitle%3DEmtricitabine%252C%2520a%2520new%2520antiretroviral%2520agent%2520with%2520activity%2520against%2520HIV%2520and%2520hepatitis%2520B%2520virus%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2006%26volume%3D42%26spage%3D126%26epage%3D131%26doi%3D10.1086%2F498348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Wensing, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Günthard, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paredes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, D. D.</span><span> </span><span class="NLM_article-title">Update of the drug resistance mutations in HIV-1</span> <span class="citation_source-journal">Top. Antivir Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=25101529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A280%3ADC%252BC2cbpslyqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=642-650&author=A.+M.+Wensingauthor=V.+Calvezauthor=H.+F.+G%C3%BCnthardauthor=V.+A.+Johnsonauthor=R.+Paredesauthor=D.+Pillayauthor=R.+W.+Shaferauthor=D.+D.+Richman&title=Update+of+the+drug+resistance+mutations+in+HIV-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">2014 Update of the drug resistance mutations in HIV-1</span></div><div class="casAuthors">Wensing Annemarie M; Calvez Vincent; Gunthard Huldrych F; Johnson Victoria A; Paredes Roger; Pillay Deenan; Shafer Robert W; Richman Douglas D</div><div class="citationInfo"><span class="NLM_cas:title">Topics in antiviral medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">642-50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This July 2014 edition of the IAS-USA drug resistance mutations list updates the figures last published in March 2013.  The following mutations have been added to existing classes or drugs: K65E/N has been added to the bars for the nucleoside and nucleotide analogue reverse transcriptase inhibitors (nRTIs) abacavir, didanosine, emtricitabine, lamivudine, stavudine, and tenofovir; L100I has been added to the bar for the nonnucleoside analogue reverse transcriptase inhibitor (NNRTI) rilpivirine; and F121Y has been added to the bars for the integrase strand transfer inhibitors (InSTIs) dolutegravir, elvitegravir, and raltegravir.  With regard to protease inhibitors (PIs), it cannot be excluded that drug resistance may be selected for outside the protease encoding region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfGd8CCEOs1JagfuraLLzSfW6udTcc2eZnR06YqoF5H7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbpslyqtQ%253D%253D&md5=f2df041240b12acaa476c6f2a16be2b0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWensing%26aufirst%3DA.%2BM.%26aulast%3DCalvez%26aufirst%3DV.%26aulast%3DG%25C3%25BCnthard%26aufirst%3DH.%2BF.%26aulast%3DJohnson%26aufirst%3DV.%2BA.%26aulast%3DParedes%26aufirst%3DR.%26aulast%3DPillay%26aufirst%3DD.%26aulast%3DShafer%26aufirst%3DR.%2BW.%26aulast%3DRichman%26aufirst%3DD.%2BD.%26atitle%3DUpdate%2520of%2520the%2520drug%2520resistance%2520mutations%2520in%2520HIV-1%26jtitle%3DTop.%2520Antivir%2520Med.%26date%3D2014%26volume%3D22%26spage%3D642%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span>Major HIV-1 drug resistance mutations updated March 9, 2015. <span class="NLM_publisher-name">Stanford University</span>; <a href="http://hivdb.stanford.edu/pages/download/resistanceMutations_handout.pdf" class="extLink">http://hivdb.stanford.edu/pages/download/resistanceMutations_handout.pdf</a> (accessed December 1,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Major+HIV-1+drug+resistance+mutations+updated+March+9%2C+2015.+Stanford+University%3B+http%3A%2F%2Fhivdb.stanford.edu%2Fpages%2Fdownload%2FresistanceMutations_handout.pdf+%28accessed+December+1%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26pub%3DStanford%2520University%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Abram, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hluhanich, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreatta, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margot, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedziela-Majka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novikov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svarovskaia, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McColl, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span> </span><span class="NLM_article-title">Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2654</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1128/AAC.02568-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1128%2FAAC.02568-12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=2654-63&author=M.+E.+Abramauthor=R.+M.+Hluhanichauthor=D.+D.+Goodmanauthor=K.+N.+Andreattaauthor=N.+A.+Margotauthor=L.+Yeauthor=A.+Niedziela-Majkaauthor=T.+L.+Barnesauthor=N.+Novikovauthor=X.+Chenauthor=E.+S.+Svarovskaiaauthor=D.+J.+McCollauthor=K.+L.+Whiteauthor=M.+D.+Miller&title=Impact+of+primary+elvitegravir+resistance-associated+mutations+in+HIV-1+integrase+on+drug+susceptibility+and+viral+replication+fitness&doi=10.1128%2FAAC.02568-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FAAC.02568-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02568-12%26sid%3Dliteratum%253Aachs%26aulast%3DAbram%26aufirst%3DM.%2BE.%26aulast%3DHluhanich%26aufirst%3DR.%2BM.%26aulast%3DGoodman%26aufirst%3DD.%2BD.%26aulast%3DAndreatta%26aufirst%3DK.%2BN.%26aulast%3DMargot%26aufirst%3DN.%2BA.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DNiedziela-Majka%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DT.%2BL.%26aulast%3DNovikov%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSvarovskaia%26aufirst%3DE.%2BS.%26aulast%3DMcColl%26aufirst%3DD.%2BJ.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26atitle%3DImpact%2520of%2520primary%2520elvitegravir%2520resistance-associated%2520mutations%2520in%2520HIV-1%2520integrase%2520on%2520drug%2520susceptibility%2520and%2520viral%2520replication%2520fitness%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D2654%26epage%3D63%26doi%3D10.1128%2FAAC.02568-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Underwood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">The activity of the integrase inhibitor dolutegravir against HIV-1 variants isolated from raltegravir-treated adults</span> <span class="citation_source-journal">JAIDS, J. Acquired Immune Defic. Syndr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span><span class="refDoi"> DOI: 10.1097/QAI.0b013e31826bfd02</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1097%2FQAI.0b013e31826bfd02" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=22878423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOltLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=297-301&author=M.+R.+Underwoodauthor=B.+A.+Johnsauthor=A.+Satoauthor=J.+N.+Martinauthor=S.+G.+Deeksauthor=T.+Fujiwara&title=The+activity+of+the+integrase+inhibitor+dolutegravir+against+HIV-1+variants+isolated+from+raltegravir-treated+adults&doi=10.1097%2FQAI.0b013e31826bfd02"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The Activity of the Integrase Inhibitor Dolutegravir Against HIV-1 Variants Isolated From Raltegravir-Treated Adults</span></div><div class="casAuthors">Underwood, Mark R.; Johns, Brian A.; Sato, Akihiko; Martin, Jeffrey N.; Deeks, Steven G.; Fujiwara, Tamio</div><div class="citationInfo"><span class="NLM_cas:title">JAIDS, Journal of Acquired Immune Deficiency Syndromes</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-301</span>CODEN:
                <span class="NLM_cas:coden">JJASFJ</span>;
        ISSN:<span class="NLM_cas:issn">1525-4135</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background: Dolutegravir (DTG, S/GSK1349572) is an integrase inhibitor with low nanomolar potency.  Susceptibility to dolutegravir and raltegravir was detd. for raltegravir-resistant clin. isolates.  Methods: Genotypic and phenotypic susceptibility to integrase inhibitors was examd. using 39 clin. isolate samples obtained from 18 adults who had exhibited incomplete viral suppression on a raltegravir-based regimen.  Results: Of 39 samples evaluated, 30 had genotypic and phenotypic resistance to raltegravir.  All samples lacking raltegravir resistance retained complete susceptibility to dolutegravir.  Of the 30 samples with genotypic evidence of raltegravir resistance, the median level of phenotypic resistance to raltegravir was high (median fold change in inhibitory concn. at 50%, >81; range, 3.7 to >87), while the level of resistance to dolutegravir was close to that of wild-type variants (median fold change, 1.5; range, 0.9-19.0).  Longitudinal samples from 5 subjects collected during long-term failure of raltegravir revealed time-dependent general decreases in phenotypic susceptibility to raltegravir, with minimal changes in phenotypic susceptibility to dolutegravir.  The median fold change to dolutegravir for isolates contg. changes at G140S + Q148H, G140S + Q148R, T97A + Y143R, and N155H (thus including raltegravir signature resistance codons) were 3.75, 13.3, 1.05, and 1.37, resp.  Conclusions: Dolutegravir retained in vitro activity against clin. isolates obtained from subjects who failed raltegravir-based therapy at near wild-type levels for variants contg. the Y143 and N155 resistance mutations.  Isolates with Q148 plus addnl. integrase mutations possessed a broader range of and more reduced susceptibility to dolutegravir.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy9wwfQcHmibVg90H21EOLACvtfcHk0linJbA6a32XOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOltLbI&md5=3e41a79982103a73fd87db812f8faf73</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1097%2FQAI.0b013e31826bfd02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAI.0b013e31826bfd02%26sid%3Dliteratum%253Aachs%26aulast%3DUnderwood%26aufirst%3DM.%2BR.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DJ.%2BN.%26aulast%3DDeeks%26aufirst%3DS.%2BG.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DThe%2520activity%2520of%2520the%2520integrase%2520inhibitor%2520dolutegravir%2520against%2520HIV-1%2520variants%2520isolated%2520from%2520raltegravir-treated%2520adults%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2012%26volume%3D61%26spage%3D297%26epage%3D301%26doi%3D10.1097%2FQAI.0b013e31826bfd02" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Delobel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saliou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiseau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coassin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Requena, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massip, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izopet, J.</span><span> </span><span class="NLM_article-title">Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2506</span><span class="NLM_x">–</span> <span class="NLM_lpage">2514</span><span class="refDoi"> DOI: 10.1093/jac/dkt249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1093%2Fjac%2Fdkt249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=23794603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CmtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=2506-2514&author=P.+Delobelauthor=M.+Cazabatauthor=A.+Saliouauthor=C.+Loiseauauthor=L.+Coassinauthor=S.+Raymondauthor=M.+Requenaauthor=B.+Marchouauthor=P.+Massipauthor=J.+Izopet&title=Primary+resistance+of+CCR5-tropic+HIV-1+to+maraviroc+cannot+be+predicted+by+the+V3+sequence&doi=10.1093%2Fjac%2Fdkt249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence</span></div><div class="casAuthors">Delobel, Pierre; Cazabat, Michelle; Saliou, Adrien; Loiseau, Claire; Coassin, Lucile; Raymond, Stephanie; Requena, Mary; Marchou, Bruno; Massip, Patrice; Izopet, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2506-2514</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives Resistance of HIV-1 to CCR5 antagonists can occur without coreceptor switching by mutations in envelope glycoproteins that enable virus entry using the inhibitor-bound form of CCR5.  We investigated whether mutations in the V3 region of HIV-1 from subjects naive to maraviroc could be assocd. with primary resistance to this drug.  Methods The frequency of CCR5-tropic HIV-1 subtype B isolates harboring putative V3 maraviroc resistance mutations was assessed among the HIV tropism database of Toulouse University Hospital, France.  Phenotypic assessment of maraviroc susceptibility was performed for 14 isolates representative of the main mutation patterns and 14 controls.  V3 mutations were reversed or introduced by site-directed mutagenesis.  Results Ninety-three of 951 (9.8%) isolates harbored V3 mutations assumed to be assocd. with maraviroc resistance.  Maraviroc completely blocked virus entry for all but 1 of the 14 isolates harbouring V3 mutations [IC50 8.6 nM; 95% CI (6.6-47.4)], as in the 14 control isolates [IC50 13.4 nM; 95% CI (7.7-50.3)] (P=0.24).  Primary resistance to maraviroc, with a plateau in entry inhibition, was found in one isolate (harbouring a 20F/21I genotype).  Site-directed mutagenesis showed that V3 mutations are necessary but not sufficient to induce maraviroc resistance.  Conclusions The impact of V3 mutations depended on the env context in which they occurred.  Simple assessment of the V3 genotype thus cannot accurately predict maraviroc resistance.  Rather, phenotypic assessment of virus particles expressing the envelope glycoprotein as a whole is required.  This approach revealed that primary resistance of CCR5-tropic HIV-1 subtype B isolates to maraviroc seems uncommon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSrjBUW38XKrVg90H21EOLACvtfcHk0ljxa6M5yaxtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CmtbbP&md5=b1a2ea3b38c79127a5b5e9a22c949c10</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt249%26sid%3Dliteratum%253Aachs%26aulast%3DDelobel%26aufirst%3DP.%26aulast%3DCazabat%26aufirst%3DM.%26aulast%3DSaliou%26aufirst%3DA.%26aulast%3DLoiseau%26aufirst%3DC.%26aulast%3DCoassin%26aufirst%3DL.%26aulast%3DRaymond%26aufirst%3DS.%26aulast%3DRequena%26aufirst%3DM.%26aulast%3DMarchou%26aufirst%3DB.%26aulast%3DMassip%26aufirst%3DP.%26aulast%3DIzopet%26aufirst%3DJ.%26atitle%3DPrimary%2520resistance%2520of%2520CCR5-tropic%2520HIV-1%2520to%2520maraviroc%2520cannot%2520be%2520predicted%2520by%2520the%2520V3%2520sequence%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2013%26volume%3D68%26spage%3D2506%26epage%3D2514%26doi%3D10.1093%2Fjac%2Fdkt249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.2174/1389200054021799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnelauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups&doi=10.2174%2F1389200054021799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0ljFfP88wju2Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnel%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225%26doi%3D10.2174%2F1389200054021799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Shkreta, L.; Blanchette, M.; Toutant, J.; Wilhem, E.; Bell, B.; Cochrane, A.; Harrigan, P. R.; Cheung, P. K.; Grierson, D. S.; Chabot, B.</span> submitted for publication.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Shkreta%2C+L.%3B+Blanchette%2C+M.%3B+Toutant%2C+J.%3B+Wilhem%2C+E.%3B+Bell%2C+B.%3B+Cochrane%2C+A.%3B+Harrigan%2C+P.+R.%3B+Cheung%2C+P.+K.%3B+Grierson%2C+D.+S.%3B+Chabot%2C+B.+submitted+for+publication."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DShkreta%26aufirst%3DL." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30a','cit30b'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zheng Sonia Lin, Xing Tong, Brian Patrick, Pierre Kennepohl, <span class="NLM_string-name hlFld-ContribAuthor">David S. Grierson</span>. </span><span class="cited-content_cbyCitation_article-title">Reaction of 3-Cl/OMe-Substituted 5-Nitrobenzisothiazoles with Hydrazine: Structural and Computational Evidence for Rearrangement Pathways Implicating Intramolecular Formation of Pivotal Meisenheimer Complexes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (9)
                                     , 6381-6389. <a href="https://doi.org/10.1021/acs.joc.1c00118" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00118%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DReaction%252Bof%252B3-Cl%25252FOMe-Substituted%252B5-Nitrobenzisothiazoles%252Bwith%252BHydrazine%25253A%252BStructural%252Band%252BComputational%252BEvidence%252Bfor%252BRearrangement%252BPathways%252BImplicating%252BIntramolecular%252BFormation%252Bof%252BPivotal%252BMeisenheimer%252BComplexes%26aulast%3DLin%26aufirst%3DZheng%2BSonia%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30012021%26date%3D14042021%26volume%3D86%26issue%3D9%26spage%3D6381%26epage%3D6389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Julius Hillenbrand, Won Seok Ham, <span class="NLM_string-name hlFld-ContribAuthor">Tobias Ritter</span>. </span><span class="cited-content_cbyCitation_article-title">C–H Pyridonation of (Hetero-)Arenes by Pyridinium Radical Cations. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (13)
                                     , 5363-5367. <a href="https://doi.org/10.1021/acs.orglett.9b02054" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02054%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DC%2525E2%252580%252593H%252BPyridonation%252Bof%252B%252528Hetero-%252529Arenes%252Bby%252BPyridinium%252BRadical%252BCations%26aulast%3DHillenbrand%26aufirst%3DJulius%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14062019%26date%3D26062019%26volume%3D21%26issue%3D13%26spage%3D5363%26epage%3D5367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Safwat
M. Rabea, Alireza Baradaran-Heravi, Aruna D. Balgi, Alexandra Krause, Sara Hosseini Farahabadi, Michel Roberge, <span class="NLM_string-name hlFld-ContribAuthor">David S. Grierson</span>. </span><span class="cited-content_cbyCitation_article-title">2-Aminothiazole-4-carboxamides Enhance Readthrough of Premature Termination Codons by Aminoglycosides. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (5)
                                     , 726-731. <a href="https://doi.org/10.1021/acsmedchemlett.8b00610" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00610%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D2-Aminothiazole-4-carboxamides%252BEnhance%252BReadthrough%252Bof%252BPremature%252BTermination%252BCodons%252Bby%252BAminoglycosides%26aulast%3DRabea%26aufirst%3DSafwat%2BM.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D03122018%26date%3D09042019%26date%3D12042019%26date%3D09042019%26volume%3D10%26issue%3D5%26spage%3D726%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shaoyong Lu, <span class="NLM_string-name hlFld-ContribAuthor">Jian Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug–Target Interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 24-45. <a href="https://doi.org/10.1021/acs.jmedchem.7b01844" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01844%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BAllosteric%252BModulators%252Bof%252BG-Protein-Coupled%252BReceptors%25253A%252BDrug%2525E2%252580%252593Target%252BInteractions%26aulast%3DLu%26aufirst%3DShaoyong%26date%3D2019%26date%3D2018%26date%3D2017%26date%3D14122017%26date%3D26022018%26date%3D19022018%26volume%3D62%26issue%3D1%26spage%3D24%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Sohail</span>, <span class="hlFld-ContribAuthor ">Lulzim  Shkreta</span>, <span class="hlFld-ContribAuthor ">Johanne  Toutant</span>, <span class="hlFld-ContribAuthor ">Safwat  Rabea</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Babeu</span>, <span class="hlFld-ContribAuthor ">Caroline  Huard</span>, <span class="hlFld-ContribAuthor ">Jasmin  Coulombe-Huntington</span>, <span class="hlFld-ContribAuthor ">Aurélie  Delannoy</span>, <span class="hlFld-ContribAuthor ">Morgane  Placet</span>, <span class="hlFld-ContribAuthor ">Sameh  Geha</span>, <span class="hlFld-ContribAuthor ">Fernand-Pierre  Gendron</span>, <span class="hlFld-ContribAuthor ">François  Boudreau</span>, <span class="hlFld-ContribAuthor ">Mike  Tyers</span>, <span class="hlFld-ContribAuthor ">David S  Grierson</span>, <span class="hlFld-ContribAuthor ">Benoit  Chabot</span>. </span><span class="cited-content_cbyCitation_article-title">A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells. </span><span class="cited-content_cbyCitation_journal-name">NAR Cancer</span><span> <strong>2021,</strong> <em>3 </em>
                                    (2)
                                     <a href="https://doi.org/10.1093/narcan/zcab019" title="DOI URL">https://doi.org/10.1093/narcan/zcab019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/narcan/zcab019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnarcan%2Fzcab019%26sid%3Dliteratum%253Aachs%26jtitle%3DNAR%2520Cancer%26atitle%3DA%252Bnovel%252Bclass%252Bof%252Binhibitors%252Bthat%252Btarget%252BSRSF10%252Band%252Bpromote%252Bp53-mediated%252Bcytotoxicity%252Bon%252Bhuman%252Bcolorectal%252Bcancer%252Bcells%26aulast%3DSohail%26aufirst%3DMuhammad%26date%3D2021%26date%3D2021%26volume%3D3%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hélène  Chabrolles</span>, <span class="hlFld-ContribAuthor ">Héloïse  Auclair</span>, <span class="hlFld-ContribAuthor ">Serena  Vegna</span>, <span class="hlFld-ContribAuthor ">Thomas  Lahlali</span>, <span class="hlFld-ContribAuthor ">Caroline  Pons</span>, <span class="hlFld-ContribAuthor ">Maud  Michelet</span>, <span class="hlFld-ContribAuthor ">Yohann  Couté</span>, <span class="hlFld-ContribAuthor ">Lucid  Belmudes</span>, <span class="hlFld-ContribAuthor ">Gilliane  Chadeuf</span>, <span class="hlFld-ContribAuthor ">Yujin  Kim</span>, <span class="hlFld-ContribAuthor ">Ariel  Di Bernardo</span>, <span class="hlFld-ContribAuthor ">Pascal  Jalaguier</span>, <span class="hlFld-ContribAuthor ">François-Loïc  Cosset</span>, <span class="hlFld-ContribAuthor ">Floriane  Fusil</span>, <span class="hlFld-ContribAuthor ">Michel  Rivoire</span>, <span class="hlFld-ContribAuthor ">Lee D.  Arnold</span>, <span class="hlFld-ContribAuthor ">Uri  Lopatin</span>, <span class="hlFld-ContribAuthor ">Christophe  Combet</span>, <span class="hlFld-ContribAuthor ">Fabien  Zoulim</span>, <span class="hlFld-ContribAuthor ">David  Grierson</span>, <span class="hlFld-ContribAuthor ">Benoit  Chabot</span>, <span class="hlFld-ContribAuthor ">Julie  Lucifora</span>, <span class="hlFld-ContribAuthor ">David  Durantel</span>, <span class="hlFld-ContribAuthor ">Anna  Salvetti</span>, . </span><span class="cited-content_cbyCitation_article-title">Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production. </span><span class="cited-content_cbyCitation_journal-name">PLOS Pathogens</span><span> <strong>2020,</strong> <em>16 </em>
                                    (11)
                                     , e1008593. <a href="https://doi.org/10.1371/journal.ppat.1008593" title="DOI URL">https://doi.org/10.1371/journal.ppat.1008593</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1008593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1008593%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Pathogens%26atitle%3DHepatitis%252BB%252Bvirus%252BCore%252Bprotein%252Bnuclear%252Binteractome%252Bidentifies%252BSRSF10%252Bas%252Ba%252Bhost%252BRNA-binding%252Bprotein%252Brestricting%252BHBV%252BRNA%252Bproduction%26aulast%3DChabrolles%26aufirst%3DH%25C3%25A9l%25C3%25A8ne%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D11%26spage%3De1008593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yahya I  Asiri</span>, <span class="hlFld-ContribAuthor ">Abdulrhman  Alsayari</span>, <span class="hlFld-ContribAuthor ">Abdullatif B  Muhsinah</span>, <span class="hlFld-ContribAuthor ">Yahia N  Mabkhot</span>, <span class="hlFld-ContribAuthor ">Mohd Z  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Benzothiazoles as potential antiviral agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacy and Pharmacology</span><span> <strong>2020,</strong> <em>72 </em>
                                    (11)
                                     , 1459-1480. <a href="https://doi.org/10.1111/jphp.13331" title="DOI URL">https://doi.org/10.1111/jphp.13331</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jphp.13331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjphp.13331%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacy%2520and%2520Pharmacology%26atitle%3DBenzothiazoles%252Bas%252Bpotential%252Bantiviral%252Bagents%26aulast%3DAsiri%26aufirst%3DYahya%2BI%26date%3D2020%26date%3D2020%26volume%3D72%26issue%3D11%26spage%3D1459%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raymond W.  Wong</span>, <span class="hlFld-ContribAuthor ">Ahalya  Balachandran</span>, <span class="hlFld-ContribAuthor ">Peter K.  Cheung</span>, <span class="hlFld-ContribAuthor ">Ran  Cheng</span>, <span class="hlFld-ContribAuthor ">Qun  Pan</span>, <span class="hlFld-ContribAuthor ">Peter  Stoilov</span>, <span class="hlFld-ContribAuthor ">P. Richard  Harrigan</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Blencowe</span>, <span class="hlFld-ContribAuthor ">Donald R.  Branch</span>, <span class="hlFld-ContribAuthor ">Alan  Cochrane</span>, . </span><span class="cited-content_cbyCitation_article-title">An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing. </span><span class="cited-content_cbyCitation_journal-name">PLOS Pathogens</span><span> <strong>2020,</strong> <em>16 </em>
                                    (2)
                                     , e1008307. <a href="https://doi.org/10.1371/journal.ppat.1008307" title="DOI URL">https://doi.org/10.1371/journal.ppat.1008307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1008307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1008307%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Pathogens%26atitle%3DAn%252Bactivator%252Bof%252BG%252Bprotein-coupled%252Breceptor%252Band%252BMEK1%25252F2-ERK1%25252F2%252Bsignaling%252Binhibits%252BHIV-1%252Breplication%252Bby%252Baltering%252Bviral%252BRNA%252Bprocessing%26aulast%3DWong%26aufirst%3DRaymond%2BW.%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D2%26spage%3De1008307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mateusz  Stoszko</span>, <span class="hlFld-ContribAuthor ">Enrico  Ne</span>, <span class="hlFld-ContribAuthor ">Erik  Abner</span>, <span class="hlFld-ContribAuthor ">Tokameh  Mahmoudi</span>. </span><span class="cited-content_cbyCitation_article-title">A broad drug arsenal to attack a strenuous latent HIV reservoir. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Virology</span><span> <strong>2019,</strong> <em>38 </em>, 37-53. <a href="https://doi.org/10.1016/j.coviro.2019.06.001" title="DOI URL">https://doi.org/10.1016/j.coviro.2019.06.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coviro.2019.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coviro.2019.06.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Virology%26atitle%3DA%252Bbroad%252Bdrug%252Barsenal%252Bto%252Battack%252Ba%252Bstrenuous%252Blatent%252BHIV%252Breservoir%26aulast%3DStoszko%26aufirst%3DMateusz%26date%3D2019%26volume%3D38%26spage%3D37%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katherine G  Zyner</span>, <span class="hlFld-ContribAuthor ">Darcie S  Mulhearn</span>, <span class="hlFld-ContribAuthor ">Santosh  Adhikari</span>, <span class="hlFld-ContribAuthor ">Sergio  Martínez Cuesta</span>, <span class="hlFld-ContribAuthor ">Marco  Di Antonio</span>, <span class="hlFld-ContribAuthor ">Nicolas  Erard</span>, <span class="hlFld-ContribAuthor ">Gregory J  Hannon</span>, <span class="hlFld-ContribAuthor ">David  Tannahill</span>, <span class="hlFld-ContribAuthor ">Shankar  Balasubramanian</span>. </span><span class="cited-content_cbyCitation_article-title">Genetic interactions of G-quadruplexes in humans. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2019,</strong> <em>8 </em><a href="https://doi.org/10.7554/eLife.46793" title="DOI URL">https://doi.org/10.7554/eLife.46793</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.46793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.46793%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DGenetic%252Binteractions%252Bof%252BG-quadruplexes%252Bin%252Bhumans%26aulast%3DZyner%26aufirst%3DKatherine%2BG%26date%3D2019%26date%3D2019%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahalya  Balachandran</span>, <span class="hlFld-ContribAuthor ">Liang  Ming</span>, <span class="hlFld-ContribAuthor ">Alan  Cochrane</span>. </span><span class="cited-content_cbyCitation_article-title">Teetering on the Edge. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 229-251. <a href="https://doi.org/10.1016/B978-0-12-811185-7.00006-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-811185-7.00006-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-811185-7.00006-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-811185-7.00006-6%26sid%3Dliteratum%253Aachs%26atitle%3DTeetering%252Bon%252Bthe%252BEdge%26aulast%3DBalachandran%26aufirst%3DAhalya%26date%3D2018%26spage%3D229%26epage%3D251%26pub%3DElsevier%26atitle%3DRetrovirus-Cell%252BInteractions%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahalya  Balachandran</span>, <span class="hlFld-ContribAuthor ">Raymond  Wong</span>, <span class="hlFld-ContribAuthor ">Peter  Stoilov</span>, <span class="hlFld-ContribAuthor ">Sandy  Pan</span>, <span class="hlFld-ContribAuthor ">Benjamin  Blencowe</span>, <span class="hlFld-ContribAuthor ">Peter  Cheung</span>, <span class="hlFld-ContribAuthor ">P. Richard  Harrigan</span>, <span class="hlFld-ContribAuthor ">Alan  Cochrane</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of small molecule modulators of HIV-1 Tat and Rev protein accumulation. </span><span class="cited-content_cbyCitation_journal-name">Retrovirology</span><span> <strong>2017,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12977-017-0330-0" title="DOI URL">https://doi.org/10.1186/s12977-017-0330-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12977-017-0330-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12977-017-0330-0%26sid%3Dliteratum%253Aachs%26jtitle%3DRetrovirology%26atitle%3DIdentification%252Bof%252Bsmall%252Bmolecule%252Bmodulators%252Bof%252BHIV-1%252BTat%252Band%252BRev%252Bprotein%252Baccumulation%26aulast%3DBalachandran%26aufirst%3DAhalya%26date%3D2017%26date%3D2017%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahalya  Balachandran</span>, <span class="hlFld-ContribAuthor ">Alan  Cochrane</span>. </span><span class="cited-content_cbyCitation_article-title">Screening for small molecule inhibitors of HIV-1 Gag expression. </span><span class="cited-content_cbyCitation_journal-name">Methods</span><span> <strong>2017,</strong> <em>126 </em>, 201-208. <a href="https://doi.org/10.1016/j.ymeth.2017.06.007" title="DOI URL">https://doi.org/10.1016/j.ymeth.2017.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ymeth.2017.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ymeth.2017.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DMethods%26atitle%3DScreening%252Bfor%252Bsmall%252Bmolecule%252Binhibitors%252Bof%252BHIV-1%252BGag%252Bexpression%26aulast%3DBalachandran%26aufirst%3DAhalya%26date%3D2017%26volume%3D126%26spage%3D201%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lulzim  Shkreta</span>, <span class="hlFld-ContribAuthor ">Marco  Blanchette</span>, <span class="hlFld-ContribAuthor ">Johanne  Toutant</span>, <span class="hlFld-ContribAuthor ">Emmanuelle  Wilhelm</span>, <span class="hlFld-ContribAuthor ">Brendan  Bell</span>, <span class="hlFld-ContribAuthor ">Benjamin A.  Story</span>, <span class="hlFld-ContribAuthor ">Ahalya  Balachandran</span>, <span class="hlFld-ContribAuthor ">Alan  Cochrane</span>, <span class="hlFld-ContribAuthor ">Peter K.  Cheung</span>, <span class="hlFld-ContribAuthor ">P. Richard  Harrigan</span>, <span class="hlFld-ContribAuthor ">David S.  Grierson</span>, <span class="hlFld-ContribAuthor ">Benoit  Chabot</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2017,</strong> <em>45 </em>
                                    (7)
                                     , 4051-4067. <a href="https://doi.org/10.1093/nar/gkw1223" title="DOI URL">https://doi.org/10.1093/nar/gkw1223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkw1223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkw1223%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DModulation%252Bof%252Bthe%252Bsplicing%252Bregulatory%252Bfunction%252Bof%252BSRSF10%252Bby%252Ba%252Bnovel%252Bcompound%252Bthat%252Bimpairs%252BHIV-1%252Breplication%26aulast%3DShkreta%26aufirst%3DLulzim%26date%3D2017%26date%3D2016%26volume%3D45%26issue%3D7%26spage%3D4051%26epage%3D4067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.K.  Terrett</span>. </span><span class="cited-content_cbyCitation_article-title">Combinatorial Chemistry Online Volume 18, Issue 5, May 2016. </span><span class="cited-content_cbyCitation_journal-name">Combinatorial Chemistry - an Online Journal</span><span> <strong>2016,</strong> <em>18 </em>
                                    (5)
                                     , 17-20. <a href="https://doi.org/10.1016/j.comche.2016.03.002" title="DOI URL">https://doi.org/10.1016/j.comche.2016.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.comche.2016.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.comche.2016.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCombinatorial%2520Chemistry%2520-%2520an%2520Online%2520Journal%26atitle%3DCombinatorial%252BChemistry%252BOnline%252BVolume%252B18%25252C%252BIssue%252B5%25252C%252BMay%252B2016%26aulast%3DTerrett%26aufirst%3DN.K.%26date%3D2016%26volume%3D18%26issue%3D5%26spage%3D17%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Strategy for the parallel synthesis of compound <b>1</b> mimics, showing the different linker motifs <b>2</b>–<b>7</b> that were investigated, the general formula <b>8</b> for the series of 119 diheteroarylamides synthesized, and the structures of the compounds <b>9</b>–<b>12</b> identified as active in the preliminary anti-HIV screen.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of the different A- and D-ring subunits employed in the synthesis of the 119 dihereroarylamides <b>8</b> present in the compound library.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (ref <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">30</a>) LDA, THF, −78 °C, then CO<sub>2</sub>; (ii) (ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a>) H<sub>2</sub>O reflux 2 h; (iii) KHCO<sub>3</sub>, DMF-H<sub>2</sub>O, then MeI, 100 °C, 1 h; (iv) SOCl<sub>2</sub>, RT or 90 °C, then 5-nitrobenzo[<i>d</i>]isothiazol-3-amine, DMF or THF, Et<sub>3</sub>N or K<sub>2</sub>CO<sub>3</sub>, rt, 10–24 h; (v) 2-methoxyethan-1-ol, Na, 90 °C, then 4-chloronicotinic acid, 90 °C, 4 h; (vi) 2-bromoethyl methyl ether, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 4 h; (vii) LiOH, THF-H<sub>2</sub>O, rt, 4 h.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Anti-HIV-1 activity of <b>9</b> against wild-type subtypes A and B and drug-resistant viruses. (A) HIV-1<sub>IIIB</sub> (subtype B), (B) 97USSN54 (subtype A), (C) (N)NRTI-resistant isolate, (D) PI-resistant isolate, (E) INI-resistant isolate, (F) Maraviroc-resistant R5 strain. The anti-HIV activity for emtricitabine (FTC) as a positive control is also shown in (A). In the presence of increasing <b>9</b> concentrations, HIV-1 infectivity on CEM-GXR cells was assessed by measuring GFP positive cells 3 days after infection. The inhibition curves were then fitted by nonlinear regression with GraphPad Prism software, allowing EC<sub>50</sub> calculation. Results represent the average of three independent determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Evaluation of <b>9</b> on CEM-GXR cell viability in the Guava ViaCount assay. Cells were analyzed after 24 h incubation with compound <b>9</b> in concentrations ranging between 0.5 and 100 μM. Results are expressed as the percentage (%) of viable cells ± SEM of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Evaluation of anti-HIV-1 activity (column) and GXR-CEM cell viability (line) for <b>1</b> (A) and <b>9</b> (B) at concentrations between 62.5 nM and 16 μM (0 provides the value when no compound was added). HIV-1 infection in CEM-GXR cells was assessed by measuring GFP positive cells 3 days after infection. CEM-GXR cell viability was measured after 24 h incubation within the same range of concentrations. Results were expressed from three independent experiments for both the anti-HIV-1 activity and cell viability assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/medium/jm-2015-01357g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Library components providing cursory SAR on compound <b>9</b> and the structure of <b>30 (</b>ABX-464).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01357/20160310/images/large/jm-2015-01357g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01357&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Logan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterne, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez-Diaz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Sighem, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wolf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costagliota, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanoy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucher, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Wyl, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casbona, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Amo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justice, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philips, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Hoyos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia de Olalla, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, M. A.</span><span> </span><span class="NLM_article-title">The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span><span class="refDoi"> DOI: 10.1097/QAD.0b013e3283324283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1097%2FQAD.0b013e3283324283" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=123-137&author=R.+M.+Loganauthor=J.+A.+Sterneauthor=S.+Hernandez-Diazauthor=J.+M.+Robinsauthor=C.+Sabinauthor=L.+Bansiauthor=A.+van+Sighemauthor=F.+de+Wolfauthor=D.+Costagliotaauthor=E.+Lanoyauthor=H.+C.+Bucherauthor=V.+von+Wylauthor=J.+Casbonaauthor=J.+del+Amoauthor=S.+Morenoauthor=A.+Justiceauthor=J.+Gouletauthor=S.+Lodiauthor=A.+Philipsauthor=R.+Sengauthor=L.+Meyerauthor=S.+Perez-Hoyosauthor=P.+Garcia+de+Olallaauthor=M.+A.+Herman&title=The+effect+of+combined+antiretroviral+therapy+on+the+overall+mortality+of+HIV-infected+individuals&doi=10.1097%2FQAD.0b013e3283324283"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1097%2FQAD.0b013e3283324283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAD.0b013e3283324283%26sid%3Dliteratum%253Aachs%26aulast%3DLogan%26aufirst%3DR.%2BM.%26aulast%3DSterne%26aufirst%3DJ.%2BA.%26aulast%3DHernandez-Diaz%26aufirst%3DS.%26aulast%3DRobins%26aufirst%3DJ.%2BM.%26aulast%3DSabin%26aufirst%3DC.%26aulast%3DBansi%26aufirst%3DL.%26aulast%3Dvan%2BSighem%26aufirst%3DA.%26aulast%3Dde%2BWolf%26aufirst%3DF.%26aulast%3DCostagliota%26aufirst%3DD.%26aulast%3DLanoy%26aufirst%3DE.%26aulast%3DBucher%26aufirst%3DH.%2BC.%26aulast%3Dvon%2BWyl%26aufirst%3DV.%26aulast%3DCasbona%26aufirst%3DJ.%26aulast%3Ddel%2BAmo%26aufirst%3DJ.%26aulast%3DMoreno%26aufirst%3DS.%26aulast%3DJustice%26aufirst%3DA.%26aulast%3DGoulet%26aufirst%3DJ.%26aulast%3DLodi%26aufirst%3DS.%26aulast%3DPhilips%26aufirst%3DA.%26aulast%3DSeng%26aufirst%3DR.%26aulast%3DMeyer%26aufirst%3DL.%26aulast%3DPerez-Hoyos%26aufirst%3DS.%26aulast%3DGarcia%2Bde%2BOlalla%26aufirst%3DP.%26aulast%3DHerman%26aufirst%3DM.%2BA.%26atitle%3DThe%2520effect%2520of%2520combined%2520antiretroviral%2520therapy%2520on%2520the%2520overall%2520mortality%2520of%2520HIV-infected%2520individuals%26jtitle%3DAIDS%26date%3D2010%26volume%3D24%26spage%3D123%26epage%3D137%26doi%3D10.1097%2FQAD.0b013e3283324283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span> </span><span class="NLM_article-title">Statistics: Worldwide</span>. <span class="NLM_publisher-name">amfAR, The Foundation for AIDS Research</span>; <a href="http://www.amfar.org/About-HIV-and-AIDS/Facts-and-Stats/Statistics--Worldwide/" class="extLink">http://www.amfar.org/About-HIV-and-AIDS/Facts-and-Stats/Statistics--Worldwide/</a> (Accessed <span class="NLM_access-date">September 2, 2014</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Statistics%3A+Worldwide.+amfAR%2C+The+Foundation+for+AIDS+Research%3B+http%3A%2F%2Fwww.amfar.org%2FAbout-HIV-and-AIDS%2FFacts-and-Stats%2FStatistics%2D%2DWorldwide%2F+%28Accessed+September+2%2C+2014%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DStatistics%253A%2520Worldwide%26pub%3DamfAR%252C%2520The%2520Foundation%2520for%2520AIDS%2520Research" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hankins, C.</span><span> </span><span class="NLM_article-title">Overview of the current state of the epidemic</span> <span class="citation_source-journal">Current HIV/AIDS Reports</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1007/s11904-013-0156-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1007%2Fs11904-013-0156-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=23579359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A280%3ADC%252BC3srksFahsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=113-123&author=C.+Hankins&title=Overview+of+the+current+state+of+the+epidemic&doi=10.1007%2Fs11904-013-0156-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the current state of the epidemic</span></div><div class="casAuthors">Hankins Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Current HIV/AIDS reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">At the end of 2011, about half of the 34.0 million [31.4-35.9 million] people living with HIV infection knew their HIV status.  With large regional variations, an estimated 0.8% of all adults aged 15 to 49 years have HIV infection and HIV subtype diversity is increasing.  Although HIV incidence has declined in 39 countries, it is stable or increasing in others.  HIV prevalence continues to rise as antiretroviral treatment scale-up results in fewer HIV-related deaths while new infections continue to occur.  Increased treatment uptake is likely reducing HIV transmission in countries with large mortality declines.  Key populations, including sex workers, men who have sex with men, transgender people, people who inject drugs and young women in high prevalence settings require effective prevention programs urgently.  Correcting mismatches in resource allocation and reducing community viral load will accelerate incidence declines and affect future epidemic trends, if concerted action is taken now.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQd2Qiai-OqeTUE-swuRqsHfW6udTcc2eacCETNO3QGMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srksFahsg%253D%253D&md5=c620e0a9d72feac6fe848db663d29bcd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs11904-013-0156-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11904-013-0156-x%26sid%3Dliteratum%253Aachs%26aulast%3DHankins%26aufirst%3DC.%26atitle%3DOverview%2520of%2520the%2520current%2520state%2520of%2520the%2520epidemic%26jtitle%3DCurrent%2520HIV%252FAIDS%2520Reports%26date%3D2013%26volume%3D10%26spage%3D113%26epage%3D123%26doi%3D10.1007%2Fs11904-013-0156-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Chesney, M.</span><span> </span><span class="NLM_article-title">Adherence to HAART regimens</span> <span class="citation_source-journal">AIDS Patient Care STDs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1089/108729103321619773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1089%2F108729103321619773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=12737640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A280%3ADC%252BD3s3hs12hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=169-177&author=M.+Chesney&title=Adherence+to+HAART+regimens&doi=10.1089%2F108729103321619773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Adherence to HAART regimens</span></div><div class="casAuthors">Chesney Margaret</div><div class="citationInfo"><span class="NLM_cas:title">AIDS patient care and STDs</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">169-77</span>
        ISSN:<span class="NLM_cas:issn">1087-2914</span>.
    </div><div class="casAbstract">The problem of inadequate adherence to prescribed highly active antiretroviral therapy (HAART) drug regimens to treat HIV infection and AIDS is ubiquitous.  Adherence can be inadequate despite both provider and patient understanding of the consequences of nonadherence.  Successful long-term treatment of HIV/AIDS requires at least 95% adherence to HAART in order to prevent emergence of drug-resistant HIV variants that lead to regimen failure and limit options for future therapy.  Despite the prevalence of inadequate adherence, many patients succeed, and HAART has transformed HIV infection into a chronic illness increasingly managed in primary care.  The barriers to adherence observed in HIV treatment resemble barriers to the successful treatment of other chronic diseases: regimen complexity, side effects resulting in poor tolerability, patient lifestyle factors, and patient-provider relationships.  Treatment of HIV infection has shown that patient-provider collaboration can result in the selection of a lifestyle-tailored regimen characterized by convenient dosing, low pill burden, and tolerable side effects that enhances adherence, effectiveness, and the patient's willingness to remain on anti-HIV therapy long term.  This review focuses on the current understanding of adherence reporting, improvement of adherence, and, hence, improvement of treatment outcomes in HIV infection and AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtEdEdYQFKP1QKX3ooHxWjfW6udTcc2eYU_hBr-fXQYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3hs12hsw%253D%253D&md5=32a8a9e816911ae9018a1539ecec3212</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1089%2F108729103321619773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F108729103321619773%26sid%3Dliteratum%253Aachs%26aulast%3DChesney%26aufirst%3DM.%26atitle%3DAdherence%2520to%2520HAART%2520regimens%26jtitle%3DAIDS%2520Patient%2520Care%2520STDs%26date%3D2003%26volume%3D17%26spage%3D169%26epage%3D177%26doi%3D10.1089%2F108729103321619773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Deeks, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havlir, D. V.</span><span> </span><span class="NLM_article-title">The end of AIDS: HIV infection as a chronic disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">382</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">–</span> <span class="NLM_lpage">1533</span><span class="refDoi"> DOI: 10.1016/S0140-6736(13)61809-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2FS0140-6736%2813%2961809-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2013&pages=1525-1533&author=S.+G.+Deeksauthor=S.+R.+Lewinauthor=D.+V.+Havlir&title=The+end+of+AIDS%3A+HIV+infection+as+a+chronic+disease&doi=10.1016%2FS0140-6736%2813%2961809-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2813%2961809-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252813%252961809-7%26sid%3Dliteratum%253Aachs%26aulast%3DDeeks%26aufirst%3DS.%2BG.%26aulast%3DLewin%26aufirst%3DS.%2BR.%26aulast%3DHavlir%26aufirst%3DD.%2BV.%26atitle%3DThe%2520end%2520of%2520AIDS%253A%2520HIV%2520infection%2520as%2520a%2520chronic%2520disease%26jtitle%3DLancet%26date%3D2013%26volume%3D382%26spage%3D1525%26epage%3D1533%26doi%3D10.1016%2FS0140-6736%2813%2961809-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Paredes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet, B.</span><span> </span><span class="NLM_article-title">Clinical management of HIV-1 resistance</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2009.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2Fj.antiviral.2009.09.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=245-265&author=R.+Paredesauthor=B.+Clotet&title=Clinical+management+of+HIV-1+resistance&doi=10.1016%2Fj.antiviral.2009.09.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2009.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2009.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DParedes%26aufirst%3DR.%26aulast%3DClotet%26aufirst%3DB.%26atitle%3DClinical%2520management%2520of%2520HIV-1%2520resistance%26jtitle%3DAntiviral%2520Res.%26date%3D2010%26volume%3D85%26spage%3D245%26epage%3D265%26doi%3D10.1016%2Fj.antiviral.2009.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gupta, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sultan, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamers, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ndembi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertagnolio, S.</span><span> </span><span class="NLM_article-title">Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">380</span><span class="NLM_x">, </span> <span class="NLM_fpage">1250</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span><span class="refDoi"> DOI: 10.1016/S0140-6736(12)61038-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2FS0140-6736%2812%2961038-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2012&pages=1250-1258&author=R.+K.+Guptaauthor=M.+R.+Jordanauthor=B.+J.+Sultanauthor=A.+Hillauthor=D.+H.+J.+Davisauthor=J.+Gregsonauthor=A.+W.+Sawyerauthor=R.+L.+Hamersauthor=N.+Ndembiauthor=D.+Pillayauthor=S.+Bertagnolio&title=Global+trends+in+antiretroviral+resistance+in+treatment-naive+individuals+with+HIV+after+rollout+of+antiretroviral+treatment+in+resource-limited+settings%3A+a+global+collaborative+study+and+meta-regression+analysis&doi=10.1016%2FS0140-6736%2812%2961038-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2812%2961038-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252812%252961038-1%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DR.%2BK.%26aulast%3DJordan%26aufirst%3DM.%2BR.%26aulast%3DSultan%26aufirst%3DB.%2BJ.%26aulast%3DHill%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DD.%2BH.%2BJ.%26aulast%3DGregson%26aufirst%3DJ.%26aulast%3DSawyer%26aufirst%3DA.%2BW.%26aulast%3DHamers%26aufirst%3DR.%2BL.%26aulast%3DNdembi%26aufirst%3DN.%26aulast%3DPillay%26aufirst%3DD.%26aulast%3DBertagnolio%26aufirst%3DS.%26atitle%3DGlobal%2520trends%2520in%2520antiretroviral%2520resistance%2520in%2520treatment-naive%2520individuals%2520with%2520HIV%2520after%2520rollout%2520of%2520antiretroviral%2520treatment%2520in%2520resource-limited%2520settings%253A%2520a%2520global%2520collaborative%2520study%2520and%2520meta-regression%2520analysis%26jtitle%3DLancet%26date%3D2012%26volume%3D380%26spage%3D1250%26epage%3D1258%26doi%3D10.1016%2FS0140-6736%2812%2961038-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hamers, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kityo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wit, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugyenyi, P.</span><span> </span><span class="NLM_article-title">Global threat from drug resistant HIV in sub-Saharan Africa</span> <span class="citation_source-journal">Br. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">e4159</span><span class="refDoi"> DOI: 10.1136/bmj.e4159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1136%2Fbmj.e4159" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2012&pages=e4159&author=R.+L.+Hamersauthor=C.+Kityoauthor=J.+M.+Langeauthor=T.+F.+de+Witauthor=P.+Mugyenyi&title=Global+threat+from+drug+resistant+HIV+in+sub-Saharan+Africa&doi=10.1136%2Fbmj.e4159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1136%2Fbmj.e4159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.e4159%26sid%3Dliteratum%253Aachs%26aulast%3DHamers%26aufirst%3DR.%2BL.%26aulast%3DKityo%26aufirst%3DC.%26aulast%3DLange%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BWit%26aufirst%3DT.%2BF.%26aulast%3DMugyenyi%26aufirst%3DP.%26atitle%3DGlobal%2520threat%2520from%2520drug%2520resistant%2520HIV%2520in%2520sub-Saharan%2520Africa%26jtitle%3DBr.%2520Med.%2520J.%26date%3D2012%26volume%3D344%26spage%3De4159%26doi%3D10.1136%2Fbmj.e4159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chun, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauci, A. S.</span><span> </span><span class="NLM_article-title">HIV reservoirs: pathogenesis and obstacles to viral eradication and cure</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span><span class="refDoi"> DOI: 10.1097/QAD.0b013e328353f3f1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1097%2FQAD.0b013e328353f3f1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=22472858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A280%3ADC%252BC38rhvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1261-1268&author=T.+W.+Chunauthor=A.+S.+Fauci&title=HIV+reservoirs%3A+pathogenesis+and+obstacles+to+viral+eradication+and+cure&doi=10.1097%2FQAD.0b013e328353f3f1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">HIV reservoirs:  pathogenesis and obstacles to viral eradication and cure</span></div><div class="casAuthors">Chun Tae-Wook; Fauci Anthony S</div><div class="citationInfo"><span class="NLM_cas:title">AIDS (London, England)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1261-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasma HIV viremia can be suppressed and maintained below the limits of detection for prolonged periods of time in the vast majority of HIV-infected individuals who receive antiretroviral therapy (ART).  Thus, the clinical outcome for HIV-infected individuals who have access to these drugs is dramatically improved.  However, ART alone cannot eradicate HIV in infected individuals and this impediment is likely in part due to the persistence of viral reservoirs in the peripheral blood and lymphoid tissues of infected individuals despite the suppression of plasma viremia.  In recent years, major research efforts have been dedicated to a better understanding of the pathogenesis of persistent HIV infection and to the development of therapeutic strategies aimed at eradicating virus in infected individuals receiving ART.  In this review, we discuss the pathophysiology of CD4 T-cell HIV reservoirs, including recent advances in our understanding of the mechanisms of persistent viral infection and perspectives for eradication of HIV in infected individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2vqyzYLGTzJotVjB3IRIyfW6udTcc2eakfRcpHN0KWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rhvF2qtw%253D%253D&md5=8923fc05a3d2a14be88259b1023ed6cb</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1097%2FQAD.0b013e328353f3f1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAD.0b013e328353f3f1%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DT.%2BW.%26aulast%3DFauci%26aufirst%3DA.%2BS.%26atitle%3DHIV%2520reservoirs%253A%2520pathogenesis%2520and%2520obstacles%2520to%2520viral%2520eradication%2520and%2520cure%26jtitle%3DAIDS%26date%3D2012%26volume%3D26%26spage%3D1261%26epage%3D1268%26doi%3D10.1097%2FQAD.0b013e328353f3f1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Taube, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterlin, B. M.</span><span> </span><span class="NLM_article-title">Lost in transcription: molecular mechanisms that control HIV latency</span> <span class="citation_source-journal">Viruses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">–</span> <span class="NLM_lpage">927</span><span class="refDoi"> DOI: 10.3390/v5030902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.3390%2Fv5030902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=23518577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsVSrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=902-927&author=R.+Taubeauthor=B.+M.+Peterlin&title=Lost+in+transcription%3A+molecular+mechanisms+that+control+HIV+latency&doi=10.3390%2Fv5030902"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Lost in transcription: molecular mechanisms that control HIV latency</span></div><div class="casAuthors">Taube, Ran; Peterlin, Boris Matija</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">902-928</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Highly active antiretroviral therapy (HAART) has limited the replication and spread of the human immunodeficiency virus (HIV).  However, despite treatment, HIV infection persists in latently infected reservoirs, and once therapy is interrupted, viral replication rebounds quickly.  Extensive efforts are being directed at eliminating these cell reservoirs.  This feat can be achieved by reactivating latent HIV while administering drugs that prevent new rounds of infection and allow the immune system to clear the virus.  However, current approaches to HIV eradication have not been effective.  Moreover, as HIV latency is multifactorial, the significance of each of its mol. mechanisms is still under debate.  Among these, transcriptional repression as a result of reduced levels and activity of the pos. transcription elongation factor b (P-TEFb: CDK9/cyclin T) plays a significant role.  Therefore, increasing levels of P-TEFb expression and activity is an excellent strategy to stimulate viral gene expression.  This review summarizes the multiple steps that cause HIV to enter into latency.  It positions the interplay between transcriptionally active and inactive host transcriptional activators and their viral partner Tat as valid targets for the development of new strategies to reactivate latent viral gene expression and eradicate HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP3nHdi5AyOLVg90H21EOLACvtfcHk0li7Ztb2Zi7Lwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsVSrtLk%253D&md5=a2ba0ed16a2b7cceef4a15e355fb63d2</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.3390%2Fv5030902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv5030902%26sid%3Dliteratum%253Aachs%26aulast%3DTaube%26aufirst%3DR.%26aulast%3DPeterlin%26aufirst%3DB.%2BM.%26atitle%3DLost%2520in%2520transcription%253A%2520molecular%2520mechanisms%2520that%2520control%2520HIV%2520latency%26jtitle%3DViruses%26date%3D2013%26volume%3D5%26spage%3D902%26epage%3D927%26doi%3D10.3390%2Fv5030902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Bakkour, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayadi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuteau-Betzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mettling, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabot, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanteur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tazi, J.</span><span> </span><span class="NLM_article-title">Small-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistance</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e159</span><span class="refDoi"> DOI: 10.1371/journal.ppat.0030159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1371%2Fjournal.ppat.0030159" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=e159&author=N.+Bakkourauthor=Y.-L.+Linauthor=S.+Marieauthor=L.+Ayadiauthor=F.+Mahuteau-Betzerauthor=C.+H.+Nguyenauthor=C.+Mettlingauthor=P.+Portalesauthor=D.+Griersonauthor=B.+Chabotauthor=P.+Jeanteurauthor=P.+Corbeauauthor=J.+Tazi&title=Small-molecule+inhibition+of+HIV+pre-mRNA+splicing+as+a+novel+antiretroviral+therapy+to+overcome+drug+resistance&doi=10.1371%2Fjournal.ppat.0030159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.0030159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.0030159%26sid%3Dliteratum%253Aachs%26aulast%3DBakkour%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DY.-L.%26aulast%3DMarie%26aufirst%3DS.%26aulast%3DAyadi%26aufirst%3DL.%26aulast%3DMahuteau-Betzer%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DC.%2BH.%26aulast%3DMettling%26aufirst%3DC.%26aulast%3DPortales%26aufirst%3DP.%26aulast%3DGrierson%26aufirst%3DD.%26aulast%3DChabot%26aufirst%3DB.%26aulast%3DJeanteur%26aufirst%3DP.%26aulast%3DCorbeau%26aufirst%3DP.%26aulast%3DTazi%26aufirst%3DJ.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520HIV%2520pre-mRNA%2520splicing%2520as%2520a%2520novel%2520antiretroviral%2520therapy%2520to%2520overcome%2520drug%2520resistance%26jtitle%3DPLoS%2520Pathog.%26date%3D2007%26volume%3D3%26spage%3De159%26doi%3D10.1371%2Fjournal.ppat.0030159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Soret, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakkour, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fic, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivalle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauzonne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanteur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tazi, J.</span><span> </span><span class="NLM_article-title">Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">8764</span><span class="NLM_x">–</span> <span class="NLM_lpage">8769</span><span class="refDoi"> DOI: 10.1073/pnas.0409829102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1073%2Fpnas.0409829102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=8764-8769&author=J.+Soretauthor=N.+Bakkourauthor=S.+Marieauthor=S.+Durandauthor=L.+Zekriauthor=M.+Gabutauthor=W.+Ficauthor=G.+Divaauthor=C.+Rivalleauthor=D.+Dauzonneauthor=C.-H.+Nguyenauthor=P.+Jeanteurauthor=J.+Tazi&title=Selective+modification+of+alternative+splicing+by+indole+derivatives+that+target+serine-arginine-rich+protein+splicing+factors&doi=10.1073%2Fpnas.0409829102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0409829102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0409829102%26sid%3Dliteratum%253Aachs%26aulast%3DSoret%26aufirst%3DJ.%26aulast%3DBakkour%26aufirst%3DN.%26aulast%3DMarie%26aufirst%3DS.%26aulast%3DDurand%26aufirst%3DS.%26aulast%3DZekri%26aufirst%3DL.%26aulast%3DGabut%26aufirst%3DM.%26aulast%3DFic%26aufirst%3DW.%26aulast%3DDiva%26aufirst%3DG.%26aulast%3DRivalle%26aufirst%3DC.%26aulast%3DDauzonne%26aufirst%3DD.%26aulast%3DNguyen%26aufirst%3DC.-H.%26aulast%3DJeanteur%26aufirst%3DP.%26aulast%3DTazi%26aufirst%3DJ.%26atitle%3DSelective%2520modification%2520of%2520alternative%2520splicing%2520by%2520indole%2520derivatives%2520that%2520target%2520serine-arginine-rich%2520protein%2520splicing%2520factors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D8764%26epage%3D8769%26doi%3D10.1073%2Fpnas.0409829102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Wong, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balachandran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrowski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochrane, A.</span><span> </span><span class="NLM_article-title">Digoxin suppresses HIV-1 replication by altering viral RNA processing</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1003241</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1003241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1371%2Fjournal.ppat.1003241" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=e1003241&author=R.+W.+Wongauthor=A.+Balachandranauthor=M.+A.+Ostrowskiauthor=A.+Cochrane&title=Digoxin+suppresses+HIV-1+replication+by+altering+viral+RNA+processing&doi=10.1371%2Fjournal.ppat.1003241"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1003241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1003241%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%2BW.%26aulast%3DBalachandran%26aufirst%3DA.%26aulast%3DOstrowski%26aufirst%3DM.%2BA.%26aulast%3DCochrane%26aufirst%3DA.%26atitle%3DDigoxin%2520suppresses%2520HIV-1%2520replication%2520by%2520altering%2520viral%2520RNA%2520processing%26jtitle%3DPLoS%2520Pathog.%26date%3D2013%26volume%3D9%26spage%3De1003241%26doi%3D10.1371%2Fjournal.ppat.1003241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wong, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balachandran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoilov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochrane, A.</span><span> </span><span class="NLM_article-title">Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">9471</span><span class="NLM_x">–</span> <span class="NLM_lpage">9483</span><span class="refDoi"> DOI: 10.1093/nar/gkt727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1093%2Fnar%2Fgkt727" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=9471-9483&author=R.+W.+Wongauthor=A.+Balachandranauthor=M.+Haalandauthor=P.+Stoilovauthor=A.+Cochrane&title=Characterization+of+novel+inhibitors+of+HIV-1+replication+that+function+via+alteration+of+viral+RNA+processing+and+rev+function&doi=10.1093%2Fnar%2Fgkt727"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt727%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%2BW.%26aulast%3DBalachandran%26aufirst%3DA.%26aulast%3DHaaland%26aufirst%3DM.%26aulast%3DStoilov%26aufirst%3DP.%26aulast%3DCochrane%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520novel%2520inhibitors%2520of%2520HIV-1%2520replication%2520that%2520function%2520via%2520alteration%2520of%2520viral%2520RNA%2520processing%2520and%2520rev%2520function%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2013%26volume%3D41%26spage%3D9471%26epage%3D9483%26doi%3D10.1093%2Fnar%2Fgkt727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balachandran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson-Belaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grey-Owen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochrane, A.</span><span> </span><span class="NLM_article-title">Differential effect of Clk SR kinases on HIV-1 expression: novel targets for therapy</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="refDoi"> DOI: 10.1186/1742-4690-8-47</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1186%2F1742-4690-8-47" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=47&author=R.+Wongauthor=A.+Balachandranauthor=A.+Maoauthor=W.+Dobson-Belaireauthor=S.+Grey-Owenauthor=A.+Cochrane&title=Differential+effect+of+Clk+SR+kinases+on+HIV-1+expression%3A+novel+targets+for+therapy&doi=10.1186%2F1742-4690-8-47"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-8-47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-8-47%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%26aulast%3DBalachandran%26aufirst%3DA.%26aulast%3DMao%26aufirst%3DA.%26aulast%3DDobson-Belaire%26aufirst%3DW.%26aulast%3DGrey-Owen%26aufirst%3DS.%26aulast%3DCochrane%26aufirst%3DA.%26atitle%3DDifferential%2520effect%2520of%2520Clk%2520SR%2520kinases%2520on%2520HIV-1%2520expression%253A%2520novel%2520targets%2520for%2520therapy%26jtitle%3DRetrovirology%26date%3D2011%26volume%3D8%26spage%3D47%26doi%3D10.1186%2F1742-4690-8-47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Fukuhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshiro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzenberg, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzenberg, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Utilization of host SR protein kinases and RNA-splicing machinery during viral replication</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">11329</span><span class="NLM_x">–</span> <span class="NLM_lpage">11333</span><span class="refDoi"> DOI: 10.1073/pnas.0604616103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1073%2Fpnas.0604616103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=11329-11333&author=T.+Fukuharaauthor=T.+Hosoyaauthor=S.+Shimizuauthor=K.+Sumiauthor=T.+Oshiroauthor=Y.+Yoshinakaauthor=M.+Suzukiauthor=N.+Yamamotoauthor=L.+A.+Herzenbergauthor=L.+A.+Herzenbergauthor=M.+Hagiwara&title=Utilization+of+host+SR+protein+kinases+and+RNA-splicing+machinery+during+viral+replication&doi=10.1073%2Fpnas.0604616103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0604616103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0604616103%26sid%3Dliteratum%253Aachs%26aulast%3DFukuhara%26aufirst%3DT.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DSumi%26aufirst%3DK.%26aulast%3DOshiro%26aufirst%3DT.%26aulast%3DYoshinaka%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DHerzenberg%26aufirst%3DL.%2BA.%26aulast%3DHerzenberg%26aufirst%3DL.%2BA.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DUtilization%2520of%2520host%2520SR%2520protein%2520kinases%2520and%2520RNA-splicing%2520machinery%2520during%2520viral%2520replication%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D11329%26epage%3D11333%26doi%3D10.1073%2Fpnas.0604616103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Campos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myburgh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vautrin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapasset, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadel, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuteau-Betzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornarelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basyuk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seveno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venables, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speck, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tazi, J.</span><span> </span><span class="NLM_article-title">Long lasting control of viral rebound with a new drug ABX464 targeting rev-mediated viral RNA biogenesis</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="refDoi"> DOI: 10.1186/s12977-015-0159-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1186%2Fs12977-015-0159-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=30&author=N.+Camposauthor=R.+Myburghauthor=A.+Garcelauthor=A.+Vautrinauthor=L.+Lapassetauthor=E.+S.+Nadelauthor=F.+Mahuteau-Betzerauthor=R.+Najmanauthor=P.+Fornarelliauthor=K.+Tantaleauthor=E.+Basyukauthor=M.+Sevenoauthor=J.+P.+Venablesauthor=B.+Pauauthor=E.+Bertrandauthor=M.+A.+Wainbergauthor=R.+F.+Speckauthor=D.+Scherrrauthor=J.+Tazi&title=Long+lasting+control+of+viral+rebound+with+a+new+drug+ABX464+targeting+rev-mediated+viral+RNA+biogenesis&doi=10.1186%2Fs12977-015-0159-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1186%2Fs12977-015-0159-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12977-015-0159-3%26sid%3Dliteratum%253Aachs%26aulast%3DCampos%26aufirst%3DN.%26aulast%3DMyburgh%26aufirst%3DR.%26aulast%3DGarcel%26aufirst%3DA.%26aulast%3DVautrin%26aufirst%3DA.%26aulast%3DLapasset%26aufirst%3DL.%26aulast%3DNadel%26aufirst%3DE.%2BS.%26aulast%3DMahuteau-Betzer%26aufirst%3DF.%26aulast%3DNajman%26aufirst%3DR.%26aulast%3DFornarelli%26aufirst%3DP.%26aulast%3DTantale%26aufirst%3DK.%26aulast%3DBasyuk%26aufirst%3DE.%26aulast%3DSeveno%26aufirst%3DM.%26aulast%3DVenables%26aufirst%3DJ.%2BP.%26aulast%3DPau%26aufirst%3DB.%26aulast%3DBertrand%26aufirst%3DE.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26aulast%3DSpeck%26aufirst%3DR.%2BF.%26aulast%3DScherrr%26aufirst%3DD.%26aulast%3DTazi%26aufirst%3DJ.%26atitle%3DLong%2520lasting%2520control%2520of%2520viral%2520rebound%2520with%2520a%2520new%2520drug%2520ABX464%2520targeting%2520rev-mediated%2520viral%2520RNA%2520biogenesis%26jtitle%3DRetrovirology%26date%3D2015%26volume%3D12%26spage%3D30%26doi%3D10.1186%2Fs12977-015-0159-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Stoltzfus, C. M.</span><span> </span><span class="NLM_article-title">Regulation of HIV-1 Alternative RNA splicing and its role in virus replication</span> <span class="citation_source-journal">Adv. Virus Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/S0065-3527(09)74001-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2FS0065-3527%2809%2974001-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=1-40&author=C.+M.+Stoltzfus&title=Regulation+of+HIV-1+Alternative+RNA+splicing+and+its+role+in+virus+replication&doi=10.1016%2FS0065-3527%2809%2974001-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0065-3527%2809%2974001-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-3527%252809%252974001-1%26sid%3Dliteratum%253Aachs%26aulast%3DStoltzfus%26aufirst%3DC.%2BM.%26atitle%3DRegulation%2520of%2520HIV-1%2520Alternative%2520RNA%2520splicing%2520and%2520its%2520role%2520in%2520virus%2520replication%26jtitle%3DAdv.%2520Virus%2520Res.%26date%3D2009%26volume%3D74%26spage%3D1%26epage%3D40%26doi%3D10.1016%2FS0065-3527%2809%2974001-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Karn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoltzfus, C. M.</span><span> </span><span class="NLM_article-title">Transcriptional and posttranscriptional regulation of HIV gene expression</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006916</span><span class="refDoi"> DOI: 10.1101/cshperspect.a006916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1101%2Fcshperspect.a006916" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=a006916&author=J.+Karnauthor=C.+M.+Stoltzfus&title=Transcriptional+and+posttranscriptional+regulation+of+HIV+gene+expression&doi=10.1101%2Fcshperspect.a006916"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006916%26sid%3Dliteratum%253Aachs%26aulast%3DKarn%26aufirst%3DJ.%26aulast%3DStoltzfus%26aufirst%3DC.%2BM.%26atitle%3DTranscriptional%2520and%2520posttranscriptional%2520regulation%2520of%2520HIV%2520gene%2520expression%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D4%26spage%3Da006916%26doi%3D10.1101%2Fcshperspect.a006916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Tazi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakkour, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayadi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboufirassi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branlant, C.</span><span> </span><span class="NLM_article-title">Alternative splicing: regulation of HIV-1 multiplication as a target for therapeutic action</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07522.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1111%2Fj.1742-4658.2009.07522.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2010&pages=867-876&author=J.+Taziauthor=N.+Bakkourauthor=V.+Marchandauthor=L.+Ayadiauthor=A.+Aboufirassiauthor=C.+Branlant&title=Alternative+splicing%3A+regulation+of+HIV-1+multiplication+as+a+target+for+therapeutic+action&doi=10.1111%2Fj.1742-4658.2009.07522.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07522.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07522.x%26sid%3Dliteratum%253Aachs%26aulast%3DTazi%26aufirst%3DJ.%26aulast%3DBakkour%26aufirst%3DN.%26aulast%3DMarchand%26aufirst%3DV.%26aulast%3DAyadi%26aufirst%3DL.%26aulast%3DAboufirassi%26aufirst%3DA.%26aulast%3DBranlant%26aufirst%3DC.%26atitle%3DAlternative%2520splicing%253A%2520regulation%2520of%2520HIV-1%2520multiplication%2520as%2520a%2520target%2520for%2520therapeutic%2520action%26jtitle%3DFEBS%2520J.%26date%3D2010%26volume%3D277%26spage%3D867%26epage%3D876%26doi%3D10.1111%2Fj.1742-4658.2009.07522.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hryckiewicz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowala-Piaskowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolewska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mozer-Lisewska, I.</span><span> </span><span class="NLM_article-title">HIV RNA splicing</span> <span class="citation_source-journal">HIV & AIDS Review</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/j.hivar.2011.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2Fj.hivar.2011.05.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=61-64&author=K.+Hryckiewiczauthor=M.+Buraauthor=A.+Kowala-Piaskowskaauthor=B.+Bolewskaauthor=I.+Mozer-Lisewska&title=HIV+RNA+splicing&doi=10.1016%2Fj.hivar.2011.05.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.hivar.2011.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.hivar.2011.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DHryckiewicz%26aufirst%3DK.%26aulast%3DBura%26aufirst%3DM.%26aulast%3DKowala-Piaskowska%26aufirst%3DA.%26aulast%3DBolewska%26aufirst%3DB.%26aulast%3DMozer-Lisewska%26aufirst%3DI.%26atitle%3DHIV%2520RNA%2520splicing%26jtitle%3DHIV%2520%2526%2520AIDS%2520Review%26date%3D2011%26volume%3D10%26spage%3D61%26epage%3D64%26doi%3D10.1016%2Fj.hivar.2011.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Florent, J.-C.</span><span> </span><span class="NLM_article-title">Chimiotheque de petites molecules, outil de recherche pour la biologie chimique</span> <span class="citation_source-journal">Biol. Aujourd'hui</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1051/jbio/2013006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1051%2Fjbio%2F2013006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=23694724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVemsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2013&pages=39-54&author=J.-C.+Florent&title=Chimiotheque+de+petites+molecules%2C+outil+de+recherche+pour+la+biologie+chimique&doi=10.1051%2Fjbio%2F2013006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Small compounds libraries: a research tool for chemical biology</span></div><div class="casAuthors">Florent, Jean-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Biologie Aujourd'hui</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-54</span>CODEN:
                <span class="NLM_cas:coden">BAIUBC</span>;
        ISSN:<span class="NLM_cas:issn">2105-0678</span>.
    
            (<span class="NLM_cas:orgname">EDP Sciences</span>)
        </div><div class="casAbstract">A review.  Obtaining and screening collections of small mols. remain a challenge for biologists.  Recent advances in anal. techniques and instrumentation now make screening possible in academia.  The history of the creation of such public or com. collections and their accessibility is related.  It shows that there is interest for an academic lab. involved in medicinal chem., chemogenomics or "chem. biol." to organize its own collection and make it available through existing networks such as the French National chimiotheque or the European partner network "European Infrastructure of open screening platforms for Chem. Biol." EU-OpenScreen under construction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2UOE0RcRGvbVg90H21EOLACvtfcHk0liiu6vuJAdlRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVemsrfF&md5=0bdfc727015126b93d534c6e7904cc95</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1051%2Fjbio%2F2013006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fjbio%252F2013006%26sid%3Dliteratum%253Aachs%26aulast%3DFlorent%26aufirst%3DJ.-C.%26atitle%3DChimiotheque%2520de%2520petites%2520molecules%252C%2520outil%2520de%2520recherche%2520pour%2520la%2520biologie%2520chimique%26jtitle%3DBiol.%2520Aujourd%2527hui%26date%3D2013%26volume%3D207%26spage%3D39%26epage%3D54%26doi%3D10.1051%2Fjbio%2F2013006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Zhong, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeld, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X. D.</span><span> </span><span class="NLM_article-title">SR proteins in vertical integration of gene expression from transcription to RNA processing to translation</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1016/j.molcel.2009.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2Fj.molcel.2009.06.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=1-10&author=X.+Y.+Zhongauthor=P.+Wangauthor=M.+G.+Rosenfeldauthor=X.+D.+Fu&title=SR+proteins+in+vertical+integration+of+gene+expression+from+transcription+to+RNA+processing+to+translation&doi=10.1016%2Fj.molcel.2009.06.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DX.%2BY.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DRosenfeld%26aufirst%3DM.%2BG.%26aulast%3DFu%26aufirst%3DX.%2BD.%26atitle%3DSR%2520proteins%2520in%2520vertical%2520integration%2520of%2520gene%2520expression%2520from%2520transcription%2520to%2520RNA%2520processing%2520to%2520translation%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D35%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.molcel.2009.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Stoltzfus, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, J. M.</span><span> </span><span class="NLM_article-title">Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative splicing</span> <span class="citation_source-journal">Curr. HIV Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.2174/157016206775197655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.2174%2F157016206775197655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=16454710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVyrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=43-45&author=C.+M.+Stoltzfusauthor=J.+M.+Madsen&title=Role+of+viral+splicing+elements+and+cellular+RNA+binding+proteins+in+regulation+of+HIV-1+alternative+splicing&doi=10.2174%2F157016206775197655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing</span></div><div class="casAuthors">Stoltzfus, C. Martin; Madsen, Joshua M.</div><div class="citationInfo"><span class="NLM_cas:title">Current HIV Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-55</span>CODEN:
                <span class="NLM_cas:coden">CHRUBF</span>;
        ISSN:<span class="NLM_cas:issn">1570-162X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In HIV-1 infected cells, over 40 different mRNA species are produced by alternative splicing of the single HIV-1 primary RNA transcript.  In addn., approx. half of the HIV-1 primary RNA transcripts are not spliced and are exported to the cytoplasm where they serve as mRNA and as genomic RNA.  In this article, we will review current knowledge of the mechanisms by which the HIV-1 alternative splicing is regulated.  Several neg. and pos.-acting cis-acting elements have been detected within the viral genome that repress or facilitate viral RNA splicing by binding to cellular proteins.  These include exonic splicing silencers (ESS) and an intronic splicing silencer (ISS) that are selectively bound either by members of the hnRNP A/B family (hnRNPs A1, A1B, A2, and B1) or by hnRNP H.  Exonic splicing enhancers (ESE) are also present within the HIV-1 genome and are selectively bound by members of the SR protein family.  ESS and ISS repression mediated by hnRNP A/B proteins occurs at early steps of splicing, prior to formation of pre-spliceosome complexes.  Current models propose that ESS elements promote cooperative binding of hnRNP A/B proteins to the exon and prevent efficient binding of essential cellular splicing factors to the 3' splice site.  SR proteins bound to ESE elements that are juxtaposed or overlapping ESS elements may counteract this inhibition.  We will review data indicating the importance of the HIV-1 splicing elements and their cognate binding proteins for efficient virus replication.  Differences in cis-acting splicing elements between the group M (major) and group O (outlier) HIV-1 strains will also be discussed.  Finally we will review evidence suggesting the possibility that there may be changes in regulation of HIV-1 alternative splicing in infected human T cells, human macrophages and rodent cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprD_VYzL2NCLVg90H21EOLACvtfcHk0lhveem1euGL2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVyrug%253D%253D&md5=a1933c3d54ae0d5211cf8063d953b1f5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F157016206775197655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157016206775197655%26sid%3Dliteratum%253Aachs%26aulast%3DStoltzfus%26aufirst%3DC.%2BM.%26aulast%3DMadsen%26aufirst%3DJ.%2BM.%26atitle%3DRole%2520of%2520viral%2520splicing%2520elements%2520and%2520cellular%2520RNA%2520binding%2520proteins%2520in%2520regulation%2520of%2520HIV-1%2520alternative%2520splicing%26jtitle%3DCurr.%2520HIV%2520Res.%26date%3D2006%26volume%3D4%26spage%3D43%26epage%3D45%26doi%3D10.2174%2F157016206775197655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Rivalle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tambourin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hloste, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisagni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherman, J. C.</span><span> </span><span class="NLM_article-title">Antitumor amino-substituted pyrido[3′,4′:4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new sidechain and heterocycle modifications</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1021/jm00356a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00356a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1983&pages=181-185&author=C.+Rivalleauthor=F.+Wendlingauthor=P.+Tambourinauthor=J.+M.+Hlosteauthor=E.+Bisagniauthor=J.+C.+Cherman&title=Antitumor+amino-substituted+pyrido%5B3%E2%80%B2%2C4%E2%80%B2%3A4%2C5%5Dpyrrolo%5B2%2C3-g%5Disoquinolines+and+pyrido%5B4%2C3-b%5Dcarbazole+derivatives%3A+synthesis+and+evaluation+of+compounds+resulting+from+new+sidechain+and+heterocycle+modifications&doi=10.1021%2Fjm00356a012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm00356a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00356a012%26sid%3Dliteratum%253Aachs%26aulast%3DRivalle%26aufirst%3DC.%26aulast%3DWendling%26aufirst%3DF.%26aulast%3DTambourin%26aufirst%3DP.%26aulast%3DHloste%26aufirst%3DJ.%2BM.%26aulast%3DBisagni%26aufirst%3DE.%26aulast%3DCherman%26aufirst%3DJ.%2BC.%26atitle%3DAntitumor%2520amino-substituted%2520pyrido%255B3%25E2%2580%25B2%252C4%25E2%2580%25B2%253A4%252C5%255Dpyrrolo%255B2%252C3-g%255Disoquinolines%2520and%2520pyrido%255B4%252C3-b%255Dcarbazole%2520derivatives%253A%2520synthesis%2520and%2520evaluation%2520of%2520compounds%2520resulting%2520from%2520new%2520sidechain%2520and%2520heterocycle%2520modifications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1983%26volume%3D26%26spage%3D181%26epage%3D185%26doi%3D10.1021%2Fjm00356a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Miller, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, F. O.</span><span> </span><span class="NLM_article-title">Isolation, biological activity and synthesis of the natural product ellipticine and related pyridocarbazoles</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">8883</span><span class="NLM_x">–</span> <span class="NLM_lpage">8918</span><span class="refDoi"> DOI: 10.1039/c2ra20584j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1039%2Fc2ra20584j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlKjtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=8883-8918&author=C.+M.+Millerauthor=F.+O.+McCarthy&title=Isolation%2C+biological+activity+and+synthesis+of+the+natural+product+ellipticine+and+related+pyridocarbazoles&doi=10.1039%2Fc2ra20584j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation, biological activity and synthesis of the natural product ellipticine and related pyridocarbazoles</span></div><div class="casAuthors">Miller, Charlotte M.; McCarthy, Florence O.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8883-8918</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The tetracyclic natural product ellipticine (5,11-dimethyl-6H-pyrido[4,3-b]carbazole) was first isolated from the plant material of Ochrosia elliptica Labill in 1959.  Woodward et al. reported the first synthesis of ellipticine later the same year, and this was followed by many different synthetic strategies in subsequent decades.  Investigation of the biol. activity of ellipticines uncovered potent anti-cancer properties and several ellipticine derivs. have been the subject of clin. trials.  The ellipticine family of compds. exert their biol. activity via several modes of action, the most well established of which are intercalation with DNA and topoisomerase II inhibition.  In recent times other modes of action have been revealed, including kinase inhibition, interaction with p53 transcription factor, bio-oxidn. and adduct formation.  The scope of this review covers key features of the biol. activity of ellipticine, with emphasis on new modes of action, followed by synthetic routes to ellipticine, including key early syntheses of pyrido[4,3-b]carbazoles and comprehensive coverage of the literature since the late 1980s, along with more recent syntheses of ellipticine analogs and substituted ellipticines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdUDXUL_E_S7Vg90H21EOLACvtfcHk0lgIBglGf5bsjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlKjtbbL&md5=cc0acb5dbdee793c83a39a145ae25e4f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2Fc2ra20584j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ra20584j%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DC.%2BM.%26aulast%3DMcCarthy%26aufirst%3DF.%2BO.%26atitle%3DIsolation%252C%2520biological%2520activity%2520and%2520synthesis%2520of%2520the%2520natural%2520product%2520ellipticine%2520and%2520related%2520pyridocarbazoles%26jtitle%3DRSC%2520Adv.%26date%3D2012%26volume%3D2%26spage%3D8883%26epage%3D8918%26doi%3D10.1039%2Fc2ra20584j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Poljakova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckschlager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrabeta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrebakova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smutny, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinek, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kizek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiborova, M.</span><span> </span><span class="NLM_article-title">The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1466</span><span class="NLM_x">–</span> <span class="NLM_lpage">1479</span><span class="refDoi"> DOI: 10.1016/j.bcp.2009.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2Fj.bcp.2009.01.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=1466-1479&author=J.+Poljakovaauthor=T.+Eckschlagerauthor=J.+Hrabetaauthor=J.+Hrebakovaauthor=S.+Smutnyauthor=E.+Freiauthor=V.+Martinekauthor=R.+Kizekauthor=M.+Stiborova&title=The+mechanism+of+cytotoxicity+and+DNA+adduct+formation+by+the+anticancer+drug+ellipticine+in+human+neuroblastoma+cells&doi=10.1016%2Fj.bcp.2009.01.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DPoljakova%26aufirst%3DJ.%26aulast%3DEckschlager%26aufirst%3DT.%26aulast%3DHrabeta%26aufirst%3DJ.%26aulast%3DHrebakova%26aufirst%3DJ.%26aulast%3DSmutny%26aufirst%3DS.%26aulast%3DFrei%26aufirst%3DE.%26aulast%3DMartinek%26aufirst%3DV.%26aulast%3DKizek%26aufirst%3DR.%26aulast%3DStiborova%26aufirst%3DM.%26atitle%3DThe%2520mechanism%2520of%2520cytotoxicity%2520and%2520DNA%2520adduct%2520formation%2520by%2520the%2520anticancer%2520drug%2520ellipticine%2520in%2520human%2520neuroblastoma%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D77%26spage%3D1466%26epage%3D1479%26doi%3D10.1016%2Fj.bcp.2009.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Stiborova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poljakova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinkova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borek-Dohalska, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckschlager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kizek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, E.</span><span> </span><span class="NLM_article-title">Ellipticine cytotoxicity to cancer cell lines- a comparative study</span> <span class="citation_source-journal">Interdiscip. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.2478/v10102-011-0017-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.2478%2Fv10102-011-0017-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=21753906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFamsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=98-105&author=M.+Stiborovaauthor=J.+Poljakovaauthor=E.+Martinkovaauthor=L.+Borek-Dohalskaauthor=T.+Eckschlagerauthor=R.+Kizekauthor=E.+Frei&title=Ellipticine+cytotoxicity+to+cancer+cell+lines-+a+comparative+study&doi=10.2478%2Fv10102-011-0017-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Ellipticine cytotoxicity to cancer cell lines a comparative study</span></div><div class="casAuthors">Stiborova, Marie; Poljakova, Jitka; Martinkova, Eva; Booek-Dohalska, Lucie; Eckschlager, Tomas; Kizek, Rene; Frei, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Interdisciplinary Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">98-105</span>CODEN:
                <span class="NLM_cas:coden">ITNOCQ</span>;
        ISSN:<span class="NLM_cas:issn">1337-6853</span>.
    
            (<span class="NLM_cas:orgname">Versita</span>)
        </div><div class="casAbstract">Ellipticine is a potent antineoplastic agent exhibiting multiple mechanisms of action.  This anticancer agent should be considered a pro-drug, whose pharmacol. efficiency and/or genotoxic side effects are dependent on its cytochrome P 450 (CYP)- and/or peroxidase-mediated activation to species forming covalent DNA adducts.  Ellipticine can also act as an inhibitor or inducer of biotransformation enzymes, thereby modulating its own metab. leading to its genotoxic and pharmacol. effects.  Here, a comparison of the toxicity of ellipticine to human breast adenocarcinoma MCF-7 cells, leukemia HL-60 and CCRF-CEM cells, neuroblastoma IMR-32, UKF-NB-3 and UKF-NB-4 cells and U87MG glioblastoma cells and mechanisms of its action to these cells were evaluated.  Treatment of all cells tested with ellipticine resulted in inhibition of cell growth and proliferation.  This effect was assocd. with formation of two covalent ellipticine-derived DNA adducts, identical to those formed by 13-hydroxy- and 12-hydroxyellipticine, the ellipticine metabolites generated by CYP and peroxidase enzymes, in MCF-7, HL-60, CCRF-CEM, UKF-NB-3, UKF-NB-4 and U87MG cells, but not in neuroblastoma UKF-NB-3 cells.  Therefore, DNA adduct formation in most cancer cell lines tested in this comparative study might be the predominant cause of their sensitivity to ellipticine treatment, whereas other mechanisms of ellipticine action also contribute to its cytotoxicity to neuroblastoma UKF-NB-3 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5I6frItT2ELVg90H21EOLACvtfcHk0lgibVUnX_Z5LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFamsLY%253D&md5=02b26a20fff3fa50213ade19d36e62e5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2478%2Fv10102-011-0017-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2478%252Fv10102-011-0017-7%26sid%3Dliteratum%253Aachs%26aulast%3DStiborova%26aufirst%3DM.%26aulast%3DPoljakova%26aufirst%3DJ.%26aulast%3DMartinkova%26aufirst%3DE.%26aulast%3DBorek-Dohalska%26aufirst%3DL.%26aulast%3DEckschlager%26aufirst%3DT.%26aulast%3DKizek%26aufirst%3DR.%26aulast%3DFrei%26aufirst%3DE.%26atitle%3DEllipticine%2520cytotoxicity%2520to%2520cancer%2520cell%2520lines-%2520a%2520comparative%2520study%26jtitle%3DInterdiscip.%2520Toxicol.%26date%3D2011%26volume%3D4%26spage%3D98%26epage%3D105%26doi%3D10.2478%2Fv10102-011-0017-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chacon-Garcia, L.</span><span> </span><span class="NLM_article-title">The search of DNA-intercalators as antitumoral drugs: what worked and what did not work</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.2174/0929867053363414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.2174%2F0929867053363414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=15638732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=127-151&author=R.+Martinezauthor=L.+Chacon-Garcia&title=The+search+of+DNA-intercalators+as+antitumoral+drugs%3A+what+worked+and+what+did+not+work&doi=10.2174%2F0929867053363414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The search of DNA-intercalators as antitumoral drugs: What it worked and what did not work</span></div><div class="casAuthors">Martinez, R.; Chacon-Garcia, L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-151</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The discovery of new compds. with antitumoral activity has become one of the most important goals in medicinal chem.  One interesting group of chemotherapeutic agents used in cancer therapy comprises mols. that interact with DNA.  Research in this area has revealed a range of DNA recognizing mols. that act as antitumoral agents, including groove binders, alkylating and intercalator compds.  DNA intercalators (mols. that intercalate between DNA base pairs) have attracted particular attention due to their antitumoral activity.  For example, a no. of acridine and anthracycline derivs. are excellent DNA intercalators that are now on the market as chemotherapeutic agents.  Com. available acridine and anthracycline derivs. were widely studied from a variety of viewpoints, such as physicochem. properties, structural requirements, synthesis and biol. activity.  However, the clin. application of these and other compds. of the same class has encountered problems such as multidrug resistance (MRD), and secondary and/or collateral effects.  These shortcomings have motivated the search for new compds. to be used either in place of, or in conjunction with, the existing compds.  Unfortunately, the results of this search have not met expectations.  The vast majority of candidate intercalator compds. tested for use as anticancer agents have shown little or no biol. activity.  Research in this area was not without benefits, however, for it has produced much information on the synthesis and antitumoral properties of hundreds of compds., which were tested on diverse tumoral cell lines.  This review considers the structural and biol. considerations relevant to the use of DNA intercalators and bis-intercalators as antitumoral agents, with an emphasis on the relationship between structure and activity, produced in last decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAY5OdG9bCCbVg90H21EOLACvtfcHk0lgibVUnX_Z5LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOqsQ%253D%253D&md5=41d600f1698c211cf7a7de160d04dd5e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F0929867053363414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867053363414%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DChacon-Garcia%26aufirst%3DL.%26atitle%3DThe%2520search%2520of%2520DNA-intercalators%2520as%2520antitumoral%2520drugs%253A%2520what%2520worked%2520and%2520what%2520did%2520not%2520work%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D127%26epage%3D151%26doi%3D10.2174%2F0929867053363414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Brockman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, G. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, T. M.</span><span> </span><span class="NLM_article-title">Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry</span> <span class="citation_source-journal">J. Virol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span><span class="refDoi"> DOI: 10.1016/j.jviromet.2005.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2Fj.jviromet.2005.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=16182382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVShtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2006&pages=134-142&author=M.+A.+Brockmanauthor=G.+O.+Tanziauthor=B.+D.+Walkerauthor=T.+M.+Allen&title=Use+of+a+novel+GFP+reporter+cell+line+to+examine+replication+capacity+of+CXCR4-+and+CCR5-tropic+HIV-1+by+flow+cytometry&doi=10.1016%2Fj.jviromet.2005.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry</span></div><div class="casAuthors">Brockman, Mark A.; Tanzi, Giancarlo O.; Walker, Bruce D.; Allen, Todd M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">134-142</span>CODEN:
                <span class="NLM_cas:coden">JVMEDH</span>;
        ISSN:<span class="NLM_cas:issn">0166-0934</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The rate of HIV-1 disease progression correlates strongly with plasma viral load and is likely to be influenced by both host and viral determinants.  Though interest in the impact of viral replication capacity during HIV-1 infection has been increasing, esp. with respect to drug resistance mutations, its influence on disease course remains poorly understood.  This is due in part to significant drawbacks in conventional means of measuring HIV-1 growth in vitro (i.e. expense, inconvenience, and exptl. variability).  A FACS-based method is described here to measure HIV-1 replication sensitively and a modification of this method can be used to det. viral titer accurately.  Importantly, the target cells used are permissive to CXCR4- and CCR5-tropic HIV-1 strains.  In pilot expts., the growth kinetics of lab.-adapted strains NL4-3 and IIIB were examd. carefully.  Using this method, differences were obsd. in growth kinetics between three lab. strains and seven primary isolates, indicating the potential for a broad range of in vitro replication capacities among individual isolates.  In conclusion, this FACS-based method provides a sensitive approach to measure the replication capacity of HIV-1 and may prove useful in studies examg. the impact of viral fitness on disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxN2IocQ7gR7Vg90H21EOLACvtfcHk0lgibVUnX_Z5LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVShtA%253D%253D&md5=8f3863a9ffb1f75d6f080e68350f66b6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.jviromet.2005.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jviromet.2005.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DBrockman%26aufirst%3DM.%2BA.%26aulast%3DTanzi%26aufirst%3DG.%2BO.%26aulast%3DWalker%26aufirst%3DB.%2BD.%26aulast%3DAllen%26aufirst%3DT.%2BM.%26atitle%3DUse%2520of%2520a%2520novel%2520GFP%2520reporter%2520cell%2520line%2520to%2520examine%2520replication%2520capacity%2520of%2520CXCR4-%2520and%2520CCR5-tropic%2520HIV-1%2520by%2520flow%2520cytometry%26jtitle%3DJ.%2520Virol.%2520Methods%26date%3D2006%26volume%3D131%26spage%3D134%26epage%3D142%26doi%3D10.1016%2Fj.jviromet.2005.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Guillier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nivoliers, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queguiner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneikus, V.</span><span> </span><span class="NLM_article-title">Combined metalation-palladium-catalyzed cross coupling strategies. A formal synthesis of the marine alkaloid amphimedine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1021/jo00107a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00107a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=292-296&author=F.+Guillierauthor=F.+Nivoliersauthor=A.+Godardauthor=F.+Marsaisauthor=G.+Queguinerauthor=M.+A.+Siddiquiauthor=V.+Sneikus&title=Combined+metalation-palladium-catalyzed+cross+coupling+strategies.+A+formal+synthesis+of+the+marine+alkaloid+amphimedine&doi=10.1021%2Fjo00107a004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Fjo00107a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00107a004%26sid%3Dliteratum%253Aachs%26aulast%3DGuillier%26aufirst%3DF.%26aulast%3DNivoliers%26aufirst%3DF.%26aulast%3DGodard%26aufirst%3DA.%26aulast%3DMarsais%26aufirst%3DF.%26aulast%3DQueguiner%26aufirst%3DG.%26aulast%3DSiddiqui%26aufirst%3DM.%2BA.%26aulast%3DSneikus%26aufirst%3DV.%26atitle%3DCombined%2520metalation-palladium-catalyzed%2520cross%2520coupling%2520strategies.%2520A%2520formal%2520synthesis%2520of%2520the%2520marine%2520alkaloid%2520amphimedine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D292%26epage%3D296%26doi%3D10.1021%2Fjo00107a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Marsais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trecourt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queguiner, G.</span><span> </span><span class="NLM_article-title">Directed lithiation of 4-halopyridines: chemoselectivity, regioselectivity, and application to synthesis</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1002/jhet.5570250112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1002%2Fjhet.5570250112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1988&pages=81-87&author=F.+Marsaisauthor=F.+Trecourtauthor=P.+Breantauthor=G.+Queguiner&title=Directed+lithiation+of+4-halopyridines%3A+chemoselectivity%2C+regioselectivity%2C+and+application+to+synthesis&doi=10.1002%2Fjhet.5570250112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570250112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570250112%26sid%3Dliteratum%253Aachs%26aulast%3DMarsais%26aufirst%3DF.%26aulast%3DTrecourt%26aufirst%3DF.%26aulast%3DBreant%26aufirst%3DP.%26aulast%3DQueguiner%26aufirst%3DG.%26atitle%3DDirected%2520lithiation%2520of%25204-halopyridines%253A%2520chemoselectivity%252C%2520regioselectivity%252C%2520and%2520application%2520to%2520synthesis%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1988%26volume%3D25%26spage%3D81%26epage%3D87%26doi%3D10.1002%2Fjhet.5570250112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Ross, W. C. J.</span><span> </span><span class="NLM_article-title">The preparation of some 4-substituted nicotinic acids and nicotinamide<i>s</i></span> <span class="citation_source-journal">J. Chem. Soc. C</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_fpage">1816</span><span class="NLM_x">–</span> <span class="NLM_lpage">1821</span><span class="refDoi"> DOI: 10.1039/j39660001816</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1039%2Fj39660001816" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADyaF28XkvF2htr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1966&pages=1816-1821&author=W.+C.+J.+Ross&title=The+preparation+of+some+4-substituted+nicotinic+acids+and+nicotinamides&doi=10.1039%2Fj39660001816"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of some 4-substituted nicotinic acids and nicotinamides</span></div><div class="casAuthors">Ross, W. C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society [Section] C:  Organic</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1816-21</span>CODEN:
                <span class="NLM_cas:coden">JSOOAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-4952</span>.
    </div><div class="casAbstract">Nicotinamide adenine dinucleotide (NAD) analogs in which the 4-position of the pyridine ring carries a substituent are potential inhibitors of the glycolytic process by which many cancer cells derive an appreciable proportion of their energy requirements.  Such analogs should be produced in vivo by the administration of 4-substituted nicotinic acid derivs.  The prepn. of the following derivs. is described: 4-hydroxy-, 4-methoxy-, 4-butoxy-, 4-(2-hydroxyethylthio)-, 4-S-cysteinyl-, 4-amino-, 4-anilino-, and 4-benzylamino-nicotinic acids and -nicotinamides.  4-Ethoxy- and 4-(2-bromoethylthio)nicotinic acids and 4-benzylthionicotinamide were also obtained.  A preliminary report on the biol. activity of some of the derivs, is given.  17 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZvCDb5NWqbbVg90H21EOLACvtfcHk0lg_1-fJvTFBOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28XkvF2htr0%253D&md5=232589877c794de9c7b09a8f225a9082</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fj39660001816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fj39660001816%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DW.%2BC.%2BJ.%26atitle%3DThe%2520preparation%2520of%2520some%25204-substituted%2520nicotinic%2520acids%2520and%2520nicotinamides%26jtitle%3DJ.%2520Chem.%2520Soc.%2520C%26date%3D1966%26spage%3D1816%26epage%3D1821%26doi%3D10.1039%2Fj39660001816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Beak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeigler, J. M.</span><span> </span><span class="NLM_article-title">Self-association and the protomeric equilibria of 4-hydroxypyridine - 4-pyridone and related compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1021/jo00395a047</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00395a047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=177-178&author=P.+Beakauthor=J.+B.+Covingtonauthor=J.+M.+Zeigler&title=Self-association+and+the+protomeric+equilibria+of+4-hydroxypyridine+-+4-pyridone+and+related+compounds&doi=10.1021%2Fjo00395a047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo00395a047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00395a047%26sid%3Dliteratum%253Aachs%26aulast%3DBeak%26aufirst%3DP.%26aulast%3DCovington%26aufirst%3DJ.%2BB.%26aulast%3DZeigler%26aufirst%3DJ.%2BM.%26atitle%3DSelf-association%2520and%2520the%2520protomeric%2520equilibria%2520of%25204-hydroxypyridine%2520-%25204-pyridone%2520and%2520related%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1978%26volume%3D43%26spage%3D177%26epage%3D178%26doi%3D10.1021%2Fjo00395a047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bernofsky, C.</span><span> </span><span class="NLM_article-title">New synthesis of the 4- and 6-pyridones of 1-methylnicotinamide and 1-methylnicotinic acid (trigonelline)</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span><span class="refDoi"> DOI: 10.1016/0003-2697(79)90572-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1016%2F0003-2697%2879%2990572-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1979&pages=189-200&author=C.+Bernofsky&title=New+synthesis+of+the+4-+and+6-pyridones+of+1-methylnicotinamide+and+1-methylnicotinic+acid+%28trigonelline%29&doi=10.1016%2F0003-2697%2879%2990572-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2879%2990572-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252879%252990572-4%26sid%3Dliteratum%253Aachs%26aulast%3DBernofsky%26aufirst%3DC.%26atitle%3DNew%2520synthesis%2520of%2520the%25204-%2520and%25206-pyridones%2520of%25201-methylnicotinamide%2520and%25201-methylnicotinic%2520acid%2520%2528trigonelline%2529%26jtitle%3DAnal.%2520Biochem.%26date%3D1979%26volume%3D96%26spage%3D189%26epage%3D200%26doi%3D10.1016%2F0003-2697%2879%2990572-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Di Marco, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferlan, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bombi, G. G.</span><span> </span><span class="NLM_article-title">Methyl-hydroxypyridinecarboxylic acids as possible bidentate chelating agents for aluminium(III): synthesis and metal-ligand solution chemistry</span> <span class="citation_source-journal">Eur. J. Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">1284</span><span class="NLM_x">–</span> <span class="NLM_lpage">1293</span><span class="refDoi"> DOI: 10.1002/ejic.200500986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1002%2Fejic.200500986" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=1284-1293&author=V.+B.+Di+Marcoauthor=A.+Deanauthor=M.+G.+Ferlanauthor=R.+A.+Yokelauthor=H.+Liauthor=A.+Venzoauthor=G.+G.+Bombi&title=Methyl-hydroxypyridinecarboxylic+acids+as+possible+bidentate+chelating+agents+for+aluminium%28III%29%3A+synthesis+and+metal-ligand+solution+chemistry&doi=10.1002%2Fejic.200500986"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1002%2Fejic.200500986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.200500986%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarco%26aufirst%3DV.%2BB.%26aulast%3DDean%26aufirst%3DA.%26aulast%3DFerlan%26aufirst%3DM.%2BG.%26aulast%3DYokel%26aufirst%3DR.%2BA.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DVenzo%26aufirst%3DA.%26aulast%3DBombi%26aufirst%3DG.%2BG.%26atitle%3DMethyl-hydroxypyridinecarboxylic%2520acids%2520as%2520possible%2520bidentate%2520chelating%2520agents%2520for%2520aluminium%2528III%2529%253A%2520synthesis%2520and%2520metal-ligand%2520solution%2520chemistry%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2006%26volume%3D2006%26spage%3D1284%26epage%3D1293%26doi%3D10.1002%2Fejic.200500986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Wallace, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarski, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otten, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorami, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woessner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, K.</span><span> </span><span class="NLM_article-title">Potent and selective mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors. 1. 4-(bromo-2-fluorophenylamino)-1-methylpyridin-2(1<i>H</i>)-ones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1021/jm050834y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050834y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=441-444&author=E.+M.+Wallaceauthor=J.+Lyssikatosauthor=J.+F.+Blakeauthor=J.+Seoauthor=H.+W.+Yangauthor=T.+C.+Yehauthor=M.+Perrierauthor=H.+Jarskiauthor=V.+Marshauthor=G.+Pochauthor=M.+G.+Livingstonauthor=J.+Ottenauthor=G.+Hingoramiauthor=R.+Woessnerauthor=P.+Leeauthor=J.+Winklerauthor=K.+Koch&title=Potent+and+selective+mitogen-activated+protein+kinase+kinase+%28MEK%29+1%2C2+inhibitors.+1.+4-%28bromo-2-fluorophenylamino%29-1-methylpyridin-2%281H%29-ones&doi=10.1021%2Fjm050834y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm050834y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050834y%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DE.%2BM.%26aulast%3DLyssikatos%26aufirst%3DJ.%26aulast%3DBlake%26aufirst%3DJ.%2BF.%26aulast%3DSeo%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DH.%2BW.%26aulast%3DYeh%26aufirst%3DT.%2BC.%26aulast%3DPerrier%26aufirst%3DM.%26aulast%3DJarski%26aufirst%3DH.%26aulast%3DMarsh%26aufirst%3DV.%26aulast%3DPoch%26aufirst%3DG.%26aulast%3DLivingston%26aufirst%3DM.%2BG.%26aulast%3DOtten%26aufirst%3DJ.%26aulast%3DHingorami%26aufirst%3DG.%26aulast%3DWoessner%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DWinkler%26aufirst%3DJ.%26aulast%3DKoch%26aufirst%3DK.%26atitle%3DPotent%2520and%2520selective%2520mitogen-activated%2520protein%2520kinase%2520kinase%2520%2528MEK%2529%25201%252C2%2520inhibitors.%25201.%25204-%2528bromo-2-fluorophenylamino%2529-1-methylpyridin-2%25281H%2529-ones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D441%26epage%3D444%26doi%3D10.1021%2Fjm050834y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Saag, M. S.</span><span> </span><span class="NLM_article-title">Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">126</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><span class="refDoi"> DOI: 10.1086/498348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1086%2F498348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=16323102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsValsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=126-131&author=M.+S.+Saag&title=Emtricitabine%2C+a+new+antiretroviral+agent+with+activity+against+HIV+and+hepatitis+B+virus&doi=10.1086%2F498348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus</span></div><div class="casAuthors">Saag, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-131</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  Emtricitabine (FTC) is a new nucleoside agent that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus.  It is very similar to lamivudine (3TC) with respect to its activity, convenience, and safety and resistance profile.  Indeed, with the exception of the longer intracellular half-life of triphosphate FTC, there is little to distinguish between the 2 drugs.  Clin. trials comparing FTC with 3TC as part of a triple-drug regimen have demonstrated their equivalence, whereas a study comparing activity of FTC with that of stavudine demonstrated FTC's superiority.  In clin. practice, the choice of 3TC vs. FTC will most likely be made in the context of drugs coformulated with them.  Although FTC is not formally approved for use in patients coinfected with HIV and hepatitis B virus, it is often a preferred choice for such patients when combined with tenofovir, which also has anti-hepatitis B virus activity.  Recent treatment guidelines for the treatment of HIV infection by both the International AIDS Society-USA and US Department of Health and Human Services have placed FTC in combination with tenofovir, didanosine, or zidovudine in the preferred category of nucleoside backbone regimens for patients receiving antiretroviral therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvgFcWq9cy_rVg90H21EOLACvtfcHk0ljxlotuviPT6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsValsw%253D%253D&md5=8c629c051a97702611a846e044b6b6fc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1086%2F498348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F498348%26sid%3Dliteratum%253Aachs%26aulast%3DSaag%26aufirst%3DM.%2BS.%26atitle%3DEmtricitabine%252C%2520a%2520new%2520antiretroviral%2520agent%2520with%2520activity%2520against%2520HIV%2520and%2520hepatitis%2520B%2520virus%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2006%26volume%3D42%26spage%3D126%26epage%3D131%26doi%3D10.1086%2F498348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Wensing, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Günthard, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paredes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, D. D.</span><span> </span><span class="NLM_article-title">Update of the drug resistance mutations in HIV-1</span> <span class="citation_source-journal">Top. Antivir Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=25101529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A280%3ADC%252BC2cbpslyqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=642-650&author=A.+M.+Wensingauthor=V.+Calvezauthor=H.+F.+G%C3%BCnthardauthor=V.+A.+Johnsonauthor=R.+Paredesauthor=D.+Pillayauthor=R.+W.+Shaferauthor=D.+D.+Richman&title=Update+of+the+drug+resistance+mutations+in+HIV-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">2014 Update of the drug resistance mutations in HIV-1</span></div><div class="casAuthors">Wensing Annemarie M; Calvez Vincent; Gunthard Huldrych F; Johnson Victoria A; Paredes Roger; Pillay Deenan; Shafer Robert W; Richman Douglas D</div><div class="citationInfo"><span class="NLM_cas:title">Topics in antiviral medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">642-50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This July 2014 edition of the IAS-USA drug resistance mutations list updates the figures last published in March 2013.  The following mutations have been added to existing classes or drugs: K65E/N has been added to the bars for the nucleoside and nucleotide analogue reverse transcriptase inhibitors (nRTIs) abacavir, didanosine, emtricitabine, lamivudine, stavudine, and tenofovir; L100I has been added to the bar for the nonnucleoside analogue reverse transcriptase inhibitor (NNRTI) rilpivirine; and F121Y has been added to the bars for the integrase strand transfer inhibitors (InSTIs) dolutegravir, elvitegravir, and raltegravir.  With regard to protease inhibitors (PIs), it cannot be excluded that drug resistance may be selected for outside the protease encoding region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfGd8CCEOs1JagfuraLLzSfW6udTcc2eb_K3U7hLYxtrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbpslyqtQ%253D%253D&md5=f2df041240b12acaa476c6f2a16be2b0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWensing%26aufirst%3DA.%2BM.%26aulast%3DCalvez%26aufirst%3DV.%26aulast%3DG%25C3%25BCnthard%26aufirst%3DH.%2BF.%26aulast%3DJohnson%26aufirst%3DV.%2BA.%26aulast%3DParedes%26aufirst%3DR.%26aulast%3DPillay%26aufirst%3DD.%26aulast%3DShafer%26aufirst%3DR.%2BW.%26aulast%3DRichman%26aufirst%3DD.%2BD.%26atitle%3DUpdate%2520of%2520the%2520drug%2520resistance%2520mutations%2520in%2520HIV-1%26jtitle%3DTop.%2520Antivir%2520Med.%26date%3D2014%26volume%3D22%26spage%3D642%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span>Major HIV-1 drug resistance mutations updated March 9, 2015. <span class="NLM_publisher-name">Stanford University</span>; <a href="http://hivdb.stanford.edu/pages/download/resistanceMutations_handout.pdf" class="extLink">http://hivdb.stanford.edu/pages/download/resistanceMutations_handout.pdf</a> (accessed December 1,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Major+HIV-1+drug+resistance+mutations+updated+March+9%2C+2015.+Stanford+University%3B+http%3A%2F%2Fhivdb.stanford.edu%2Fpages%2Fdownload%2FresistanceMutations_handout.pdf+%28accessed+December+1%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26pub%3DStanford%2520University%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Abram, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hluhanich, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreatta, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margot, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedziela-Majka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novikov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svarovskaia, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McColl, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span> </span><span class="NLM_article-title">Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2654</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1128/AAC.02568-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1128%2FAAC.02568-12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=2654-63&author=M.+E.+Abramauthor=R.+M.+Hluhanichauthor=D.+D.+Goodmanauthor=K.+N.+Andreattaauthor=N.+A.+Margotauthor=L.+Yeauthor=A.+Niedziela-Majkaauthor=T.+L.+Barnesauthor=N.+Novikovauthor=X.+Chenauthor=E.+S.+Svarovskaiaauthor=D.+J.+McCollauthor=K.+L.+Whiteauthor=M.+D.+Miller&title=Impact+of+primary+elvitegravir+resistance-associated+mutations+in+HIV-1+integrase+on+drug+susceptibility+and+viral+replication+fitness&doi=10.1128%2FAAC.02568-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FAAC.02568-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02568-12%26sid%3Dliteratum%253Aachs%26aulast%3DAbram%26aufirst%3DM.%2BE.%26aulast%3DHluhanich%26aufirst%3DR.%2BM.%26aulast%3DGoodman%26aufirst%3DD.%2BD.%26aulast%3DAndreatta%26aufirst%3DK.%2BN.%26aulast%3DMargot%26aufirst%3DN.%2BA.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DNiedziela-Majka%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DT.%2BL.%26aulast%3DNovikov%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSvarovskaia%26aufirst%3DE.%2BS.%26aulast%3DMcColl%26aufirst%3DD.%2BJ.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26atitle%3DImpact%2520of%2520primary%2520elvitegravir%2520resistance-associated%2520mutations%2520in%2520HIV-1%2520integrase%2520on%2520drug%2520susceptibility%2520and%2520viral%2520replication%2520fitness%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D2654%26epage%3D63%26doi%3D10.1128%2FAAC.02568-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Underwood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">The activity of the integrase inhibitor dolutegravir against HIV-1 variants isolated from raltegravir-treated adults</span> <span class="citation_source-journal">JAIDS, J. Acquired Immune Defic. Syndr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span><span class="refDoi"> DOI: 10.1097/QAI.0b013e31826bfd02</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1097%2FQAI.0b013e31826bfd02" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=22878423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOltLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=297-301&author=M.+R.+Underwoodauthor=B.+A.+Johnsauthor=A.+Satoauthor=J.+N.+Martinauthor=S.+G.+Deeksauthor=T.+Fujiwara&title=The+activity+of+the+integrase+inhibitor+dolutegravir+against+HIV-1+variants+isolated+from+raltegravir-treated+adults&doi=10.1097%2FQAI.0b013e31826bfd02"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The Activity of the Integrase Inhibitor Dolutegravir Against HIV-1 Variants Isolated From Raltegravir-Treated Adults</span></div><div class="casAuthors">Underwood, Mark R.; Johns, Brian A.; Sato, Akihiko; Martin, Jeffrey N.; Deeks, Steven G.; Fujiwara, Tamio</div><div class="citationInfo"><span class="NLM_cas:title">JAIDS, Journal of Acquired Immune Deficiency Syndromes</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-301</span>CODEN:
                <span class="NLM_cas:coden">JJASFJ</span>;
        ISSN:<span class="NLM_cas:issn">1525-4135</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background: Dolutegravir (DTG, S/GSK1349572) is an integrase inhibitor with low nanomolar potency.  Susceptibility to dolutegravir and raltegravir was detd. for raltegravir-resistant clin. isolates.  Methods: Genotypic and phenotypic susceptibility to integrase inhibitors was examd. using 39 clin. isolate samples obtained from 18 adults who had exhibited incomplete viral suppression on a raltegravir-based regimen.  Results: Of 39 samples evaluated, 30 had genotypic and phenotypic resistance to raltegravir.  All samples lacking raltegravir resistance retained complete susceptibility to dolutegravir.  Of the 30 samples with genotypic evidence of raltegravir resistance, the median level of phenotypic resistance to raltegravir was high (median fold change in inhibitory concn. at 50%, >81; range, 3.7 to >87), while the level of resistance to dolutegravir was close to that of wild-type variants (median fold change, 1.5; range, 0.9-19.0).  Longitudinal samples from 5 subjects collected during long-term failure of raltegravir revealed time-dependent general decreases in phenotypic susceptibility to raltegravir, with minimal changes in phenotypic susceptibility to dolutegravir.  The median fold change to dolutegravir for isolates contg. changes at G140S + Q148H, G140S + Q148R, T97A + Y143R, and N155H (thus including raltegravir signature resistance codons) were 3.75, 13.3, 1.05, and 1.37, resp.  Conclusions: Dolutegravir retained in vitro activity against clin. isolates obtained from subjects who failed raltegravir-based therapy at near wild-type levels for variants contg. the Y143 and N155 resistance mutations.  Isolates with Q148 plus addnl. integrase mutations possessed a broader range of and more reduced susceptibility to dolutegravir.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy9wwfQcHmibVg90H21EOLACvtfcHk0lgb1ESkhh3YdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOltLbI&md5=3e41a79982103a73fd87db812f8faf73</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1097%2FQAI.0b013e31826bfd02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAI.0b013e31826bfd02%26sid%3Dliteratum%253Aachs%26aulast%3DUnderwood%26aufirst%3DM.%2BR.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DJ.%2BN.%26aulast%3DDeeks%26aufirst%3DS.%2BG.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DThe%2520activity%2520of%2520the%2520integrase%2520inhibitor%2520dolutegravir%2520against%2520HIV-1%2520variants%2520isolated%2520from%2520raltegravir-treated%2520adults%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2012%26volume%3D61%26spage%3D297%26epage%3D301%26doi%3D10.1097%2FQAI.0b013e31826bfd02" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Delobel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saliou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiseau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coassin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Requena, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massip, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izopet, J.</span><span> </span><span class="NLM_article-title">Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2506</span><span class="NLM_x">–</span> <span class="NLM_lpage">2514</span><span class="refDoi"> DOI: 10.1093/jac/dkt249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.1093%2Fjac%2Fdkt249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=23794603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CmtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=2506-2514&author=P.+Delobelauthor=M.+Cazabatauthor=A.+Saliouauthor=C.+Loiseauauthor=L.+Coassinauthor=S.+Raymondauthor=M.+Requenaauthor=B.+Marchouauthor=P.+Massipauthor=J.+Izopet&title=Primary+resistance+of+CCR5-tropic+HIV-1+to+maraviroc+cannot+be+predicted+by+the+V3+sequence&doi=10.1093%2Fjac%2Fdkt249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence</span></div><div class="casAuthors">Delobel, Pierre; Cazabat, Michelle; Saliou, Adrien; Loiseau, Claire; Coassin, Lucile; Raymond, Stephanie; Requena, Mary; Marchou, Bruno; Massip, Patrice; Izopet, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2506-2514</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives Resistance of HIV-1 to CCR5 antagonists can occur without coreceptor switching by mutations in envelope glycoproteins that enable virus entry using the inhibitor-bound form of CCR5.  We investigated whether mutations in the V3 region of HIV-1 from subjects naive to maraviroc could be assocd. with primary resistance to this drug.  Methods The frequency of CCR5-tropic HIV-1 subtype B isolates harboring putative V3 maraviroc resistance mutations was assessed among the HIV tropism database of Toulouse University Hospital, France.  Phenotypic assessment of maraviroc susceptibility was performed for 14 isolates representative of the main mutation patterns and 14 controls.  V3 mutations were reversed or introduced by site-directed mutagenesis.  Results Ninety-three of 951 (9.8%) isolates harbored V3 mutations assumed to be assocd. with maraviroc resistance.  Maraviroc completely blocked virus entry for all but 1 of the 14 isolates harbouring V3 mutations [IC50 8.6 nM; 95% CI (6.6-47.4)], as in the 14 control isolates [IC50 13.4 nM; 95% CI (7.7-50.3)] (P=0.24).  Primary resistance to maraviroc, with a plateau in entry inhibition, was found in one isolate (harbouring a 20F/21I genotype).  Site-directed mutagenesis showed that V3 mutations are necessary but not sufficient to induce maraviroc resistance.  Conclusions The impact of V3 mutations depended on the env context in which they occurred.  Simple assessment of the V3 genotype thus cannot accurately predict maraviroc resistance.  Rather, phenotypic assessment of virus particles expressing the envelope glycoprotein as a whole is required.  This approach revealed that primary resistance of CCR5-tropic HIV-1 subtype B isolates to maraviroc seems uncommon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSrjBUW38XKrVg90H21EOLACvtfcHk0lgb1ESkhh3YdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CmtbbP&md5=b1a2ea3b38c79127a5b5e9a22c949c10</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt249%26sid%3Dliteratum%253Aachs%26aulast%3DDelobel%26aufirst%3DP.%26aulast%3DCazabat%26aufirst%3DM.%26aulast%3DSaliou%26aufirst%3DA.%26aulast%3DLoiseau%26aufirst%3DC.%26aulast%3DCoassin%26aufirst%3DL.%26aulast%3DRaymond%26aufirst%3DS.%26aulast%3DRequena%26aufirst%3DM.%26aulast%3DMarchou%26aufirst%3DB.%26aulast%3DMassip%26aufirst%3DP.%26aulast%3DIzopet%26aufirst%3DJ.%26atitle%3DPrimary%2520resistance%2520of%2520CCR5-tropic%2520HIV-1%2520to%2520maraviroc%2520cannot%2520be%2520predicted%2520by%2520the%2520V3%2520sequence%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2013%26volume%3D68%26spage%3D2506%26epage%3D2514%26doi%3D10.1093%2Fjac%2Fdkt249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.2174/1389200054021799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnelauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups&doi=10.2174%2F1389200054021799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0liRWEQk7EkHGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnel%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225%26doi%3D10.2174%2F1389200054021799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Shkreta, L.; Blanchette, M.; Toutant, J.; Wilhem, E.; Bell, B.; Cochrane, A.; Harrigan, P. R.; Cheung, P. K.; Grierson, D. S.; Chabot, B.</span> submitted for publication.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Shkreta%2C+L.%3B+Blanchette%2C+M.%3B+Toutant%2C+J.%3B+Wilhem%2C+E.%3B+Bell%2C+B.%3B+Cochrane%2C+A.%3B+Harrigan%2C+P.+R.%3B+Cheung%2C+P.+K.%3B+Grierson%2C+D.+S.%3B+Chabot%2C+B.+submitted+for+publication."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DShkreta%26aufirst%3DL." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i25"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01357">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81283"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01357">10.1021/acs.jmedchem.5b01357</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Composition of the 256-membered library of compound <b>1</b> “mimics” (<a class="ref internalNav" href="#tbl1">Table 1</a>), plus bar graph presentation of the preliminary anti-HIV screening results (<a class="ref internalNav" href="#fig1">Figure 1</a>a–d), and NMR (<sup>1</sup>H and <sup>13</sup>C) and high-resolution mass spectral data for the active compounds <b>9</b>–<b>12</b> and synthetic intermediates <b>15</b>–<b>21</b> described in the <a class="ref internalNav" href="#sec4">Experimental Section</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01357/suppl_file/jm5b01357_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES string for all compounds prepared (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01357/suppl_file/jm5b01357_si_002.xls">XLS</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01357/suppl_file/jm5b01357_si_001.pdf">jm5b01357_si_001.pdf (5.33 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01357/suppl_file/jm5b01357_si_002.xls">jm5b01357_si_002.xls (26.5 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01357&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01357%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01357" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799adbcdbe53d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
